[
	{
		"organisation": [
			"Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)"
		],
		"location": [
			"Bonn",
			"Bonn Beuel",
			"Bonn Hardtberg"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [
			"https://doi.org/10.1101/2020.08.24.20181206",
			"https://doi.org/10.1038/s41467-021-22351-5"
		],
		"title": "Rheinland Corona Studie",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Bonn Beuel, Bonn Hardtberg and surrounding areas",
		"organisation_raw": "Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)",
		"information_url": "https://www.rheinland-studie.de/die-studie/die-corona-studie.html",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Participants already included in the Rhineland-Study",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 30,
		"sample_design": "Cohort-sample - Sampling from existing cohort study in the general population",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 4755,
		"sample_size_rounded": 4800,
		"start_date": "2020-04-24",
		"end_date": "2020-06-30",
		"results_seroprevalence_information": "Adjusted antibody-prevalence among participants of the Rheinland-Corona-study",
		"results_publication_url": "https://doi.org/10.1038/s41467-021-22351-5",
		"results_publication_date": "2021-04-09",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Not adjusted",
		"results_seroprevalence_sensitivity": 0.868,
		"results_seroprevalence_specificity": 1,
		"results_seroprevalence_positive": 0.0097,
		"results_seroprevalence_positive_95pct_lower": 0.0072,
		"results_seroprevalence_positive_95pct_upper": 0.013,
		"record_created": "2021-11-01",
		"record_modified": "2021-09-18",
		"results_underreporting": 4.2
	},
	{
		"organisation": [
			"Universitätsklinikum Bonn, Institut für Virologie",
			"Universitätsklinikum Bonn"
		],
		"location": [
			"Gangelt"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [
			"https://doi.org/10.1101/2020.05.04.20090076",
			"https://doi.org/10.1038/s41467-020-19509-y",
			"https://doi.org/10.1101/2022.01.26.22269805"
		],
		"title": "COVID-19 Case-Cluster-Study",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Gangelt",
		"organisation_raw": "Institut für Virologie, Universitätsklinikum Bonn",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021306",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Gangelt and their household members",
		"scope_population": "General population",
		"scope_age": "Multiple",
		"age_max": 90,
		"age_min": 1,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 919,
		"sample_size_rounded": 900,
		"start_date": "2020-03-31",
		"end_date": "2020-04-06",
		"results_seroprevalence_information": "Seroprevalence of Gangelts` citizen",
		"results_publication_url": "https://doi.org/10.1038/s41467-020-19509-y",
		"results_publication_date": "2020-11-17",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_sensitivity": 0.909,
		"results_seroprevalence_specificity": 0.991,
		"results_seroprevalence_positive": 0.141,
		"results_seroprevalence_positive_95pct_lower": 0.112,
		"results_seroprevalence_positive_95pct_upper": 0.173,
		"record_created": "2021-07-30",
		"record_modified": "2021-10-28",
		"results_underreporting": 5
	},
	{
		"organisation": [
			"Universitätsklinikum Bonn, Institut für Virologie",
			"Universitätsklinikum Bonn"
		],
		"location": [
			"Gangelt"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN",
			"ROCHE N"
		],
		"resource_url": [],
		"title": "COVID-19 Case-Cluster-Study",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Gangelt",
		"organisation_raw": "Institut für Virologie, Universitätsklinikum Bonn",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021306",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Gangelt and their household members",
		"scope_population": "General population",
		"scope_age": "Multiple",
		"age_max": 90,
		"age_min": 1,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 587,
		"sample_size_rounded": 600,
		"start_date": "2020-10-01",
		"end_date": "2020-10-31",
		"results_seroprevalence_information": "Seroprevalence of Gangelts` citizen for October 2020",
		"results_publication_url": "https://doi.org/10.1101/2022.01.26.22269805",
		"results_publication_date": "2022-01-28",
		"results_publication_type": "Preprint",
		"analysis_data_source": "whole blood",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN; ROCHE N",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity",
		"results_seroprevalence_sensitivity": 0.909,
		"results_seroprevalence_specificity": 0.991,
		"results_seroprevalence_positive": 0.181,
		"results_seroprevalence_positive_95pct_lower": 0.137,
		"results_seroprevalence_positive_95pct_upper": 0.23,
		"record_created": "2022-02-15",
		"record_modified": "2022-02-15"
	},
	{
		"organisation": [
			"Universitätsklinikum Bonn, Institut für Virologie",
			"Universitätsklinikum Bonn"
		],
		"location": [
			"Gangelt"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN",
			"ROCHE N"
		],
		"resource_url": [],
		"title": "COVID-19 Case-Cluster-Study",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Gangelt",
		"organisation_raw": "Institut für Virologie, Universitätsklinikum Bonn",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021306",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Gangelt and their household members",
		"scope_population": "General population",
		"scope_age": "Multiple",
		"age_max": 90,
		"age_min": 1,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 488,
		"sample_size_rounded": 500,
		"start_date": "2021-01-01",
		"end_date": "2021-01-31",
		"results_seroprevalence_information": "Seroprevalence of Gangelts` citizen for January 2021",
		"results_publication_url": "https://doi.org/10.1101/2022.01.26.22269805",
		"results_publication_date": "2022-01-28",
		"results_publication_type": "Preprint",
		"analysis_data_source": "whole blood",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN; ROCHE N",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity",
		"results_seroprevalence_sensitivity": 0.909,
		"results_seroprevalence_specificity": 0.991,
		"results_seroprevalence_positive": 0.21,
		"results_seroprevalence_positive_95pct_lower": 0.162,
		"results_seroprevalence_positive_95pct_upper": 0.261,
		"record_created": "2022-02-15",
		"record_modified": "2022-02-15"
	},
	{
		"organisation": [
			"Universitätsklinikum Bonn, Institut für Virologie",
			"Universitätsklinikum Bonn"
		],
		"location": [
			"Gangelt"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN",
			"ROCHE N"
		],
		"resource_url": [],
		"title": "COVID-19 Case-Cluster-Study",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Gangelt",
		"organisation_raw": "Institut für Virologie, Universitätsklinikum Bonn",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021306",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Gangelt and their household members",
		"scope_population": "General population",
		"scope_age": "Multiple",
		"age_max": 90,
		"age_min": 1,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 406,
		"sample_size_rounded": 400,
		"start_date": "2021-04-01",
		"end_date": "2021-04-30",
		"results_seroprevalence_information": "Seroprevalence of Gangelts` citizen for April 2021",
		"results_publication_url": "https://doi.org/10.1101/2022.01.26.22269805",
		"results_publication_date": "2022-01-28",
		"results_publication_type": "Preprint",
		"analysis_data_source": "whole blood",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN; ROCHE N",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity",
		"results_seroprevalence_sensitivity": 0.909,
		"results_seroprevalence_specificity": 0.991,
		"results_seroprevalence_positive": 0.359,
		"results_seroprevalence_positive_95pct_lower": 0.3,
		"results_seroprevalence_positive_95pct_upper": 0.42,
		"record_created": "2022-02-15",
		"record_modified": "2022-02-15"
	},
	{
		"organisation": [
			"Ludwig-Maximilians-Universität (LMU) München",
			"Helmholtz Zentrum München",
			"Tropeninstitut der Ludwig-Maximilians-Universität (LMU) München"
		],
		"location": [
			"Munich"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1186/s12889-020-09164-9",
			"https://doi.org/10.3390/ijerph18073572",
			"https://doi.org/10.1186/s12879-021-06589-4",
			"http://www.klinikum.uni-muenchen.de/Abteilung-fuer-Infektions-und-Tropenmedizin/download/de/KoCo19/Runde-4/KoCo19_Zusammenfassung_Runde4.pdf"
		],
		"title": "Prospective Covid-19 cohort study Munich (KoCo19)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Munich",
		"organisation_raw": "Tropeninstitut der Ludwig-Maximilians-Universität (LMU) München; Helmholtz Zentrum München",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021698",
		"information_url": "www.koco19.de",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Munich households",
		"scope_population": "General population",
		"scope_age": "Multiple",
		"age_min": 14,
		"sample_design": "Random sampling (not central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 5313,
		"sample_size_rounded": 5300,
		"start_date": "2020-04-05",
		"end_date": "2020-06-12"
	},
	{
		"organisation": [
			"Ludwig-Maximilians-Universität (LMU) München",
			"Helmholtz Zentrum München",
			"Tropeninstitut der Ludwig-Maximilians-Universität (LMU) München"
		],
		"location": [
			"Munich"
		],
		"analysis_test_manufacturer": [
			"ROCHE N"
		],
		"resource_url": [],
		"title": "Prospektive Covid-19 Kohorte München (KoCo19)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Munich",
		"organisation_raw": "Tropeninstitut der Ludwig-Maximilians-Universität (LMU) München; Helmholtz Zentrum München",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021698",
		"information_url": "www.koco19.de",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Munich households",
		"scope_population": "General population",
		"scope_age": "Multiple",
		"age_min": 14,
		"sample_design": "Random sampling (not central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 5313,
		"sample_size_rounded": 5300,
		"start_date": "2020-04-05",
		"end_date": "2020-06-12",
		"results_seroprevalence_information": "Seroprevalence from the first wave of the survey in Munich households.",
		"results_publication_url": "https://doi.org/10.3390/ijerph18073572",
		"results_publication_date": "2021-03-30",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti Nucleocapsid",
		"analysis_isotype": "Total antibody",
		"analysis_test": "Elektrochemolumineszenz (ECL)-Immunassay; LIPS",
		"analysis_test_manufacturer_raw": "ROCHE N",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_sensitivity": 0.886,
		"results_seroprevalence_specificity": 0.997,
		"results_seroprevalence_positive": 0.018,
		"results_seroprevalence_positive_95pct_lower": 0.013,
		"results_seroprevalence_positive_95pct_upper": 0.024,
		"record_created": "2021-08-11",
		"record_modified": "2021-10-11",
		"results_underreporting": 4
	},
	{
		"organisation": [
			"Ludwig-Maximilians-Universität (LMU) München",
			"Helmholtz Zentrum München",
			"Tropeninstitut der Ludwig-Maximilians-Universität (LMU) München"
		],
		"location": [
			"Munich"
		],
		"analysis_test_manufacturer": [
			"ROCHE N"
		],
		"resource_url": [],
		"title": "Prospektive Covid-19 Kohorte München (KoCo19)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Munich",
		"organisation_raw": "Tropeninstitut der LMU und Helmholtz Zentrum München",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021699",
		"information_url": "www.koco19.de",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Munich households",
		"scope_population": "General population",
		"scope_age": "Multiple",
		"age_min": 14,
		"sample_design": "Random sampling (not central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 4433,
		"sample_size_rounded": 4400,
		"start_date": "2020-11-02",
		"end_date": "2021-01-31",
		"results_seroprevalence_information": "Seroprevalence from the second wave of the survey in Munich households (infection-induced)",
		"results_publication_url": "https://doi.org/10.1186/s12879-021-06589-4",
		"results_publication_date": "2021-09-08",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "capillary blood",
		"analysis_target": "anti Nucleocapsid",
		"analysis_isotype": "Total antibody",
		"analysis_test": "Elektrochemolumineszenz (ECL)-Immunassay; LIPS",
		"analysis_test_manufacturer_raw": "ROCHE N",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_sensitivity": 0.992,
		"results_seroprevalence_specificity": 0.987,
		"results_seroprevalence_positive": 0.036,
		"results_seroprevalence_positive_95pct_lower": 0.029,
		"results_seroprevalence_positive_95pct_upper": 0.043,
		"record_modified": "2021-10-29",
		"results_underreporting": 2
	},
	{
		"organisation": [
			"Ludwig-Maximilians-Universität (LMU) München",
			"Helmholtz Zentrum München",
			"Tropeninstitut der Ludwig-Maximilians-Universität (LMU) München"
		],
		"location": [
			"Munich"
		],
		"analysis_test_manufacturer": [
			"ROCHE N"
		],
		"resource_url": [],
		"title": "Prospektive Covid-19 Kohorte München (KoCo19)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Munich",
		"organisation_raw": "Tropeninstitut der Ludwig-Maximilians-Universität (LMU) München; Helmholtz Zentrum München",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021698",
		"information_url": "www.koco19.de",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Munich households",
		"scope_population": "General population",
		"scope_age": "Multiple",
		"age_min": 14,
		"sample_design": "Random sampling (not central registration-based)",
		"sample_analysis_unit": "Participants",
		"start_date": "2021-03-15",
		"end_date": "2021-04-15",
		"results_seroprevalence_information": "Seroprevalence from the third wave of the survey in Munich households (infection-induced)",
		"results_publication_url": "http://www.klinikum.uni-muenchen.de/Abteilung-fuer-Infektions-und-Tropenmedizin/de/COVID-19/KoCo19/index.html",
		"results_publication_date": "2021-07-19",
		"results_publication_type": "Institutional report",
		"analysis_data_source": "capillary blood",
		"analysis_target": "anti Nucleocapsid",
		"analysis_isotype": "Total antibody",
		"analysis_test": "Elektrochemolumineszenz (ECL)-Immunassay; LIPS",
		"analysis_test_manufacturer_raw": "ROCHE N",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_positive": 0.065,
		"record_created": "2021-08-11",
		"record_modified": "2021-10-29"
	},
	{
		"organisation": [
			"Ludwig-Maximilians-Universität (LMU) München",
			"Helmholtz Zentrum München",
			"Tropeninstitut der Ludwig-Maximilians-Universität (LMU) München"
		],
		"location": [
			"Munich"
		],
		"analysis_test_manufacturer": [
			"ROCHE N"
		],
		"resource_url": [],
		"title": "Prospektive Covid-19 Kohorte München (KoCo19)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Munich",
		"organisation_raw": "Tropeninstitut der Ludwig-Maximilians-Universität (LMU) München; Helmholtz Zentrum München",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021698",
		"information_url": "www.koco19.de",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Munich households",
		"scope_population": "General population",
		"scope_age": "Multiple",
		"age_min": 14,
		"sample_design": "Random sampling (not central registration-based)",
		"sample_analysis_unit": "Participants",
		"start_date": "2021-07-15",
		"end_date": "2021-10-15",
		"results_seroprevalence_information": "Seroprevalence from the fourth wave of the survey in Munich households (infection-induced)",
		"results_publication_url": "http://www.klinikum.uni-muenchen.de/Abteilung-fuer-Infektions-und-Tropenmedizin/download/de/KoCo19/Runde-4/KoCo19_Zusammenfassung_Runde4.pdf",
		"results_publication_date": "2021-10-28",
		"results_publication_type": "Institutional report",
		"analysis_data_source": "capillary blood",
		"analysis_target": "anti Nucleocapsid",
		"analysis_isotype": "Total antibody",
		"analysis_test": "Elektrochemolumineszenz (ECL)-Immunassay; LIPS",
		"analysis_test_manufacturer_raw": "ROCHE N",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_positive": 0.079,
		"record_created": "2021-11-03"
	},
	{
		"organisation": [
			"Technische Universität München",
			"Klinikum rechts der Isar"
		],
		"location": [
			"Munich"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1101/2020.10.04.20206136",
			"http://dx.doi.org/10.2139/ssrn.3678599",
			"https://doi.org/10.3201/eid2803.204436"
		],
		"title": "Prospektive Kohorten-Studie zur Ermittlung der Seroprävalenz für SARS-CoV2- Antikörper bei Mitarbeiterinnen und Mitarbeitern\r\nam Klinikum rechts der Isar der Technischen Universität München (SeCoMRI)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Munich",
		"organisation_raw": "Klinikum rechts der Isar der Technischen Universität (TU) München",
		"information_url": "https://www.mri.tum.de/news/grosse-mitarbeiter-studie-am-klinikum-rechts-der-isar-gestartet",
		"type": "Cross sectional",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Employees of the hospital Rechts der Isar and medical students of the TU München",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Entire sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 4554,
		"sample_size_rounded": 4600,
		"start_date": "2020-04-14",
		"end_date": "2020-05-29",
		"record_modified": "2022-03-23"
	},
	{
		"organisation": [
			"St. Adolf-Stift, Reinbek",
			"Krankenhaus Reinbek"
		],
		"location": [
			"Reinbek"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1016/j.ijid.2020.10.026",
			"https://doi.org/10.1101/2021.03.29.21254538",
			"https://doi.org/10.3390/ijerph182010972"
		],
		"title": "Prospective molecular biological and serological examination for the detection of SARS-CoV-2 (COVID-19) in employees of a hospital of regular care in Germany (ProCoV)",
		"scope_regionality": "Local/Regional",
		"region": "Schleswig-Holstein",
		"location_raw": "Reinbek",
		"organisation_raw": "Krankenhaus Reinbek St. Adolf-Stift, Reinbek",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021270",
		"information_url": "https://www.krankenhaus-reinbek.de/aktuelles/2020-05-11/nicht-nur-eine-gefuehlte-sondern-eine-tatsaechliche-sicherheit-fuer-die ",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Employees of the hospital Reinbeck St. Adolf-Stift",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_max": 90,
		"age_min": 18,
		"sample_design": "Entire sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 871,
		"sample_size_rounded": 900,
		"start_date": "2020-04-14",
		"end_date": "2020-06-16"
	},
	{
		"organisation": [
			"Performa Nord",
			"Zentrum für Gesunde Arbeit der Freien Hansestadt Bremen",
			"Zentrum für Gesunde Arbeit der Freien Hansestadt Bremen, Arbeitsmedizinischer Dienst"
		],
		"location": [
			"Bremen"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://www.asu-arbeitsmedizin.com/node/153868/print"
		],
		"title": "Study on SARS-CoV-2-Serology (COVID-19) in Bremen's public sector",
		"scope_regionality": "Local/Regional",
		"region": "Bremen",
		"location_raw": "Bremen",
		"organisation_raw": "Performa Nord, Zentrum für Gesunde Arbeit, Arbeitsmedizinischer Dienst\r\n",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021289",
		"type": "Cross sectional",
		"subject_frame": "Non-essential workers and unemployed persons",
		"subject_information": "Employees in several organizational areas of Bremen's public service sector",
		"scope_population": "Selected population groups",
		"scope_age": "Multiple",
		"age_max": 67,
		"age_min": 16,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 281,
		"sample_size_rounded": 300,
		"start_date": "2020-03-31",
		"end_date": "2020-05-16"
	},
	{
		"organisation": [
			"Medizinische Hochschule Hannover"
		],
		"location": [
			"Hannover"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1007/s15010-020-01461-0",
			"https://doi.org/10.1007/s40121-020-00334-1",
			"https://doi.org/10.1101/2020.12.02.20242479"
		],
		"title": "COVID-19 Contact Study - Immunoreaction after possible SARS-CoV-2 / COVID-19 contact (CoCo Study)",
		"scope_regionality": "Local/Regional",
		"region": "Lower Saxony",
		"location_raw": "Hannover",
		"organisation_raw": "Medizinische Hochschule Hannover",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021152",
		"information_url": "www.cocostudie.de",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Employees from the health care sector at Hannover Medical School",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 1000,
		"start_date": "2020-03-23",
		"end_date": "2020-04-17"
	},
	{
		"organisation": [
			"Universitätsmedizin Rostock, Zentrum für Innere Medizin, Abteilung für Infektionskrankheiten und Tropenmedizin",
			"Universitätsmedizin Rostock, Institut für Medizinische Mikrobiologie, Virologie und Hygiene",
			"Bernhard Nocht Institut für Tropenmedizin, Hamburg ",
			"Universitätsmedizin Rostock "
		],
		"location": [
			"Rostock"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1055/a-1197-4293"
		],
		"title": "Mütter-Screening in einem COVID-19-Niedrig-Pandemiegebiet: Bestimmung SARS-CoV-2 spezifischer Antikörper bei 401 Rostocker Müttern mittels ELISA und Immunfluoreszenz-Bestätigungstest",
		"scope_regionality": "Local/Regional",
		"region": "Mecklenburg-Western Pomerania",
		"location_raw": "Rostock",
		"organisation_raw": "Abt. für Tropenmedizin und Infektionskrankheiten und Institut für Medizinische Mikrobiologie, Virologie und Hygiene, Universitätsmedizin Rostock; Bernhard Nocht Institut für Tropenmedizin, Hamburg  ",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021614",
		"information_url": "https://www.med.uni-rostock.de/medien/pressemitteilungen/aktuelles/news/rostocker-studie-soll-die-covid-infektionen-bei-kindern-und-familien-aufklaeren",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Mothers of children under the age of 10",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 401,
		"sample_size_rounded": 400,
		"start_date": "2020-04-20",
		"end_date": "2020-04-22"
	},
	{
		"organisation": [
			"Universitätsklinikum  Regensburg",
			"Universitätsklinikum Erlangen",
			"Institut für klinische Mikrobiologie und Hygiene, Universitätsklinikum  Regensburg",
			"Virologisches Institut, Universitätsklinikum Erlangen"
		],
		"location": [
			"Tirschenreuth"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://www.kreis-tir.de/buergerservice/aktuelles/news/news/detail/News/erste-runde-der-blutabnahmen-erfolgreich-abgeschlossen/",
			"https://doi.org/10.1101/2021.03.29.21254343",
			"https://doi.org/10.3390/v13061118",
			"https://doi.org/10.3390/v14061168"
		],
		"title": "Prospektive Covid 19 Kohorte Tirschenreuth (TiKoCo 19)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Tirschenreuth",
		"organisation_raw": "Institut für klinische Mikrobiologie und Hygiene, Universitätsklinikum Regensburg; Virologisches Institut, Universitätsklinikum Erlangen",
		"information_url": "https://www.uni-regensburg.de/pressearchiv/pressemitteilung/1066465.html",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of the rural district Tirschenreuth",
		"scope_population": "General population",
		"scope_age": "Multiple",
		"age_min": 14,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 4200,
		"sample_size_rounded": 4200,
		"start_date": "2020-06-15"
	},
	{
		"organisation": [
			"Universitätsklinikum  Regensburg",
			"Universitätsklinikum Erlangen",
			"Institut für klinische Mikrobiologie und Hygiene, Universitätsklinikum  Regensburg",
			"Virologisches Institut, Universitätsklinikum Erlangen"
		],
		"location": [
			"Tirschenreuth"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN",
			"In-house",
			"ROCHE N",
			"YHLO"
		],
		"resource_url": [],
		"title": "Prospektive Covid 19 Kohorte Tirschenreuth (TiKoCo 19)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Tirschenreuth",
		"organisation_raw": "Institut für klinische Mikrobiologie und Hygiene, Universitätsklinikum  Regensburg und Virologisches Institut, Universitätsklinikum Erlangen",
		"information_url": "https://www.ukr.de/service/aktuelles/06346.php",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of the rural district Tirschenreuth",
		"scope_population": "General population",
		"scope_age": "Multiple",
		"age_min": 14,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 4201,
		"sample_size_rounded": 4200,
		"start_date": "2020-06-28",
		"end_date": "2020-07-10",
		"results_seroprevalence_information": "Residents of the rural district Tirschenreuth",
		"results_publication_url": "https://doi.org/10.3390/v13061118",
		"results_publication_date": "2021-06-10",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN; In-house, ROCHE N, YHLO",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.086,
		"results_seroprevalence_positive_95pct_lower": 0.0777,
		"results_seroprevalence_positive_95pct_upper": 0.0945,
		"record_modified": "2021-11-01",
		"results_underreporting": 5
	},
	{
		"organisation": [
			"Universitätsklinikum  Regensburg",
			"Universitätsklinikum Erlangen",
			"Institut für klinische Mikrobiologie und Hygiene, Universitätsklinikum  Regensburg",
			"Virologisches Institut, Universitätsklinikum Erlangen"
		],
		"location": [
			"Tirschenreuth"
		],
		"analysis_test_manufacturer": [
			"ROCHE N"
		],
		"resource_url": [],
		"title": "Prospektive Covid 19 Kohorte Tirschenreuth (TiKoCo 19)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Tirschenreuth",
		"organisation_raw": "Institut für klinische Mikrobiologie und Hygiene, Universitätsklinikum  Regensburg und Virologisches Institut, Universitätsklinikum Erlangen",
		"information_url": "https://www.ukr.de/service/aktuelles/06346.php",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of the rural district Tirschenreuth",
		"scope_population": "General population",
		"scope_age": "Multiple",
		"age_min": 14,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 4203,
		"sample_size_rounded": 4200,
		"start_date": "2020-06-28",
		"end_date": "2020-07-10",
		"results_seroprevalence_information": "Seroprevalence of antibodies against the nucleocapsid among residents of Tirschenreuth for the period of June and July 2020",
		"results_publication_url": "https://doi.org/10.3390/v14061168",
		"results_publication_date": "2022-05-27",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti Nucleocapsid",
		"analysis_isotype": "Total antibody",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "ROCHE N",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_positive": 0.0918,
		"results_seroprevalence_positive_95pct_lower": 0.0834,
		"results_seroprevalence_positive_95pct_upper": 0.1009,
		"record_modified": "2022-06-06",
		"results_underreporting": 5.35
	},
	{
		"organisation": [
			"Universitätsklinikum  Regensburg",
			"Universitätsklinikum Erlangen",
			"Institut für klinische Mikrobiologie und Hygiene, Universitätsklinikum  Regensburg",
			"Virologisches Institut, Universitätsklinikum Erlangen"
		],
		"location": [
			"Tirschenreuth"
		],
		"analysis_test_manufacturer": [
			"ROCHE N"
		],
		"resource_url": [],
		"title": "Prospektive Covid 19 Kohorte Tirschenreuth (TiKoCo 19)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Tirschenreuth",
		"organisation_raw": "Institut für klinische Mikrobiologie und Hygiene, Universitätsklinikum  Regensburg und Virologisches Institut, Universitätsklinikum Erlangen",
		"information_url": "https://www.ukr.de/service/aktuelles/06346.php",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of the rural district Tirschenreuth",
		"scope_population": "General population",
		"scope_age": "Multiple",
		"age_min": 14,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 3513,
		"sample_size_rounded": 3500,
		"start_date": "2020-11-16",
		"end_date": "2020-11-27",
		"results_seroprevalence_information": "Seroprevalence of antibodies against the nucleocapsid among residents of Tirschenreuth for the period of November 2020",
		"results_publication_url": "https://doi.org/10.3390/v14061168",
		"results_publication_date": "2022-05-27",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti Nucleocapsid",
		"analysis_isotype": "Total antibody",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "ROCHE N",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_positive": 0.0997,
		"results_seroprevalence_positive_95pct_lower": 0.0903,
		"results_seroprevalence_positive_95pct_upper": 0.1101,
		"record_modified": "2022-06-01",
		"results_underreporting": 1
	},
	{
		"organisation": [
			"Universitätsklinikum  Regensburg",
			"Universitätsklinikum Erlangen",
			"Institut für klinische Mikrobiologie und Hygiene, Universitätsklinikum  Regensburg",
			"Virologisches Institut, Universitätsklinikum Erlangen"
		],
		"location": [
			"Tirschenreuth"
		],
		"analysis_test_manufacturer": [
			"ROCHE N"
		],
		"resource_url": [],
		"title": "Prospektive Covid 19 Kohorte Tirschenreuth (TiKoCo 19)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Tirschenreuth",
		"organisation_raw": "Institut für klinische Mikrobiologie und Hygiene, Universitätsklinikum  Regensburg und Virologisches Institut, Universitätsklinikum Erlangen",
		"information_url": "https://www.ukr.de/service/aktuelles/06346.php",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of the rural district Tirschenreuth",
		"scope_population": "General population",
		"scope_age": "Multiple",
		"age_min": 14,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 3374,
		"sample_size_rounded": 3400,
		"start_date": "2021-04-19",
		"end_date": "2021-04-30",
		"results_seroprevalence_information": "Seroprevalence of antibodies against the nucleocapsid among residents of Tirschenreuth for the period of April 2021",
		"results_publication_url": "https://doi.org/10.3390/v14061168",
		"results_publication_date": "2022-05-27",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti Nucleocapsid",
		"analysis_isotype": "Total antibody",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "ROCHE N",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_positive": 0.1543,
		"results_seroprevalence_positive_95pct_lower": 0.1425,
		"results_seroprevalence_positive_95pct_upper": 0.1669,
		"record_modified": "2022-06-01",
		"results_underreporting": 1.14
	},
	{
		"organisation": [
			"Universitätsklinikum  Regensburg",
			"Universitätsklinikum Erlangen",
			"Institut für klinische Mikrobiologie und Hygiene, Universitätsklinikum  Regensburg",
			"Virologisches Institut, Universitätsklinikum Erlangen"
		],
		"location": [
			"Tirschenreuth"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Prospektive Covid 19 Kohorte Tirschenreuth (TiKoCo 19)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Tirschenreuth",
		"organisation_raw": "Institut für klinische Mikrobiologie und Hygiene, Universitätsklinikum  Regensburg und Virologisches Institut, Universitätsklinikum Erlangen",
		"information_url": "https://www.ukr.de/service/aktuelles/06346.php",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of the rural district Tirschenreuth",
		"scope_population": "General population",
		"scope_age": "Multiple",
		"age_min": 14,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 3374,
		"sample_size_rounded": 3400,
		"start_date": "2021-04-19",
		"end_date": "2021-04-30",
		"results_seroprevalence_information": "Seroprevalence of antibodies against the spike protein among residents of Tirschenreuth for the period of April 2021",
		"results_publication_url": "https://doi.org/10.3390/v14061168",
		"results_publication_date": "2022-05-27",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_positive": 0.4579,
		"results_seroprevalence_positive_95pct_lower": 0.4411,
		"results_seroprevalence_positive_95pct_upper": 0.4747,
		"record_modified": "2022-06-01",
		"results_underreporting": 1.14
	},
	{
		"organisation": [
			"Universitätsmedizin Marburg",
			"Universitätsmedizin Marburg - Campus Fulda"
		],
		"location": [
			"Fulda"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"http://dx.doi.org/10.1055/a-1198-1243"
		],
		"title": "Immunitätsstudie gegen SARS-CoV-2",
		"scope_regionality": "Local/Regional",
		"region": "Hesse",
		"location_raw": "Fulda",
		"organisation_raw": "Universitätsmedizin Marburg - Campus Fulda - Medizinische Klinik 4",
		"information_url": "https://www.klinikum-fulda.de/wp-content/uploads/2020/04/20200423-Pressemeldung-Antikörperstudie-1-0.pdf",
		"type": "Repeated cross-sectional",
		"subject_frame": "Other groups",
		"subject_information": "Employees of the hospital Fulda and employees of the retail segment in Fulda",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Entire sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1780,
		"sample_size_rounded": 1800,
		"start_date": "2020-04-09",
		"end_date": "2020-04-16"
	},
	{
		"organisation": [
			"Robert Koch-Institut, Berlin"
		],
		"location": [
			"Berlin"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://www.bg-kliniken.de/unfallkrankenhaus-berlin/ueber-uns/bg-klinikum-unfallkrankenhaus-berlin/aktuelles/detail/das-unfallkrankenhaus-berlin-im-dienst-der-wissenschaft/",
			"https://doi.org/10.1186/s12879-022-07057-3"
		],
		"title": "SARS-CoV-2 Infektionen bei Gesundheitspersonal in Krankenhäusern in Deutschland (SGK)",
		"scope_regionality": "Local/Regional",
		"region": "Berlin",
		"location_raw": "Unfallklinikum Berlin-Marzahn",
		"organisation_raw": "Robert Koch-Institut, Berlin",
		"type": "Repeated cross-sectional",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Health care personnel in selected areas at the Unfallkrankenhaus Berlin",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Entire sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1477,
		"sample_size_rounded": 1500,
		"start_date": "2020-05-15",
		"end_date": "2020-12-16"
	},
	{
		"organisation": [
			"Gesundheitsamt Stuttgart",
			"Klinikum Stuttgart",
			"Universitätsklinik Tübingen"
		],
		"location": [
			"Stuttgart"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1007/s15010-022-01830-x"
		],
		"title": "Die Ausbreitung des neuen Coronavirus (SARS-CoV-2) und die gesundheitlichen Folgen (CoKoS)",
		"scope_regionality": "Local/Regional",
		"region": "Baden-Wuerttemberg",
		"location_raw": "Stuttgart",
		"organisation_raw": "Gesundheitsamt Stuttgart, Klinikum Stuttgart, Universitätsklinik Tübingen",
		"information_url": "https://www.klinikum-stuttgart.de/aktuell-im-klinikum/presse/presseinformation/studie-zur-verbreitung-des-corona-virus-in-stuttgart",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Stuttgart general population (sample A) and participants with a known past infection (sample B)",
		"scope_population": "General population and selected population groups",
		"scope_age": "Multiple",
		"age_min": 5,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 1400,
		"start_date": "2020-05-15"
	},
	{
		"organisation": [
			"Gesundheitsamt Stuttgart",
			"Klinikum Stuttgart",
			"Universitätsklinik Tübingen"
		],
		"location": [
			"Stuttgart"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Die Ausbreitung des neuen Coronavirus (SARS-CoV-2) und die gesundheitlichen Folgen (CoKoS)",
		"scope_regionality": "Local/Regional",
		"region": "Baden-Wuerttemberg",
		"location_raw": "Stuttgart",
		"organisation_raw": "Gesundheitsamt Stuttgart, Klinikum Stuttgart, Universitätsklinik Tübingen",
		"information_url": "https://www.stuttgarter-zeitung.de/inhalt.forschungsprojekt-in-stuttgart-antikoerper-studie-zu-corona-in-der-stadt.50b185f5-ab99-4f1a-9268-00ed87f97bf2.html\r\nhttps://www.klinikum-stuttgart.de/aktuell-im-klinikum/presse/presseinformation/studie-zur-verbreitung-des-corona-virus-in-stuttgart",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Stuttgart general population (sample A) and participants with a known past infection (sample B)",
		"scope_population": "General population",
		"scope_age": "Multiple",
		"age_min": 5,
		"sample_design": "Random sampling (not central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 5000,
		"start_date": "2020-05-15",
		"end_date": "2020-07-14",
		"results_seroprevalence_information": "Seroprevalence of antibodies against the spike protein among inhabitants of Stuttgart for the period of June to July 2021",
		"results_publication_url": "https://doi.org/10.1007/s15010-022-01830-x",
		"results_publication_date": "2022-06-01",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "capillary blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_positive": 0.716,
		"record_modified": "2022-06-13"
	},
	{
		"organisation": [
			"Gesundheitsamt Stuttgart",
			"Klinikum Stuttgart",
			"Universitätsklinik Tübingen"
		],
		"location": [
			"Stuttgart"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Die Ausbreitung des neuen Coronavirus (SARS-CoV-2) und die gesundheitlichen Folgen (CoKoS)",
		"scope_regionality": "Local/Regional",
		"region": "Baden-Wuerttemberg",
		"location_raw": "Stuttgart",
		"organisation_raw": "Gesundheitsamt Stuttgart, Klinikum Stuttgart, Universitätsklinik Tübingen",
		"information_url": "https://www.stuttgarter-zeitung.de/inhalt.forschungsprojekt-in-stuttgart-antikoerper-studie-zu-corona-in-der-stadt.50b185f5-ab99-4f1a-9268-00ed87f97bf2.html\r\nhttps://www.klinikum-stuttgart.de/aktuell-im-klinikum/presse/presseinformation/studie-zur-verbreitung-des-corona-virus-in-stuttgart",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Stuttgart general population (sample A) and participants with a known past infection (sample B)",
		"scope_population": "General population",
		"scope_age": "Multiple",
		"age_min": 5,
		"sample_design": "Random sampling (not central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 5000,
		"start_date": "2020-05-15",
		"end_date": "2020-07-14",
		"results_seroprevalence_information": "Seroprevalence of antibodies against the spike protein among inhabitants of Stuttgart for the period of June to July 2021",
		"results_publication_url": "https://doi.org/10.1007/s15010-022-01830-x",
		"results_publication_date": "2022-06-01",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "capillary blood",
		"analysis_target": "anti Nucleocapsid",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_positive": 0.048,
		"record_modified": "2022-06-13"
	},
	{
		"organisation": [
			"Otto-von-Guericke-Universität Magdeburg"
		],
		"location": [
			"Magdeburg"
		],
		"analysis_test_manufacturer": [
			"N/A"
		],
		"resource_url": [],
		"title": "Serologische Untersuchungen bei Blutspendern des Großraumes Magdeburg auf Antikörper gegen SARS-CoV-2 (SeMaCo)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony-Anhalt",
		"location_raw": "Magdeburg",
		"organisation_raw": "Medizinische Fakultät, Otto-von-Guericke-Universität Magdeburg",
		"information_url": "http://www.itib.ovgu.de/Forschung+_+Lehre.html",
		"type": "Repeated cross-sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from Magdeburg and the surrounding area",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 268,
		"sample_size_rounded": 300,
		"start_date": "2021-01-20",
		"end_date": "2021-01-31",
		"results_seroprevalence_information": "Seroprevalence among blood donors for the period January 2021",
		"results_publication_url": "https://www.karger.com/Article/Pdf/518751",
		"results_publication_date": "2021-09-07",
		"results_publication_type": "Presentation",
		"analysis_data_source": "whole blood",
		"analysis_test_manufacturer_raw": "N/A",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_positive": 0.037,
		"record_created": "2022-04-25",
		"record_modified": "2022-05-10"
	},
	{
		"organisation": [
			"Otto-von-Guericke-Universität Magdeburg"
		],
		"location": [
			"Magdeburg"
		],
		"analysis_test_manufacturer": [
			"N/A"
		],
		"resource_url": [],
		"title": "Serologische Untersuchungen bei Blutspendern des Großraumes Magdeburg auf Antikörper gegen SARS-CoV-2 (SeMaCo)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony-Anhalt",
		"location_raw": "Magdeburg",
		"organisation_raw": "Medizinische Fakultät, Otto-von-Guericke-Universität Magdeburg",
		"information_url": "http://www.itib.ovgu.de/Forschung+_+Lehre.html",
		"type": "Repeated cross-sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from Magdeburg and the surrounding area",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 566,
		"sample_size_rounded": 600,
		"start_date": "2021-02-01",
		"end_date": "2021-02-28",
		"results_seroprevalence_information": "Seroprevalence among blood donors for the period February 2021",
		"results_publication_url": "https://www.karger.com/Article/Pdf/518751",
		"results_publication_date": "2021-09-07",
		"results_publication_type": "Presentation",
		"analysis_data_source": "whole blood",
		"analysis_test_manufacturer_raw": "N/A",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_positive": 0.074,
		"record_created": "2022-04-25",
		"record_modified": "2022-05-10"
	},
	{
		"organisation": [
			"Otto-von-Guericke-Universität Magdeburg"
		],
		"location": [
			"Magdeburg"
		],
		"analysis_test_manufacturer": [
			"N/A"
		],
		"resource_url": [],
		"title": "Serologische Untersuchungen bei Blutspendern des Großraumes Magdeburg auf Antikörper gegen SARS-CoV-2 (SeMaCo)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony-Anhalt",
		"location_raw": "Magdeburg",
		"organisation_raw": "Medizinische Fakultät, Otto-von-Guericke-Universität Magdeburg",
		"information_url": "http://www.itib.ovgu.de/Forschung+_+Lehre.html",
		"type": "Repeated cross-sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from Magdeburg and the surrounding area",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 888,
		"sample_size_rounded": 900,
		"start_date": "2021-03-01",
		"end_date": "2021-03-31",
		"results_seroprevalence_information": "Seroprevalence among blood donors for the period March 2021",
		"results_publication_url": "https://www.karger.com/Article/Pdf/518751",
		"results_publication_date": "2021-09-07",
		"results_publication_type": "Presentation",
		"analysis_data_source": "whole blood",
		"analysis_test_manufacturer_raw": "N/A",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_positive": 0.12,
		"record_created": "2022-04-25",
		"record_modified": "2022-05-10"
	},
	{
		"organisation": [
			"Otto-von-Guericke-Universität Magdeburg"
		],
		"location": [
			"Magdeburg"
		],
		"analysis_test_manufacturer": [
			"N/A"
		],
		"resource_url": [],
		"title": "Serologische Untersuchungen bei Blutspendern des Großraumes Magdeburg auf Antikörper gegen SARS-CoV-2 (SeMaCo)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony-Anhalt",
		"location_raw": "Magdeburg",
		"organisation_raw": "Medizinische Fakultät, Otto-von-Guericke-Universität Magdeburg",
		"information_url": "http://www.itib.ovgu.de/Forschung+_+Lehre.html",
		"type": "Repeated cross-sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from Magdeburg and the surrounding area",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 514,
		"sample_size_rounded": 500,
		"start_date": "2021-04-01",
		"end_date": "2021-04-30",
		"results_seroprevalence_information": "Seroprevalence among blood donors for the period April 2021",
		"results_publication_url": "https://www.karger.com/Article/Pdf/518751",
		"results_publication_date": "2021-09-07",
		"results_publication_type": "Presentation",
		"analysis_data_source": "whole blood",
		"analysis_test_manufacturer_raw": "N/A",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_positive": 0.253,
		"record_created": "2022-04-25",
		"record_modified": "2022-05-10"
	},
	{
		"organisation": [
			"Otto-von-Guericke-Universität Magdeburg"
		],
		"location": [
			"Magdeburg"
		],
		"analysis_test_manufacturer": [
			"N/A"
		],
		"resource_url": [
			"https://www.med.uni-magdeburg.de/Kommunikation+_+Presse/Marketing_+Kommunikation+und+Medien/Presse/Pressemitteilungen/Universit%C3%A4tsmedizin+Magdeburg/UMMD+_+03_06_2021+Erste+Ergebnisse+der+Magdeburger+Antik%C3%B6rperstudie+zu+COVID_19_+Von+einer+breiten+Immunit%C3%A4t+noch+weit+entfernt-p-22890.html",
			"https://www.karger.com/Article/Pdf/518751"
		],
		"title": "Serologische Untersuchungen bei Blutspendern des Großraumes Magdeburg auf Antikörper gegen SARS-CoV-2 (SeMaCo)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony-Anhalt",
		"location_raw": "Magdeburg",
		"organisation_raw": "Medizinische Fakultät, Otto-von-Guericke-Universität Magdeburg",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00023263",
		"information_url": "http://www.itib.ovgu.de/Forschung+_+Lehre.html",
		"type": "Repeated cross-sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from Magdeburg and the surrounding area",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2236,
		"sample_size_rounded": 2200,
		"start_date": "2021-01-20",
		"end_date": "2021-04-30",
		"results_seroprevalence_information": "Seroprevalence among all participating blood donors January to April 2021",
		"results_publication_url": "https://www.karger.com/Article/Pdf/518751",
		"results_publication_date": "2022-09-07",
		"results_publication_type": "Presentation",
		"analysis_data_source": "whole blood",
		"analysis_test_manufacturer_raw": "N/A",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_positive": 0.129,
		"record_created": "2021-09-03",
		"record_modified": "2022-05-10"
	},
	{
		"organisation": [
			"Otto-von-Guericke-Universität Magdeburg"
		],
		"location": [
			"Magdeburg"
		],
		"analysis_test_manufacturer": [
			"N/A"
		],
		"resource_url": [],
		"title": "Serologische Untersuchungen bei Blutspendern des Großraumes Magdeburg auf Antikörper gegen SARS-CoV-2 (SeMaCo)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony-Anhalt",
		"location_raw": "Magdeburg",
		"organisation_raw": "Medizinische Fakultät, Otto-von-Guericke-Universität Magdeburg",
		"information_url": "http://www.itib.ovgu.de/Forschung+_+Lehre.html",
		"type": "Repeated cross-sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from Magdeburg and the surrounding area",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1895,
		"sample_size_rounded": 1900,
		"start_date": "2021-01-18",
		"end_date": "2021-04-30",
		"results_seroprevalence_information": "Seroprevalence among unvaccinated blood donors January to April 2021",
		"results_publication_url": "https://www.med.uni-magdeburg.de/Kommunikation+_+Presse/Marketing_+Kommunikation+und+Medien/Presse/Pressemitteilungen/Universit%C3%A4tsmedizin+Magdeburg/UMMD+_+03_06_2021+Erste+Ergebnisse+der+Magdeburger+Antik%C3%B6rperstudie+zu+COVID_19_+Von+einer+breiten+Immunit%C3%A4t+noch+weit+entfernt-p-22890.html",
		"results_publication_date": "2021-06-03",
		"results_publication_type": "Press release",
		"analysis_data_source": "whole blood",
		"analysis_test_manufacturer_raw": "N/A",
		"subject_vaccination": "Seroprevalence unvaccinated participants",
		"results_seroprevalence_positive": 0.06,
		"record_created": "2021-09-03",
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Universitätsklinikum Düsseldorf",
			"Stadt Düsseldorf"
		],
		"location": [
			"Dusseldorf"
		],
		"analysis_test_manufacturer": [
			"ROCHE"
		],
		"resource_url": [
			"https://doi.org/10.1016/j.puhe.2022.03.009"
		],
		"title": "Seroprävalenz COVID-19 Düsseldorf: junge Düsseldorfer/-innen (SERODUS I)",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Dusseldorf",
		"organisation_raw": "Universitätsklinikum Düsseldorf und Stadt Düsseldorf",
		"information_url": "https://www.uniklinik-duesseldorf.de/patienten-besucher/klinikeninstitutezentren/institut-fuer-medizinische-soziologie/das-institut/forschung/serodus",
		"type": "Cross sectional",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Düsseldorf",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 30,
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2186,
		"sample_size_rounded": 2200,
		"start_date": "2020-11-02",
		"end_date": "2020-11-27",
		"results_seroprevalence_information": "Seroprevalence of 18 to 30 year old residents of Düsseldorf",
		"results_publication_url": "https://doi.org/10.1016/j.puhe.2022.03.009",
		"results_publication_date": "2022-03-23",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti Nucleocapsid",
		"analysis_isotype": "Total antibody",
		"analysis_test": "Elektrochemolumineszenz (ECL)-Immunassay; LIPS",
		"analysis_test_manufacturer_raw": "ROCHE",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity",
		"results_seroprevalence_sensitivity": 0.995,
		"results_seroprevalence_specificity": 0.998,
		"results_seroprevalence_positive": 0.031,
		"results_seroprevalence_positive_95pct_lower": 0.024,
		"results_seroprevalence_positive_95pct_upper": 0.04,
		"record_modified": "2022-05-10",
		"results_underreporting": 1.7
	},
	{
		"organisation": [
			"Germany"
		],
		"location": [
			"Germany"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "SARS-CoV-2-KIDS study",
		"scope_regionality": "Nationwide",
		"region": "Nationwide",
		"location_raw": "14 paediatric clinics from all over Germany, focus on North Rhine-Westphalia",
		"organisation_raw": "14 large paediatric clinics",
		"information_url": "https://www.umm.de/medien/pressemitteilungen/pressemitteilung/news/sars-cov-2-kids-studie-grosse-multizentrische-studie-mit-kindern-und-jugendlichen/",
		"type": "Repeated cross-sectional",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Children and adolescents up to 17 years of age from participating children's hospitals",
		"scope_population": "Selected population groups",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 17,
		"age_min": 0,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"start_date": "2020-06-01",
		"end_date": "2020-09-30",
		"results_seroprevalence_information": "Seroprevalence in children and adolescents up to the age of 17 for the period June - September 2020",
		"results_publication_url": "https://doi.org/10.1038/s41467-022-30482-6",
		"results_publication_date": "2022-06-06",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Population-weighted",
		"results_seroprevalence_positive": 0.02,
		"results_seroprevalence_positive_95pct_lower": 0.016,
		"results_seroprevalence_positive_95pct_upper": 0.025,
		"record_created": "2022-01-10",
		"record_modified": "2022-02-11"
	},
	{
		"organisation": [
			"Germany"
		],
		"location": [
			"Germany"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "SARS-CoV-2-KIDS study",
		"scope_regionality": "Nationwide",
		"region": "Nationwide",
		"location_raw": "14 paediatric clinics from all over Germany, focus on North Rhine-Westphalia",
		"organisation_raw": "14 large paediatric clinics",
		"information_url": "https://www.umm.de/medien/pressemitteilungen/pressemitteilung/news/sars-cov-2-kids-studie-grosse-multizentrische-studie-mit-kindern-und-jugendlichen/",
		"type": "Repeated cross-sectional",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Children and adolescents up to 17 years of age from participating children's hospitals",
		"scope_population": "Selected population groups",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 17,
		"age_min": 0,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"start_date": "2020-10-01",
		"end_date": "2021-03-31",
		"results_seroprevalence_information": "Seroprevalence in children and adolescents up to the age of 17 for the period October 2020 - March 2021",
		"results_publication_url": "https://doi.org/10.1038/s41467-022-30482-6",
		"results_publication_date": "2022-06-06",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Population-weighted",
		"results_seroprevalence_positive": 0.108,
		"results_seroprevalence_positive_95pct_lower": 0.087,
		"results_seroprevalence_positive_95pct_upper": 0.129,
		"record_created": "2022-01-10",
		"record_modified": "2022-02-11"
	},
	{
		"organisation": [
			"Germany"
		],
		"location": [
			"Germany"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.2139/ssrn.3965378",
			"https://doi.org/10.1038/s41467-022-30482-6"
		],
		"title": "SARS-CoV-2-KIDS study",
		"scope_regionality": "Nationwide",
		"region": "Nationwide",
		"location_raw": "14 paediatric clinics from all over Germany, focus on North Rhine-Westphalia",
		"organisation_raw": "14 large paediatric clinics",
		"information_url": "https://www.umm.de/medien/pressemitteilungen/pressemitteilung/news/sars-cov-2-kids-studie-grosse-multizentrische-studie-mit-kindern-und-jugendlichen/",
		"type": "Repeated cross-sectional",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Children and adolescents up to 17 years of age from participating children's hospitals",
		"scope_population": "Selected population groups",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 17,
		"age_min": 0,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 10358,
		"sample_size_rounded": 10400,
		"start_date": "2020-06-01",
		"end_date": "2021-05-31",
		"record_created": "2021-12-03",
		"record_modified": "2021-12-07"
	},
	{
		"organisation": [
			"Ministerium für Soziales, Gesundheit, Frauen und Familie",
			"Staatliche Medizinaluntersuchungsstelle des Saarlandes",
			"Universitätsklinikum des Saarlandes",
			" Institut für Virologie, Universitätsklinikum des Saarlandes"
		],
		"location": [
			"Saarland"
		],
		"analysis_test_manufacturer": [
			"ROCHE N"
		],
		"resource_url": [
			"https://www.uniklinikum-saarland.de/de/aktuelles/einzelansicht_news/aktuellesseite/article/saarlaendische-antikoerperstudie-zur-coronavirus-infektion-abgeschlossen-institut-fuer-virologie-am/",
			"https://doi.org/10.1038/s43856-022-00100-z"
		],
		"title": "Saarlandweite Coronavirus-Antikörper-Prävalenzstudie (SaarCoPS)",
		"scope_regionality": "Local/Regional",
		"region": "Saarland",
		"location_raw": "Saarland",
		"organisation_raw": "Ministerium für Soziales, Gesundheit, Frauen und Familie; Staatliche Medizinaluntersuchungsstelle des Saarlandes, Institut für Virologie, Universitätsklinikum des Saarlandes \r\n",
		"information_url": "https://www.uniklinikum-saarland.de/de/einrichtungen/kliniken_institute/infektionsmedizin/virologie/saarcops/",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Saarland",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 95,
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2940,
		"sample_size_rounded": 2900,
		"start_date": "2020-07-22",
		"end_date": "2020-10-15",
		"results_seroprevalence_information": "Seroprevalence of the adult population from the federal state of Saarland for the period from July 2020 to Octobre 2020",
		"results_publication_url": "https://doi.org/10.1038/s43856-022-00100-z",
		"results_publication_date": "2022-05-18",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "Multiple antibodies",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "Roche N",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_positive": 0.0102,
		"results_seroprevalence_positive_95pct_lower": 0.0064,
		"results_seroprevalence_positive_95pct_upper": 0.0144,
		"record_modified": "2022-06-06",
		"results_underreporting": 2.68
	},
	{
		"organisation": [
			"Helmholtz Zentrum München, Institut für Diabetesforschung",
			"Helmholtz Zentrum München"
		],
		"location": [
			"Bavaria"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1016/j.medj.2020.10.003"
		],
		"title": "Fr1da-COVID19: Messung der Entwicklung von Immunität gegen SARS-CoV-2 in einer Kinderkohorte in Bayern (2019-2022 )",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Bavaria",
		"organisation_raw": "Institut für Diabetesforschung, Helmholtz Zentrum München",
		"information_url": "https://www.typ1diabetes-frueherkennung.de/informationen-fuer-aerzte/fr1daplus-sars-cov-2.html",
		"type": "Repeated cross-sectional",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Participating children of the Fr1da study (children's cohort for early detection of type 1 diabetes)",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 10,
		"age_min": 2,
		"sample_design": "Cohort-sample - Sampling from existing cohort study in the general population",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 75000,
		"start_date": "2020-01-01",
		"record_modified": "2021-09-27"
	},
	{
		"organisation": [
			"Helmholtz Zentrum München, Institut für Diabetesforschung",
			"Helmholtz Zentrum München"
		],
		"location": [
			"Bavaria"
		],
		"analysis_test_manufacturer": [
			"Author designed"
		],
		"resource_url": [],
		"title": "Fr1da-COVID19: Messung der Entwicklung von Immunität gegen SARS-CoV-2 in einer Kinderkohorte in Bayern (2019-2022 )",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Bavaria",
		"organisation_raw": "Institut für Diabetesforschung, Helmholtz Zentrum München",
		"information_url": "https://www.typ1diabetes-frueherkennung.de/informationen-fuer-aerzte/fr1daplus-sars-cov-2.html",
		"type": "Repeated cross-sectional",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Participating children (1 - 10 years of age) of the Fr1da study (children's cohort for early detection of type 1 diabetes) from Jan 2020 to Aug 2020",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 10,
		"age_min": 1,
		"sample_design": "Cohort-sample - Sampling from existing cohort study in the general population",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 15523,
		"sample_size_rounded": 15500,
		"start_date": "2020-01-01",
		"end_date": "2020-08-31",
		"results_seroprevalence_information": "Total seroprevalence of children 1 to 10 years old participating in the Fr1da study for the period from January to August 2020",
		"results_publication_url": "https://doi.org/10.1016/j.medj.2021.03.019",
		"results_publication_date": "2021-05-14",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "capillary blood",
		"analysis_target": "multiple",
		"analysis_isotype": "Total antibody",
		"analysis_test": "Elektrochemolumineszenz (ECL)-Immunassay; LIPS",
		"analysis_test_manufacturer_raw": "Author designed",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity",
		"results_seroprevalence_sensitivity": 0.973,
		"results_seroprevalence_specificity": 1,
		"results_seroprevalence_positive": 0.0068,
		"results_seroprevalence_positive_95pct_lower": 0.0056,
		"results_seroprevalence_positive_95pct_upper": 0.0082,
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Helmholtz Zentrum München, Institut für Diabetesforschung",
			"Helmholtz Zentrum München"
		],
		"location": [
			"Bavaria"
		],
		"analysis_test_manufacturer": [
			"Author designed"
		],
		"resource_url": [],
		"title": "Fr1da-COVID19: Messung der Entwicklung von Immunität gegen SARS-CoV-2 in einer Kinderkohorte in Bayern (2019-2022 )",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Bavaria",
		"organisation_raw": "Institut für Diabetesforschung, Helmholtz Zentrum München",
		"information_url": "https://www.typ1diabetes-frueherkennung.de/informationen-fuer-aerzte/fr1daplus-sars-cov-2.html",
		"type": "Repeated cross-sectional",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Participating children (1 - 10 years of age) of the Fr1da study (children's cohort for early detection of type 1 diabetes) from Sept 2020 to Feb 2021",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 10,
		"age_min": 1,
		"sample_design": "Cohort-sample - Sampling from existing cohort study in the general population",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 11380,
		"sample_size_rounded": 11400,
		"start_date": "2020-09-01",
		"end_date": "2021-02-28",
		"results_seroprevalence_information": "Total seroprevalence of children 1 to 10 years old participating in the Fr1da study for the period from September 2020 to February 2021",
		"results_publication_url": "https://doi.org/10.1016/j.medj.2021.03.019",
		"results_publication_date": "2021-05-14",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "capillary blood",
		"analysis_target": "multiple",
		"analysis_isotype": "Total antibody",
		"analysis_test": "Elektrochemolumineszenz (ECL)-Immunassay; LIPS",
		"analysis_test_manufacturer_raw": "Author designed",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity",
		"results_seroprevalence_sensitivity": 0.973,
		"results_seroprevalence_specificity": 1,
		"results_seroprevalence_positive": 0.0392,
		"results_seroprevalence_positive_95pct_lower": 0.0357,
		"results_seroprevalence_positive_95pct_upper": 0.0429,
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Helmholtz Zentrum München, Institut für Diabetesforschung",
			"Helmholtz Zentrum München"
		],
		"location": [
			"Bavaria"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [],
		"title": "Fr1da-COVID19: Messung der Entwicklung von Immunität gegen SARS-CoV-2 in einer Kinderkohorte in Bayern (2019-2022 )",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Bavaria",
		"organisation_raw": "Institut für Diabetesforschung, Helmholtz Zentrum München",
		"information_url": "https://www.typ1diabetes-frueherkennung.de/informationen-fuer-aerzte/fr1daplus-sars-cov-2.html",
		"type": "Repeated cross-sectional",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Participating children (1 - 10 years of age) of the Fr1da study (children's cohort for early detection of type 1 diabetes) in July 2020",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 18,
		"age_min": 1,
		"sample_design": "Cohort-sample - Sampling from existing cohort study in the general population",
		"sample_analysis_unit": "Participants",
		"start_date": "2020-03-01",
		"end_date": "2020-03-31",
		"results_seroprevalence_information": "Under reporting factor of children 1 to 18 years old participating in the Fr1da study for March 2020",
		"results_publication_url": "https://doi.org/10.1016/j.medj.2020.10.003",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"record_modified": "2022-02-15",
		"results_underreporting": 2
	},
	{
		"organisation": [
			"Helmholtz Zentrum München, Institut für Diabetesforschung",
			"Helmholtz Zentrum München"
		],
		"location": [
			"Bavaria"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [],
		"title": "Fr1da-COVID19: Messung der Entwicklung von Immunität gegen SARS-CoV-2 in einer Kinderkohorte in Bayern (2019-2022 )",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Bavaria",
		"organisation_raw": "Institut für Diabetesforschung, Helmholtz Zentrum München",
		"information_url": "https://www.typ1diabetes-frueherkennung.de/informationen-fuer-aerzte/fr1daplus-sars-cov-2.html",
		"type": "Repeated cross-sectional",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Participating children (1 - 10 years of age) of the Fr1da study (children's cohort for early detection of type 1 diabetes) in July 2020",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 18,
		"age_min": 1,
		"sample_design": "Cohort-sample - Sampling from existing cohort study in the general population",
		"sample_analysis_unit": "Participants",
		"start_date": "2020-04-01",
		"end_date": "2020-07-31",
		"results_seroprevalence_information": "Under reporting factor of children 1 to 18 years old participating in the Fr1da study for April to Juli 2020",
		"results_publication_url": "https://doi.org/10.1016/j.medj.2020.10.003",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"record_modified": "2022-02-15",
		"results_underreporting": 7.5
	},
	{
		"organisation": [
			"Universitätsklinikum Jena"
		],
		"location": [
			"Neustadt am Rennsteig"
		],
		"analysis_test_manufacturer": [
			"EPITOPE",
			"DIASORIN",
			"SNIBE",
			"SEROPRAX",
			"EUROIMMUN",
			"ABBOTT",
			"ROCHE"
		],
		"resource_url": [
			"https://doi.org/10.1101/2020.07.15.20154112",
			"https://doi.org/10.1016/j.cmi.2020.11.009"
		],
		"title": "Seroprevalence of SARS-CoV-2 antibodies in a quarantined community after a COVID-19 outbreak (Co-NAN)",
		"scope_regionality": "Local/Regional",
		"region": "Thuringia",
		"location_raw": "Neustadt am Rennsteig",
		"organisation_raw": "Universitätsklinikum Jena",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022416",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Neustadt am Rennsteig",
		"scope_population": "General population",
		"scope_age": "Multiple",
		"age_max": 97,
		"age_min": 1,
		"sample_design": "Entire sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 620,
		"sample_size_rounded": 600,
		"start_date": "2020-05-13",
		"end_date": "2020-05-22",
		"results_seroprevalence_information": "Residents of Neustadt am Rennsteig",
		"results_publication_url": "https://doi.org/10.1016/j.cmi.2020.11.009",
		"results_publication_date": "2020-11-20",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "EPITOPE; DIASORIN; SNIBE; SEROPRAX; EUROIMMUN; ABBOTT; ROCHE",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_positive": 0.115,
		"results_seroprevalence_positive_95pct_lower": 0.091,
		"results_seroprevalence_positive_95pct_upper": 0.142,
		"record_created": "2021-07-11",
		"record_modified": "2021-10-08",
		"results_underreporting": 2
	},
	{
		"organisation": [
			"Universitätsklinikum Hamburg-Eppendorf"
		],
		"location": [
			"Hamburg"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [],
		"title": "Hamburg City Health Study (HCHS): Covid-19 Modul",
		"scope_regionality": "Local/Regional",
		"region": "Hamburg",
		"location_raw": "Hamburg",
		"organisation_raw": "Universitätsklinikum Hamburg-Eppendorf (UKE)",
		"information_url": "https://www.uke.de/allgemein/presse/pressemitteilungen/detailseite_93825.html",
		"type": "Cross sectional",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Particpants of the Hamburg City Health Study",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 74,
		"age_min": 45,
		"sample_design": "Cohort-sample - Sampling from existing cohort study in the general population",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 6000,
		"sample_size_rounded": 6000,
		"start_date": "2020-04-29"
	},
	{
		"organisation": [
			"Universitätsklinikum Hamburg-Eppendorf"
		],
		"location": [
			"Hamburg"
		],
		"analysis_test_manufacturer": [
			"DIASORIN",
			"ROCHE"
		],
		"resource_url": [
			"https://www.uke.de/allgemein/presse/pressemitteilungen/detailseite_95874.html",
			"https://doi.org/10.1101/2022.02.11.22270611 ",
			"https://doi.org/10.1055/s-0042-1742988"
		],
		"title": "Covid-19 Children Health Investigation of Latent Disease in Hamburg (C19.CHILD HAMBURG)",
		"scope_regionality": "Local/Regional",
		"region": "Hamburg",
		"location_raw": "Hamburg",
		"organisation_raw": "Klinik für Kinder- und Jugendmedizin und Institut für Mikrobiologie, Universitätsklinikum Eppendorf",
		"information_url": "http://c19child.hamburg",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Inpatients and outpatients of all Hamburg children's hospitals",
		"scope_population": "General population and selected population groups",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 17,
		"age_min": 0,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 4657,
		"sample_size_rounded": 4700,
		"start_date": "2020-05-11",
		"end_date": "2020-06-30",
		"results_seroprevalence_information": "Total seroprevalence of outpatients and inpatients of the Hamburg pedriatric hospitals for the period of May to June 2020",
		"results_publication_url": "https://doi.org/10.1101/2022.02.11.22270611 ",
		"results_publication_date": "2022-02-11",
		"results_publication_type": "Preprint",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "Total antibody",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "DIASORIN; Roche",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.0144,
		"record_modified": "2022-05-04"
	},
	{
		"organisation": [
			"Universitätsklinikum Hamburg-Eppendorf"
		],
		"location": [
			"Hamburg"
		],
		"analysis_test_manufacturer": [
			"DIASORIN",
			"ROCHE"
		],
		"resource_url": [],
		"title": "Covid-19 Children Health Investigation of Latent Disease in Hamburg (C19.CHILD HAMBURG)",
		"scope_regionality": "Local/Regional",
		"region": "Hamburg",
		"location_raw": "Hamburg",
		"organisation_raw": "Klinik für Kinder- und Jugendmedizin und Institut für Mikrobiologie, Universitätsklinikum Eppendorf",
		"information_url": "http://c19child.hamburg",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Inpatients and outpatients of all Hamburg children's hospitals 0 - 9 years old",
		"scope_population": "General population and selected population groups",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 5,
		"age_min": 0,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 0,
		"start_date": "2020-05-11",
		"end_date": "2020-06-30",
		"results_seroprevalence_information": "Seroprevalence of outpatients and inpatients of the Hamburg pedriatric hospitals aged 0 to 5 years old for the period of May to June 2020",
		"results_publication_url": "https://doi.org/10.1101/2022.02.11.22270611 ",
		"results_publication_date": "2022-02-11",
		"results_publication_type": "Preprint",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "Total antibody",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "DIASORIN; Roche",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.0058,
		"results_seroprevalence_positive_95pct_lower": 0.0036,
		"results_seroprevalence_positive_95pct_upper": 0.008,
		"record_modified": "2022-05-04"
	},
	{
		"organisation": [
			"Universitätsklinikum Hamburg-Eppendorf"
		],
		"location": [
			"Hamburg"
		],
		"analysis_test_manufacturer": [
			"DIASORIN",
			"ROCHE"
		],
		"resource_url": [],
		"title": "Covid-19 Children Health Investigation of Latent Disease in Hamburg (C19.CHILD HAMBURG)",
		"scope_regionality": "Local/Regional",
		"region": "Hamburg",
		"location_raw": "Hamburg",
		"organisation_raw": "Klinik für Kinder- und Jugendmedizin und Institut für Mikrobiologie, Universitätsklinikum Eppendorf",
		"information_url": "http://c19child.hamburg",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Inpatients and outpatients of all Hamburg children's hospitals 10 - 18 years old",
		"scope_population": "General population and selected population groups",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 12,
		"age_min": 6,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 0,
		"start_date": "2020-05-11",
		"end_date": "2020-06-30",
		"results_seroprevalence_information": "Seroprevalence of outpatients and inpatients of the Hamburg pedriatric hospitals aged 6 to 12 years old for the period of May to June 2020",
		"results_publication_url": "https://doi.org/10.1101/2022.02.11.22270611 ",
		"results_publication_date": "2022-02-11",
		"results_publication_type": "Preprint",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "Total antibody",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "DIASORIN; Roche",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.0184,
		"results_seroprevalence_positive_95pct_lower": 0.0099,
		"results_seroprevalence_positive_95pct_upper": 0.027,
		"record_modified": "2022-05-04"
	},
	{
		"organisation": [
			"Universitätsklinikum Hamburg-Eppendorf"
		],
		"location": [
			"Hamburg"
		],
		"analysis_test_manufacturer": [
			"DIASORIN",
			"ROCHE"
		],
		"resource_url": [],
		"title": "Covid-19 Children Health Investigation of Latent Disease in Hamburg (C19.CHILD HAMBURG)",
		"scope_regionality": "Local/Regional",
		"region": "Hamburg",
		"location_raw": "Hamburg",
		"organisation_raw": "Klinik für Kinder- und Jugendmedizin und Institut für Mikrobiologie, Universitätsklinikum Eppendorf",
		"information_url": "http://c19child.hamburg",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Inpatients and outpatients of all Hamburg children's hospitals (total seroprevalence)",
		"scope_population": "General population and selected population groups",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 17,
		"age_min": 13,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 0,
		"start_date": "2020-05-11",
		"end_date": "2020-06-30",
		"results_seroprevalence_information": "Seroprevalence of outpatients and inpatients of the Hamburg pedriatric hospitals aged 13 to 17 years old for the period of May to June 2020",
		"results_publication_url": "https://doi.org/10.1101/2022.02.11.22270611 ",
		"results_publication_date": "2022-02-11",
		"results_publication_type": "Preprint",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "Total antibody",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "DIASORIN; Roche",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.0194,
		"results_seroprevalence_positive_95pct_lower": 0.011,
		"results_seroprevalence_positive_95pct_upper": 0.0278,
		"record_modified": "2022-05-04"
	},
	{
		"organisation": [
			"Universitätsklinikum Hamburg-Eppendorf, Institut für Transfusionsmedizin",
			"Universitätsklinikum Hamburg-Eppendorf (UKE)"
		],
		"location": [
			"Hamburg"
		],
		"analysis_test_manufacturer": [
			"ROCHE N",
			"DIASORIN",
			"EUROIMMUN",
			"WANTAI"
		],
		"resource_url": [
			"https://www.uke.de/allgemein/presse/pressemitteilungen/detailseite_95424.html"
		],
		"title": "Blutspende-Studie Hamburg",
		"scope_regionality": "Local/Regional",
		"region": "Hamburg",
		"location_raw": "Hamburg",
		"organisation_raw": "Institut für Transfusionsmedizin, Universitätsklinikum Hamburg-Eppendorf (UKE)",
		"type": "Cross sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from Hamburg",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Samples of participants",
		"sample_size_obtained": 300,
		"sample_size_rounded": 300,
		"start_date": "2020-04-06",
		"end_date": "2020-04-10",
		"results_seroprevalence_information": "Seroprevalence among blood donors in Hamburg for the period of April 2020",
		"results_publication_url": "https://www.uke.de/allgemein/presse/pressemitteilungen/detailseite_95424.html",
		"results_publication_date": "2020-06-09",
		"results_publication_type": "Webseite",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "Multiple antibodies",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "ROCHE N; DIASORIN; EUROIMMUN; WANTAI",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_sensitivity": 0.864,
		"results_seroprevalence_specificity": 0.998,
		"results_seroprevalence_positive": 0.003,
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Universitätsklinikum Hamburg-Eppendorf, Institut für Transfusionsmedizin",
			"Universitätsklinikum Hamburg-Eppendorf (UKE)"
		],
		"location": [
			"Hamburg"
		],
		"analysis_test_manufacturer": [
			"ROCHE N",
			"DIASORIN",
			"EUROIMMUN",
			"WANTAI"
		],
		"resource_url": [],
		"title": "Blutspende-Studie Hamburg",
		"scope_regionality": "Local/Regional",
		"region": "Hamburg",
		"location_raw": "Hamburg",
		"organisation_raw": "Institut für Transfusionsmedizin, Universitätsklinikum Hamburg-Eppendorf (UKE)",
		"type": "Cross sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from Hamburg",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Samples of participants",
		"sample_size_obtained": 288,
		"sample_size_rounded": 300,
		"start_date": "2020-05-04",
		"end_date": "2020-05-06",
		"results_seroprevalence_information": "Seroprevalence among blood donors in Hamburg for the period of May 2020",
		"results_publication_url": "https://www.uke.de/allgemein/presse/pressemitteilungen/detailseite_95424.html",
		"results_publication_date": "2020-06-09",
		"results_publication_type": "Webseite",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "Multiple antibodies",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "ROCHE N; DIASORIN; EUROIMMUN; WANTAI",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_sensitivity": 0.864,
		"results_seroprevalence_specificity": 0.998,
		"results_seroprevalence_positive": 0.007,
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Universitätsklinikum Hamburg-Eppendorf, Institut für Transfusionsmedizin",
			"Universitätsklinikum Hamburg-Eppendorf (UKE)"
		],
		"location": [
			"Hamburg"
		],
		"analysis_test_manufacturer": [
			"ROCHE N",
			"DIASORIN",
			"EUROIMMUN",
			"WANTAI"
		],
		"resource_url": [],
		"title": "Blutspende-Studie Hamburg",
		"scope_regionality": "Local/Regional",
		"region": "Hamburg",
		"location_raw": "Hamburg",
		"organisation_raw": "Institut für Transfusionsmedizin, Universitätsklinikum Hamburg-Eppendorf (UKE)",
		"type": "Cross sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from Hamburg",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Samples of participants",
		"sample_size_obtained": 326,
		"sample_size_rounded": 300,
		"start_date": "2020-06-02",
		"end_date": "2020-06-05",
		"results_seroprevalence_information": "Seroprevalence among blood donors in Hamburg for the period of June 2020",
		"results_publication_url": "https://www.uke.de/allgemein/presse/pressemitteilungen/detailseite_95424.html",
		"results_publication_date": "2020-06-09",
		"results_publication_type": "Webseite",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "Multiple antibodies",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "ROCHE N; DIASORIN; EUROIMMUN; WANTAI",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_sensitivity": 0.864,
		"results_seroprevalence_specificity": 0.998,
		"results_seroprevalence_positive": 0.003,
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Institut für Virologie, Essen",
			"Universitätsklinikum Essen"
		],
		"location": [
			"Essen"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1016/j.jcv.2020.104437",
			"https://doi.org/10.3390/ijerph18094540"
		],
		"title": "SARS-CoV-2 spezifische Immunität und Serokonversion von medizinischem Personal mit COVID-19 Exposititon",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Essen",
		"organisation_raw": "Klinik für Infektiologie, Institut für Virologie, Essen",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Employees of the hospital ",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 800,
		"start_date": "2020-03-01"
	},
	{
		"organisation": [
			"Universitätsmedizin Greifswald",
			"Friedrich-Loeffler-Institut",
			"Friedrich-Loeffler-Institut für Medizinische Mikrobiologie",
			"Friedrich-Loeffler-Institut, Zentralbereich Hygiene"
		],
		"location": [
			"Greifswald"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [],
		"title": "Screening for COVID-19 and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers (SeCo)",
		"scope_regionality": "Local/Regional",
		"region": "Mecklenburg-Western Pomerania",
		"location_raw": "Greifswald",
		"organisation_raw": "Universitätsmedizin Greifswald, Friedrich-Loeffler-Institut für Medizinische Mikrobiologie und Zentralbereich Hygiene",
		"registry_url": "https://clinicaltrials.gov/ct2/show/record/NCT04370119",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Employees of the University Medical Center Greifswald",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 4000,
		"start_date": "2020-04-27"
	},
	{
		"organisation": [
			"Universitätsklinikum Heidelberg"
		],
		"location": [
			"Rhine-Neckar district",
			"Heidelberg"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [],
		"title": "Serial cross-sectional seroprevalence study of SARS-CoV-2 infection during and after the COVID-19 epidemic in Heidelberg and the Rhein-Neckar region",
		"scope_regionality": "Local/Regional",
		"region": "Baden-Wuerttemberg",
		"location_raw": "Heidelberg, Rhine-Neckar district",
		"organisation_raw": "Universitätsklinikum Heidelberg, Sektion Tropenmedizin",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021709",
		"type": "Repeated cross-sectional",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Heidelberg and the Rhine-Neckar district",
		"scope_population": "General population",
		"scope_age": "Multiple",
		"age_min": 5,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1500,
		"sample_size_rounded": 1500,
		"start_date": "2020-05-15"
	},
	{
		"organisation": [
			"Universität Leipzig",
			"Universitätsklinik Leipzig",
			"LIFE Child"
		],
		"location": [
			"Dresden",
			"Zwickau",
			"Leipzig",
			"Werdau",
			"Borna"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [],
		"title": "Study on the Evaluation of the Infectious Process of SARS-CoV-2 in Teachers and Students in Saxony (COVID-19) (SCHULERHEBUNG \"CORONA\")",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Dresden, Zwickau, Leipzig, Werdau and Borna",
		"organisation_raw": "LIFE Child, Medizinische Fakultät der Universität Leipzig, Institut für Virologie der Universitätsklinik Leipzig",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022032",
		"information_url": "https://home.uni-leipzig.de/lifechild/schulerhebung-corona/",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Students and teachers from primary and secondary schools in Saxony",
		"scope_population": "General population and selected population groups",
		"scope_age": "Multiple",
		"age_max": 67,
		"age_min": 7,
		"sample_design": "Multistage, partial random sampling",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 3000,
		"start_date": "2020-05-27",
		"record_modified": "2021-09-27"
	},
	{
		"organisation": [
			"Universität Leipzig",
			"Universitätsklinik Leipzig",
			"LIFE Child"
		],
		"location": [
			"Dresden",
			"Zwickau",
			"Leipzig",
			"Werdau",
			"Borna"
		],
		"analysis_test_manufacturer": [
			"ABBOTT N"
		],
		"resource_url": [],
		"title": "Study on the Evaluation of the Infectious Process of SARS-CoV-2 in Teachers and Students in Saxony (COVID-19) (SCHULERHEBUNG \"CORONA\")",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Dresden, Zwickau, Leipzig, Werdau and Borna",
		"organisation_raw": "LIFE Child, Medizinische Fakultät der Universität Leipzig, Institut für Virologie der Universitätsklinik Leipzig",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022032",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Students secondary schools in Saxony",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 17,
		"sample_design": "Multistage, partial random sampling",
		"sample_analysis_unit": "Participants",
		"start_date": "2020-11-01",
		"end_date": "2020-11-30",
		"results_seroprevalence_information": "Seroprevelence among students in secondary schools in Saxony for the period of November 2020",
		"results_publication_url": "https://home.uni-leipzig.de/lifechild/schulerhebung-corona/",
		"results_publication_type": "Webseite",
		"analysis_data_source": "whole blood",
		"analysis_isotype": "IgG",
		"analysis_test_manufacturer_raw": "ABBOTT N",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.018,
		"record_modified": "2021-09-27"
	},
	{
		"organisation": [
			"Universität Leipzig",
			"Universitätsklinik Leipzig",
			"LIFE Child"
		],
		"location": [
			"Dresden",
			"Zwickau",
			"Leipzig",
			"Werdau",
			"Borna"
		],
		"analysis_test_manufacturer": [
			"ABBOTT N"
		],
		"resource_url": [],
		"title": "Study on the Evaluation of the Infectious Process of SARS-CoV-2 in Teachers and Students in Saxony (COVID-19) (SCHULERHEBUNG \"CORONA\")",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Dresden, Zwickau, Leipzig, Werdau and Borna",
		"organisation_raw": "LIFE Child, Medizinische Fakultät der Universität Leipzig, Institut für Virologie der Universitätsklinik Leipzig",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022032",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Students and teachers from primary and secondary schools in Saxony May to June 2020",
		"scope_population": "General population and selected population groups",
		"scope_age": "Multiple",
		"age_max": 67,
		"age_min": 7,
		"sample_design": "Multistage, partial random sampling",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2344,
		"sample_size_rounded": 2300,
		"start_date": "2020-05-27",
		"end_date": "2020-06-30",
		"results_seroprevalence_information": "Seroprevalence among students and teachers from primary and secondary schools in Saxony for the period from May to June 2020",
		"results_publication_url": "https://home.uni-leipzig.de/lifechild/schulerhebung-corona/",
		"results_publication_type": "Webseite",
		"analysis_data_source": "whole blood",
		"analysis_isotype": "IgG",
		"analysis_test_manufacturer_raw": "ABBOTT N",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.006,
		"record_modified": "2021-09-27"
	},
	{
		"organisation": [
			"Universität Leipzig",
			"Universitätsklinik Leipzig",
			"LIFE Child"
		],
		"location": [
			"Dresden",
			"Zwickau",
			"Leipzig",
			"Werdau",
			"Borna"
		],
		"analysis_test_manufacturer": [
			"ABBOTT N"
		],
		"resource_url": [],
		"title": "Study on the Evaluation of the Infectious Process of SARS-CoV-2 in Teachers and Students in Saxony (COVID-19) (SCHULERHEBUNG \"CORONA\")",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Dresden, Zwickau, Leipzig, Werdau and Borna",
		"organisation_raw": "LIFE Child, Medizinische Fakultät der Universität Leipzig, Institut für Virologie der Universitätsklinik Leipzig",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022032",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Students and teachers from primary and secondary schools in Saxony September 2020",
		"scope_population": "General population and selected population groups",
		"scope_age": "Multiple",
		"age_max": 67,
		"age_min": 7,
		"sample_design": "Multistage, partial random sampling",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2191,
		"sample_size_rounded": 2200,
		"start_date": "2020-09-01",
		"end_date": "2020-09-30",
		"results_seroprevalence_information": "Seroprevalence among students and teachers from primary and secondary schools in Saxony for the period of September 2020",
		"results_publication_url": "https://home.uni-leipzig.de/lifechild/schulerhebung-corona/",
		"results_publication_type": "Webseite",
		"analysis_data_source": "whole blood",
		"analysis_isotype": "IgG",
		"analysis_test_manufacturer_raw": "ABBOTT N",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.006,
		"record_modified": "2021-09-27"
	},
	{
		"organisation": [
			"Universität Leipzig",
			"Universitätsklinik Leipzig",
			"LIFE Child"
		],
		"location": [
			"Dresden",
			"Zwickau",
			"Leipzig",
			"Werdau",
			"Borna"
		],
		"analysis_test_manufacturer": [
			"ABBOTT N"
		],
		"resource_url": [],
		"title": "Study on the Evaluation of the Infectious Process of SARS-CoV-2 in Teachers and Students in Saxony (COVID-19) (SCHULERHEBUNG \"CORONA\")",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Dresden, Zwickau, Leipzig, Werdau and Borna",
		"organisation_raw": "LIFE Child, Medizinische Fakultät der Universität Leipzig, Institut für Virologie der Universitätsklinik Leipzig",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022032",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Students from primary schools in Saxony November 2020",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 17,
		"sample_design": "Multistage, partial random sampling",
		"sample_analysis_unit": "Participants",
		"start_date": "2020-11-01",
		"end_date": "2020-11-30",
		"results_seroprevalence_information": "Seroprevelance among students from primary schools in Saxony for the period of November 2020",
		"results_publication_url": "https://home.uni-leipzig.de/lifechild/schulerhebung-corona/",
		"results_publication_type": "Webseite",
		"analysis_data_source": "whole blood",
		"analysis_isotype": "IgG",
		"analysis_test_manufacturer_raw": "ABBOTT N",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.005,
		"record_modified": "2021-09-27"
	},
	{
		"organisation": [
			"Universität Leipzig",
			"Universitätsklinik Leipzig",
			"LIFE Child"
		],
		"location": [
			"Dresden",
			"Zwickau",
			"Leipzig",
			"Werdau",
			"Borna"
		],
		"analysis_test_manufacturer": [
			"ABBOTT N"
		],
		"resource_url": [],
		"title": "Study on the Evaluation of the Infectious Process of SARS-CoV-2 in Teachers and Students in Saxony (COVID-19) (SCHULERHEBUNG \"CORONA\")",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Dresden, Zwickau, Leipzig, Werdau and Borna",
		"organisation_raw": "LIFE Child, Medizinische Fakultät der Universität Leipzig, Institut für Virologie der Universitätsklinik Leipzig",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022032",
		"information_url": "https://home.uni-leipzig.de/lifechild/schulerhebung-corona/",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Students and teachers from primary and secondary schools in Saxony November 2020",
		"scope_population": "General population and selected population groups",
		"scope_age": "Multiple",
		"age_max": 67,
		"age_min": 7,
		"sample_design": "Multistage, partial random sampling",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2194,
		"sample_size_rounded": 2200,
		"start_date": "2020-11-01",
		"end_date": "2020-11-30",
		"results_seroprevalence_information": "Total seroprevelance among students from primary and secondary schools in Saxony for the period of November 2020",
		"results_publication_url": "https://home.uni-leipzig.de/lifechild/schulerhebung-corona/",
		"results_publication_type": "Webseite",
		"analysis_data_source": "whole blood",
		"analysis_isotype": "IgG",
		"analysis_test_manufacturer_raw": "ABBOTT N",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.014,
		"record_modified": "2021-09-27"
	},
	{
		"organisation": [
			"Helmholtz Zentrum für Infektionsforschung (HZI)"
		],
		"location": [
			"Aachen"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1101/2021.05.04.21256597",
			"https://doi.org/10.3238/arztebl.m2021.0364"
		],
		"title": "Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Aachen (MuSPAD)",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Aachen",
		"organisation_raw": "Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335",
		"information_url": "https://hzi-c19-antikoerperstudie.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Aachen",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2023,
		"sample_size_rounded": 2000,
		"start_date": "2020-09-09",
		"end_date": "2021-02-22",
		"record_modified": "2022-03-23"
	},
	{
		"organisation": [
			"Helmholtz Zentrum für Infektionsforschung (HZI)"
		],
		"location": [
			"Aachen"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Aachen (MuSPAD)",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Aachen",
		"organisation_raw": "Helmholtz Zentrum für Infektionsforschung (HZI)",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335",
		"information_url": "https://hzi-c19-antikoerperstudie.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Aachen",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 99,
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1888,
		"sample_size_rounded": 1900,
		"start_date": "2021-01-27",
		"end_date": "2021-02-22",
		"results_seroprevalence_information": "Seroprevalence from the second wave of the survey in Aachen",
		"results_publication_url": "https://doi.org/10.3238/arztebl.m2021.0364",
		"results_publication_date": "2021-11-05",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_sensitivity": 0.883,
		"results_seroprevalence_specificity": 0.992,
		"results_seroprevalence_positive": 0.054,
		"results_seroprevalence_positive_95pct_lower": 0.044,
		"results_seroprevalence_positive_95pct_upper": 0.065,
		"record_modified": "2022-03-23",
		"results_underreporting": 1.8
	},
	{
		"organisation": [
			"Helmholtz Zentrum für Infektionsforschung (HZI)"
		],
		"location": [
			"Aachen"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Aachen (MuSPAD)",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Aachen",
		"organisation_raw": "Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335",
		"information_url": "https://hzi-c19-antikoerperstudie.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Aachen",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 99,
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2023,
		"sample_size_rounded": 2000,
		"start_date": "2020-09-09",
		"end_date": "2020-10-09",
		"results_seroprevalence_information": "Seroprevalence from the first wave of the survey in Aachen",
		"results_publication_url": "https://doi.org/10.3238/arztebl.m2021.0364",
		"results_publication_date": "2021-11-05",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_sensitivity": 0.883,
		"results_seroprevalence_specificity": 0.992,
		"results_seroprevalence_positive": 0.023,
		"results_seroprevalence_positive_95pct_lower": 0.017,
		"results_seroprevalence_positive_95pct_upper": 0.031,
		"record_modified": "2022-03-23",
		"results_underreporting": 4.9
	},
	{
		"organisation": [
			"Helmholtz Zentrum für Infektionsforschung (HZI)"
		],
		"location": [
			"Chemnitz"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1101/2021.05.04.21256597",
			"https://doi.org/10.3238/arztebl.m2021.0364"
		],
		"title": "Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Chemnitz (MuSPAD)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Chemnitz",
		"organisation_raw": "Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335",
		"information_url": "https://hzi-c19-antikoerperstudie.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Chemnitz",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2701,
		"sample_size_rounded": 2700,
		"start_date": "2021-03-03",
		"end_date": "2021-08-17",
		"record_modified": "2022-03-23"
	},
	{
		"organisation": [
			"Helmholtz Zentrum für Infektionsforschung (HZI)"
		],
		"location": [
			"Chemnitz"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Chemnitz (MuSPAD)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Chemnitz",
		"organisation_raw": "Helmholtz Zentrum für Infektionsforschung (HZI)",
		"information_url": "https://hzi-c19-antikoerperstudie.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Chemnitz",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 99,
		"age_min": 19,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 358,
		"sample_size_rounded": 400,
		"start_date": "2021-07-21",
		"end_date": "2021-08-17",
		"results_seroprevalence_information": "Seroprevalence from the second wave of the survey in Chemnitz",
		"results_publication_url": "https://doi.org/10.3238/arztebl.m2021.0364",
		"results_publication_date": "2021-11-05",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_sensitivity": 0.883,
		"results_seroprevalence_specificity": 0.992,
		"results_seroprevalence_positive": 0.324,
		"results_seroprevalence_positive_95pct_lower": 0.274,
		"results_seroprevalence_positive_95pct_upper": 0.378,
		"record_created": "2021-09-21",
		"record_modified": "2022-03-23"
	},
	{
		"organisation": [
			"Helmholtz Zentrum für Infektionsforschung (HZI)"
		],
		"location": [
			"Chemnitz"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Chemnitz (MuSPAD)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Chemnitz",
		"organisation_raw": "Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335",
		"information_url": "https://hzi-c19-antikoerperstudie.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Chemnitz",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 99,
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2701,
		"sample_size_rounded": 2700,
		"start_date": "2021-03-03",
		"end_date": "2021-03-31",
		"results_seroprevalence_information": "Seroprevalence from the first wave of the survey in Chemnitz",
		"results_publication_url": "https://doi.org/10.3238/arztebl.m2021.0364",
		"results_publication_date": "2021-11-05",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_sensitivity": 0.883,
		"results_seroprevalence_specificity": 0.992,
		"results_seroprevalence_positive": 0.131,
		"results_seroprevalence_positive_95pct_lower": 0.115,
		"results_seroprevalence_positive_95pct_upper": 0.149,
		"record_modified": "2022-03-23",
		"results_underreporting": 2.9
	},
	{
		"organisation": [
			"Helmholtz Zentrum für Infektionsforschung (HZI)"
		],
		"location": [
			"Freiburg"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1101/2021.05.04.21256597",
			"https://doi.org/10.3238/arztebl.m2021.0364"
		],
		"title": "Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Freiburg (MuSPAD)",
		"scope_regionality": "Local/Regional",
		"region": "Baden-Wuerttemberg",
		"location_raw": "Freiburg",
		"organisation_raw": "Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335",
		"information_url": "https://hzi-c19-antikoerperstudie.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Freiburg",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2867,
		"sample_size_rounded": 2900,
		"start_date": "2020-08-05",
		"end_date": "2020-12-15",
		"record_modified": "2022-03-23"
	},
	{
		"organisation": [
			"Helmholtz Zentrum für Infektionsforschung (HZI)"
		],
		"location": [
			"Freiburg"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Freiburg (MuSPAD)",
		"scope_regionality": "Local/Regional",
		"region": "Baden-Wuerttemberg",
		"location_raw": "Freiburg",
		"organisation_raw": "Helmholtz Zentrum für Infektionsforschung (HZI)",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335",
		"information_url": "https://hzi-c19-antikoerperstudie.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Freiburg",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 99,
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1788,
		"sample_size_rounded": 1800,
		"start_date": "2020-11-18",
		"end_date": "2020-12-15",
		"results_seroprevalence_information": "Seroprevalence from the second wave of the survey in Freiburg",
		"results_publication_url": "https://doi.org/10.3238/arztebl.m2021.0364",
		"results_publication_date": "2021-11-05",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_sensitivity": 0.883,
		"results_seroprevalence_specificity": 0.992,
		"results_seroprevalence_positive": 0.024,
		"results_seroprevalence_positive_95pct_lower": 0.021,
		"results_seroprevalence_positive_95pct_upper": 0.037,
		"record_modified": "2022-03-23",
		"results_underreporting": 2.2
	},
	{
		"organisation": [
			"Helmholtz Zentrum für Infektionsforschung (HZI)"
		],
		"location": [
			"Freiburg"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Freiburg (MuSPAD)",
		"scope_regionality": "Local/Regional",
		"region": "Baden-Wuerttemberg",
		"location_raw": "Freiburg",
		"organisation_raw": "Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335",
		"information_url": "https://hzi-c19-antikoerperstudie.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Freiburg",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 99,
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2867,
		"sample_size_rounded": 2900,
		"start_date": "2020-08-05",
		"end_date": "2020-09-02",
		"results_seroprevalence_information": "Seroprevalence from the first wave of the survey in Freiburg",
		"results_publication_url": "https://doi.org/10.3238/arztebl.m2021.0364",
		"results_publication_date": "2021-11-05",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_sensitivity": 0.883,
		"results_seroprevalence_specificity": 0.992,
		"results_seroprevalence_positive": 0.015,
		"results_seroprevalence_positive_95pct_lower": 0.011,
		"results_seroprevalence_positive_95pct_upper": 0.02,
		"record_modified": "2022-03-23",
		"results_underreporting": 3
	},
	{
		"organisation": [
			"Helmholtz Zentrum für Infektionsforschung (HZI)"
		],
		"location": [
			"Hannover"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://hannover.nako.de/2021/05/28/3-000-nako-teilnehmende-aus-hannover-haben-die-moeglichkeit-an-der-zusatzstudie-muspad-in-der-nako-teilzunehmen/"
		],
		"title": "Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Hannover (MuSPAD)",
		"scope_regionality": "Local/Regional",
		"region": "Lower Saxony",
		"location_raw": "Hannover",
		"organisation_raw": "Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335",
		"information_url": "https://hzi-c19-antikoerperstudie.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Participants of the NAKO Health Study from Hannover",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Cohort-sample - Sampling from existing cohort study in the general population",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 3000,
		"start_date": "2021-06-16",
		"end_date": "2021-07-13"
	},
	{
		"organisation": [
			"Helmholtz Zentrum für Infektionsforschung (HZI)"
		],
		"location": [
			"Magdeburg"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1101/2021.05.04.21256597",
			"https://doi.org/10.3238/arztebl.m2021.0364"
		],
		"title": "Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Magdeburg (MuSPAD)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony-Anhalt",
		"location_raw": "Magdeburg",
		"organisation_raw": "Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335",
		"information_url": "https://hzi-c19-antikoerperstudie.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Magdeburg",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2713,
		"sample_size_rounded": 2700,
		"start_date": "2020-11-18",
		"end_date": "2020-12-15"
	},
	{
		"organisation": [
			"Helmholtz Zentrum für Infektionsforschung (HZI)"
		],
		"location": [
			"Magdeburg"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Magdeburg (MuSPAD)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony-Anhalt",
		"location_raw": "Magdeburg",
		"organisation_raw": "Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335",
		"information_url": "https://hzi-c19-antikoerperstudie.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Magdeburg",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 99,
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1118,
		"sample_size_rounded": 1100,
		"start_date": "2021-04-07",
		"end_date": "2021-05-05",
		"results_seroprevalence_information": "Seroprevalence from the second wave of the survey in Magdeburg",
		"results_publication_url": "https://doi.org/10.3238/arztebl.m2021.0364",
		"results_publication_date": "2021-11-05",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_sensitivity": 0.883,
		"results_seroprevalence_specificity": 0.992,
		"results_seroprevalence_positive": 0.06,
		"results_seroprevalence_positive_95pct_lower": 0.037,
		"results_seroprevalence_positive_95pct_upper": 0.097,
		"record_created": "2021-11-15",
		"record_modified": "2022-03-23"
	},
	{
		"organisation": [
			"Helmholtz Zentrum für Infektionsforschung (HZI)"
		],
		"location": [
			"Magdeburg"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Magdeburg (MuSPAD)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony-Anhalt",
		"location_raw": "Magdeburg",
		"organisation_raw": "Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335",
		"information_url": "https://hzi-c19-antikoerperstudie.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Magdeburg",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 99,
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2713,
		"sample_size_rounded": 2700,
		"start_date": "2020-11-18",
		"end_date": "2020-12-15",
		"results_seroprevalence_information": "Seroprevalence from the first wave of the survey in Magdeburg",
		"results_publication_url": "https://doi.org/10.3238/arztebl.m2021.0364",
		"results_publication_date": "2021-11-05",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_sensitivity": 0.883,
		"results_seroprevalence_specificity": 0.992,
		"results_seroprevalence_positive": 0.024,
		"results_seroprevalence_positive_95pct_lower": 0.019,
		"results_seroprevalence_positive_95pct_upper": 0.031,
		"record_modified": "2022-03-23",
		"results_underreporting": 5.1
	},
	{
		"organisation": [
			"Helmholtz Zentrum für Infektionsforschung (HZI)"
		],
		"location": [
			"Osnabrück"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1101/2021.05.04.21256597",
			"https://doi.org/10.3238/arztebl.m2021.0364"
		],
		"title": "Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Osnabrück (MuSPAD)",
		"scope_regionality": "Local/Regional",
		"region": "Lower Saxony",
		"location_raw": "Osnabrück",
		"organisation_raw": "Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335",
		"information_url": "https://hzi-c19-antikoerperstudie.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Osnabrück",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1611,
		"sample_size_rounded": 1600,
		"start_date": "2020-10-15",
		"end_date": "2020-11-15"
	},
	{
		"organisation": [
			"Helmholtz Zentrum für Infektionsforschung (HZI)"
		],
		"location": [
			"Osnabrück"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Osnabrück (MuSPAD)",
		"scope_regionality": "Local/Regional",
		"region": "Lower Saxony",
		"location_raw": "Osnabrück",
		"organisation_raw": "Helmholtz Zentrum für Infektionsforschung (HZI)",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335",
		"information_url": "https://hzi-c19-antikoerperstudie.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Osnabrück",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 99,
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1611,
		"sample_size_rounded": 1600,
		"start_date": "2021-03-03",
		"end_date": "2021-03-30",
		"results_seroprevalence_information": "Seroprevalence from the second wave of the survey in Osnabrück",
		"results_publication_url": "https://doi.org/10.3238/arztebl.m2021.0364",
		"results_publication_date": "2021-11-05",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_sensitivity": 0.883,
		"results_seroprevalence_specificity": 0.992,
		"results_seroprevalence_positive": 0.041,
		"results_seroprevalence_positive_95pct_lower": 0.032,
		"results_seroprevalence_positive_95pct_upper": 0.052,
		"record_modified": "2022-03-23",
		"results_underreporting": 1.3
	},
	{
		"organisation": [
			"Helmholtz Zentrum für Infektionsforschung (HZI)"
		],
		"location": [
			"Osnabrück"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Osnabrück (MuSPAD)",
		"scope_regionality": "Local/Regional",
		"region": "Lower Saxony",
		"location_raw": "Osnabrück",
		"organisation_raw": "Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335",
		"information_url": "https://hzi-c19-antikoerperstudie.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Osnabrück",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 99,
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2923,
		"sample_size_rounded": 2900,
		"start_date": "2020-10-14",
		"end_date": "2020-11-10",
		"results_seroprevalence_information": "Seroprevalence from the first wave of the survey in Osnabrück",
		"results_publication_url": "https://doi.org/10.3238/arztebl.m2021.0364",
		"results_publication_date": "2021-11-05",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_sensitivity": 0.883,
		"results_seroprevalence_specificity": 0.992,
		"results_seroprevalence_positive": 0.013,
		"results_seroprevalence_positive_95pct_lower": 0.01,
		"results_seroprevalence_positive_95pct_upper": 0.018,
		"record_modified": "2022-03-23",
		"results_underreporting": 2.6
	},
	{
		"organisation": [
			"Helmholtz Zentrum für Infektionsforschung (HZI)"
		],
		"location": [
			"Reutlingen"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1101/2021.05.04.21256597",
			"https://doi.org/10.3238/arztebl.m2021.0364"
		],
		"title": "Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Reutlingen (MuSPAD)",
		"scope_regionality": "Local/Regional",
		"region": "Baden-Wuerttemberg",
		"location_raw": "Reutlingen",
		"organisation_raw": "Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335",
		"information_url": "https://hzi-c19-antikoerperstudie.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Reutlingen",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2360,
		"sample_size_rounded": 2400,
		"start_date": "2020-07-01",
		"end_date": "2020-07-28"
	},
	{
		"organisation": [
			"Helmholtz Zentrum für Infektionsforschung (HZI)"
		],
		"location": [
			"Reutlingen"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Reutlingen (MuSPAD)",
		"scope_regionality": "Local/Regional",
		"region": "Baden-Wuerttemberg",
		"location_raw": "Reutlingen",
		"organisation_raw": "Helmholtz Zentrum für Infektionsforschung (HZI)",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335",
		"information_url": "https://hzi-c19-antikoerperstudie.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Reutlingen",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 99,
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2360,
		"sample_size_rounded": 2400,
		"start_date": "2020-10-14",
		"end_date": "2020-11-10",
		"results_seroprevalence_information": "Seroprevalence from the second wave of the survey in Reutlingen",
		"results_publication_url": "https://doi.org/10.3238/arztebl.m2021.0364",
		"results_publication_date": "2021-11-05",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_sensitivity": 0.883,
		"results_seroprevalence_specificity": 0.992,
		"results_seroprevalence_positive": 0.028,
		"results_seroprevalence_positive_95pct_lower": 0.021,
		"results_seroprevalence_positive_95pct_upper": 0.037,
		"record_modified": "2022-03-23",
		"results_underreporting": 3.5
	},
	{
		"organisation": [
			"Helmholtz Zentrum für Infektionsforschung (HZI)"
		],
		"location": [
			"Reutlingen"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Reutlingen (MuSPAD)",
		"scope_regionality": "Local/Regional",
		"region": "Baden-Wuerttemberg",
		"location_raw": "Reutlingen",
		"organisation_raw": "Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335",
		"information_url": "https://hzi-c19-antikoerperstudie.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Reutlingen",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 99,
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2407,
		"sample_size_rounded": 2400,
		"start_date": "2020-07-01",
		"end_date": "2020-07-28",
		"results_seroprevalence_information": "Seroprevalence from the first wave of the survey in Reutlingen",
		"results_publication_url": "https://doi.org/10.3238/arztebl.m2021.0364",
		"results_publication_date": "2021-11-05",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_sensitivity": 0.883,
		"results_seroprevalence_specificity": 0.992,
		"results_seroprevalence_positive": 0.026,
		"results_seroprevalence_positive_95pct_lower": 0.02,
		"results_seroprevalence_positive_95pct_upper": 0.033,
		"record_modified": "2022-03-23",
		"results_underreporting": 4.1
	},
	{
		"organisation": [
			"Helmholtz Zentrum für Infektionsforschung (HZI)"
		],
		"location": [
			"Greifswald"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.3238/arztebl.m2021.0364"
		],
		"title": "Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Vorpommern-Greifswald (MuSPAD)",
		"scope_regionality": "Local/Regional",
		"region": "Mecklenburg-Western Pomerania",
		"location_raw": "Western Pomerania - Greifswald",
		"organisation_raw": "Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335",
		"information_url": "https://hzi-c19-antikoerperstudie.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Vorpommern-Greifswald",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 954,
		"sample_size_rounded": 1000,
		"start_date": "2021-05-12",
		"end_date": "2021-06-08"
	},
	{
		"organisation": [
			"Helmholtz Zentrum für Infektionsforschung (HZI)"
		],
		"location": [
			"Greifswald"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany - Vorpommern-Greifswald (MuSPAD)",
		"scope_regionality": "Local/Regional",
		"region": "Mecklenburg-Western Pomerania",
		"location_raw": "Western Pomerania - Greifswald",
		"organisation_raw": "Helmholtz Zentrum für Infektionsforschung (HZI), Braunschweig",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022335",
		"information_url": "https://hzi-c19-antikoerperstudie.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Vorpommern-Greifswald",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 99,
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 954,
		"sample_size_rounded": 1000,
		"start_date": "2021-05-12",
		"end_date": "2021-06-08",
		"results_seroprevalence_information": "Seroprevalence from the first wave of the survey in Vorpommern-Greifswald",
		"results_publication_url": "https://doi.org/10.3238/arztebl.m2021.0364",
		"results_publication_date": "2021-11-05",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_sensitivity": 0.883,
		"results_seroprevalence_specificity": 0.992,
		"results_seroprevalence_positive": 0.116,
		"results_seroprevalence_positive_95pct_lower": 0.094,
		"results_seroprevalence_positive_95pct_upper": 0.143,
		"record_modified": "2022-03-23"
	},
	{
		"organisation": [
			"Universität Marburg, Institut für Virologie",
			"Infraserv GmbH & Co.",
			"Höchst KG",
			"Universitätsklinikum Frankfurt, Institut für Medizinische Virologie",
			"Gesundheitsamt Frankfurt",
			"Universität Marburg",
			"Universitätsklinikum Frankfurt"
		],
		"location": [
			"Frankfurt am Main"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1101/2020.05.20.20107730"
		],
		"title": "Prävalenz von SARS-CoV-2-Infektionen und neutralisierenden Antikörpern bei Mitarbeitern eines Industrieunternehmens in Frankfurt am Main",
		"scope_regionality": "Local/Regional",
		"region": "Hesse",
		"location_raw": "Frankfurt am Main",
		"organisation_raw": "Institut für Virologie Marburg; Infraserv GmbH & Co. Höchst KG; Institut für Medizinische Virologie, Frankfurt; Gesundheitsamt Frankfurt",
		"type": "Cross sectional",
		"subject_frame": "Non-essential workers and unemployed persons",
		"subject_information": "Employees of Infraserv Höchst",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 998,
		"sample_size_rounded": 1000,
		"start_date": "2020-04-06",
		"end_date": "2020-04-14"
	},
	{
		"organisation": [
			"Universitätskinderklinik Bochum",
			"St. Josef-Hospital, Klinikum der Ruhr-Universität-Bochum"
		],
		"location": [
			"Bochum",
			"Herne",
			"Gütersloh",
			"Ruhr Area"
		],
		"analysis_test_manufacturer": [
			"ROCHE N"
		],
		"resource_url": [],
		"title": "COVID19/ SARS-CoV-2 seroconversion in kids (CorKid)",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Ruhr area (Bochum, Herne, Gütersloh)",
		"organisation_raw": "Universitätskinderklinik Bochum, St. Josef-Hospital, Klinikum der Ruhr-Universität-Bochum",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022434",
		"information_url": "https://corkid.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Children (6 months and older) and adolescents presenting for scheduled screening at participating pediatric practices in Gütersloh, and their families",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 18,
		"age_min": 0,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 3000,
		"start_date": "2020-06-01",
		"end_date": "2020-06-30",
		"results_seroprevalence_information": "Underreporting factor of children and adolescents who visited a pediatrician's practice in Gütersloh, Herne or Bochum for screening in the period June 2020",
		"results_publication_url": "https://doi.org/10.3390/idr13040088",
		"results_publication_date": "2021-11-12",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_target": "anti Nucleocapsid",
		"analysis_isotype": "Multiple antibodies",
		"analysis_test": "Elektrochemolumineszenz (ECL)-Immunassay; LIPS",
		"analysis_test_manufacturer_raw": "ROCHE N",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Population-weighted",
		"record_modified": "2022-02-11",
		"results_underreporting": 2
	},
	{
		"organisation": [
			"Universitätskinderklinik Bochum",
			"St. Josef-Hospital, Klinikum der Ruhr-Universität-Bochum"
		],
		"location": [
			"Bochum",
			"Herne",
			"Gütersloh",
			"Ruhr Area"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1101/2021.10.21.21265322",
			"https://doi.org/10.3390/idr13040088"
		],
		"title": "COVID19/ SARS-CoV-2 seroconversion in kids (CorKid)",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Ruhr area (Bochum, Herne, Gütersloh)",
		"organisation_raw": "Universitätskinderklinik Bochum, St. Josef-Hospital, Klinikum der Ruhr-Universität-Bochum",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022434",
		"information_url": "https://corkid.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Children (6 months and older) and adolescents presenting for scheduled screening at participating pediatric practices, and their families",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 18,
		"age_min": 0,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2090,
		"sample_size_rounded": 2100,
		"start_date": "2020-06-15",
		"end_date": "2021-02-15",
		"record_modified": "2022-02-01"
	},
	{
		"organisation": [
			"Universitätskinderklinik Bochum",
			"St. Josef-Hospital, Klinikum der Ruhr-Universität-Bochum"
		],
		"location": [
			"Gütersloh",
			"Ruhr Area"
		],
		"analysis_test_manufacturer": [
			"ROCHE N"
		],
		"resource_url": [],
		"title": "COVID19/ SARS-CoV-2 seroconversion in kids (CorKid)",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Ruhr Area (Gütersloh)",
		"organisation_raw": "Universitätskinderklinik Bochum, St. Josef-Hospital, Klinikum der Ruhr-Universität-Bochum",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022434",
		"information_url": "https://corkid.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Children (6 months and older) and adolescents presenting for scheduled screening at participating pediatric practices in Gütersloh, and their families",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 18,
		"age_min": 0,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 819,
		"sample_size_rounded": 800,
		"start_date": "2021-02-01",
		"end_date": "2021-02-15",
		"results_seroprevalence_information": "Underreporting factor of children and adolescents who visited a pediatrician's practice in Bochum for screening in the period February 2021",
		"results_publication_url": "https://doi.org/10.3390/idr13040088",
		"results_publication_date": "2021-11-12",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_target": "anti Nucleocapsid",
		"analysis_isotype": "Multiple antibodies",
		"analysis_test": "Elektrochemolumineszenz (ECL)-Immunassay; LIPS",
		"analysis_test_manufacturer_raw": "ROCHE N",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Population-weighted",
		"record_modified": "2022-01-27",
		"results_underreporting": 4
	},
	{
		"organisation": [
			"Universitätskinderklinik Bochum",
			"St. Josef-Hospital, Klinikum der Ruhr-Universität-Bochum"
		],
		"location": [
			"Bochum",
			"Herne",
			"Ruhr Area"
		],
		"analysis_test_manufacturer": [
			"ROCHE N"
		],
		"resource_url": [],
		"title": "COVID19/ SARS-CoV-2 seroconversion in kids (CorKid)",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Ruhr Area (Bochum and Herne)",
		"organisation_raw": "Universitätskinderklinik Bochum, St. Josef-Hospital, Klinikum der Ruhr-Universität-Bochum",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022434",
		"information_url": "https://corkid.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Children (6 months and older) and adolescents presenting for scheduled screening at participating pediatric practices in Bochum or Herne, and their families",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 18,
		"age_min": 0,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1271,
		"sample_size_rounded": 1300,
		"start_date": "2021-02-01",
		"end_date": "2021-02-15",
		"results_seroprevalence_information": "Underreporting factor of children and adolescents who visited a pediatrician's practice in Gütersloh or Herne for screening in the period February 2021",
		"results_publication_url": "https://doi.org/10.3390/idr13040088",
		"results_publication_date": "2021-11-12",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_target": "anti Nucleocapsid",
		"analysis_isotype": "Multiple antibodies",
		"analysis_test": "Elektrochemolumineszenz (ECL)-Immunassay; LIPS",
		"analysis_test_manufacturer_raw": "ROCHE N",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Population-weighted",
		"record_modified": "2022-01-27",
		"results_underreporting": 3
	},
	{
		"organisation": [
			"Universitätskinderklinik Bochum",
			"St. Josef-Hospital, Klinikum der Ruhr-Universität-Bochum"
		],
		"location": [
			"Bochum",
			"Herne",
			"Gütersloh",
			"Ruhr Area"
		],
		"analysis_test_manufacturer": [
			"ROCHE N"
		],
		"resource_url": [],
		"title": "COVID19/ SARS-CoV-2 seroconversion in kids (CorKid)",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Ruhr area (Bochum, Herne, Gütersloh)",
		"organisation_raw": "Universitätskinderklinik Bochum, St. Josef-Hospital, Klinikum der Ruhr-Universität-Bochum",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022434",
		"information_url": "https://corkid.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Children (6 months and older) and adolescents presenting for scheduled screening at participating pediatric practices in Bochum, Herne or Gütersloh, and their families",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 18,
		"age_min": 0,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2090,
		"sample_size_rounded": 2100,
		"start_date": "2021-02-01",
		"end_date": "2021-02-15",
		"results_seroprevalence_information": "Seroprevalence of children and adolescents who visited a pediatrician's practice in the Ruhr area for screening in the period of February 2021",
		"results_publication_url": "https://doi.org/10.3390/idr13040088",
		"results_publication_date": "2021-11-12",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_target": "anti Nucleocapsid",
		"analysis_isotype": "Multiple antibodies",
		"analysis_test": "Elektrochemolumineszenz (ECL)-Immunassay; LIPS",
		"analysis_test_manufacturer_raw": "ROCHE N",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Population-weighted",
		"results_seroprevalence_positive": 0.08,
		"record_modified": "2022-01-27"
	},
	{
		"organisation": [
			"Universitätskinderklinik Bochum",
			"St. Josef-Hospital, Klinikum der Ruhr-Universität-Bochum"
		],
		"location": [
			"Bochum",
			"Herne",
			"Gütersloh",
			"Ruhr Area"
		],
		"analysis_test_manufacturer": [
			"ROCHE N"
		],
		"resource_url": [],
		"title": "COVID19/ SARS-CoV-2 seroconversion in kids (CorKid)",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Ruhr area (Bochum, Herne, Gütersloh)",
		"organisation_raw": "Universitätskinderklinik Bochum, St. Josef-Hospital, Klinikum der Ruhr-Universität-Bochum",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022434",
		"information_url": "https://corkid.de/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Children (6 months and older) and adolescents presenting for scheduled screening at participating pediatric practices, and their families",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 18,
		"age_min": 0,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2090,
		"start_date": "2020-06-15",
		"end_date": "2020-06-30",
		"results_seroprevalence_information": "Seroprevalence of children and adolescents who visited a pediatrician's practice in the Ruhr area for screening in the period of June 2020",
		"results_publication_url": "https://doi.org/10.3390/idr13040088",
		"results_publication_date": "2021-11-12",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_target": "anti Nucleocapsid",
		"analysis_isotype": "Multiple antibodies",
		"analysis_test": "Elektrochemolumineszenz (ECL)-Immunassay; LIPS",
		"analysis_test_manufacturer_raw": "ROCHE N",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Population-weighted",
		"results_seroprevalence_positive": 0.005,
		"record_modified": "2022-02-01"
	},
	{
		"organisation": [
			"Universitätsfrauenklinik Erlangen"
		],
		"location": [
			"Franconia"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [],
		"title": "Prevalence of SARS-CoV-2 (COVID-19) in pregnancy and at delivery in Franconia, Germany (SCENARIO)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Franconia",
		"organisation_raw": "Universitätsfrauenklinik Erlangen",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022088",
		"information_url": "http://www.covid19scenario.de",
		"type": "Repeated cross-sectional",
		"subject_frame": "Other groups",
		"subject_information": "Pregnant women and obstetric staff of maternity hospitals in Franconia",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 2600,
		"start_date": "2020-06-02"
	},
	{
		"organisation": [
			"Universitätsmedizin Greifswald"
		],
		"location": [
			"Western Pomerania"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [],
		"title": "Bevölkerungsbasierte infektionsepidemiologische SARS-CoV-2 Surveillance in Mecklenburg-Vorpommern (SHIP-COVID)",
		"scope_regionality": "Local/Regional",
		"region": "Mecklenburg-Western Pomerania",
		"location_raw": "Western Pomerania except the islands",
		"organisation_raw": "Universitätsmedizin Greifswald KöR",
		"information_url": "https://www.regierung-mv.de/Landesregierung/wm/Aktuell/?id=165334&processor=processor.sa.pressemitteilung",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Participants already included in the SHIP (Study of Health in Pomerania) cohort and additional participants",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 40,
		"sample_design": "Cohort-sample - Sampling from existing cohort study in the general population",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 1000,
		"start_date": "2020-10-01"
	},
	{
		"organisation": [
			"Charité - Universitätsmedizin Berlin, Institut für Tropenmedizin und Internationale Gesundheit",
			"Charité - Universitätsmedizin Berlin"
		],
		"location": [
			"Berlin"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1101/2020.12.08.20245910",
			"https://doi.org/10.3390/ijerph18052739",
			"https://doi.org/10.1093/eurpub/ckab079"
		],
		"title": "Berliner Corona Schul-und Kitastudie (BECOSS)",
		"scope_regionality": "Local/Regional",
		"region": "Berlin",
		"location_raw": "Berlin",
		"organisation_raw": "Institut für Tropenmedizin und Internationale Gesundheit, Charité - Universitätsmedizin Berlin",
		"information_url": "https://www.charite.de/klinikum/themen_klinikum/themenschwerpunkt_coronavirus/teststrategie/wissenschaftliche_studien/",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Pupils, daycare children, their household members and pedagogical staff from Berlin schools and daycare centers",
		"scope_population": "General population and selected population groups",
		"scope_age": "Multiple",
		"sample_design": "Multistage, partial random sampling",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 2000,
		"start_date": "2020-06-01",
		"record_modified": "2021-09-28"
	},
	{
		"organisation": [
			"Charité - Universitätsmedizin Berlin, Institut für Tropenmedizin und Internationale Gesundheit",
			"Charité - Universitätsmedizin Berlin"
		],
		"location": [
			"Berlin"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Berliner Corona Schul-und Kitastudie (BECOSS-Kita)",
		"scope_regionality": "Local/Regional",
		"region": "Berlin",
		"location_raw": "Berlin",
		"organisation_raw": "Institut für Tropenmedizin und Internationale Gesundheit, Charité - Universitätsmedizin Berlin",
		"information_url": "https://www.charite.de/klinikum/themen_klinikum/themenschwerpunkt_coronavirus/teststrategie/wissenschaftliche_studien/",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Pre-school children from kindergartens in Berlin for the period from September to October 2020",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 6,
		"age_min": 1,
		"sample_design": "Multistage, partial random sampling",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 155,
		"sample_size_rounded": 200,
		"start_date": "2020-09-28",
		"end_date": "2020-10-02",
		"results_seroprevalence_information": "Seroprevalence among pre-school children from kindergartens in Berlin for the period from September to October 2020",
		"results_publication_url": "https://doi.org/10.1093/eurpub/ckab079",
		"results_publication_date": "2021-05-06",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "capillary blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Not adjusted",
		"results_seroprevalence_positive": 0,
		"record_modified": "2021-09-28"
	},
	{
		"organisation": [
			"Charité - Universitätsmedizin Berlin, Institut für Tropenmedizin und Internationale Gesundheit",
			"Charité - Universitätsmedizin Berlin"
		],
		"location": [
			"Berlin"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Berliner Corona Schul-und Kitastudie (BECOSS-Schule)",
		"scope_regionality": "Local/Regional",
		"region": "Berlin",
		"location_raw": "Berlin",
		"organisation_raw": "Institut für Tropenmedizin und Internationale Gesundheit, Charité - Universitätsmedizin Berlin",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Students from schools in Berlin June 2020",
		"scope_population": "Selected population groups",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 18,
		"age_min": 8,
		"sample_design": "Multistage, partial random sampling",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 385,
		"sample_size_rounded": 400,
		"start_date": "2020-06-11",
		"end_date": "2020-06-19",
		"results_seroprevalence_information": "Seroprevalence among students from schools in Berlin for the period of June 2020",
		"results_publication_url": "https://doi.org/10.3390/ijerph18052739",
		"results_publication_date": "2021-08-26",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "capillary blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Not adjusted",
		"results_seroprevalence_positive": 0.013,
		"record_modified": "2021-11-03"
	},
	{
		"organisation": [
			"Charité - Universitätsmedizin Berlin, Institut für Tropenmedizin und Internationale Gesundheit",
			"Charité - Universitätsmedizin Berlin"
		],
		"location": [
			"Berlin"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Berliner Corona Schul-und Kitastudie (BECOSS-Schule)",
		"scope_regionality": "Local/Regional",
		"region": "Berlin",
		"location_raw": "Berlin",
		"organisation_raw": "Institut für Tropenmedizin und Internationale Gesundheit, Charité - Universitätsmedizin Berlin",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Students from schools in Berlin November 2020",
		"scope_population": "Selected population groups",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 18,
		"age_min": 9,
		"sample_design": "Multistage, partial random sampling",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 352,
		"sample_size_rounded": 400,
		"start_date": "2020-11-02",
		"end_date": "2020-11-16",
		"results_seroprevalence_information": "Seroprevalence among students from schools in Berlin for the period of November 2020",
		"results_publication_url": "https://doi.org/10.2807/1560-7917.ES.2021.26.34.2100184",
		"results_publication_date": "2021-08-26",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "capillary blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Not adjusted",
		"results_seroprevalence_positive": 0.02,
		"results_seroprevalence_positive_95pct_lower": 0.008,
		"results_seroprevalence_positive_95pct_upper": 0.041,
		"record_modified": "2021-11-03"
	},
	{
		"organisation": [
			"Robert Koch-Institut, Berlin"
		],
		"location": [
			"Bad Feilnbach"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [
			"http://dx.doi.org/10.25646/7053",
			"https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Bad_Feilnbach.html"
		],
		"title": "Seroepidemiologische Studie zur Verbreitung von SARS-CoV-2 in der Bevölkerung an besonders betroffenen Orten in Deutschland - Bad Feilnbach (CORONA-MONITORING lokal)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Bad Feilnbach",
		"organisation_raw": "Robert Koch-Institut, Berlin",
		"information_url": "https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/cml-studie_node.html",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Bad Feilnbach",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 98,
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2150,
		"sample_size_rounded": 2200,
		"start_date": "2020-06-23",
		"end_date": "2020-07-04",
		"results_seroprevalence_information": "Seroprevalence among inhabitants of Bad Feilnbach",
		"results_publication_url": "https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Bad_Feilnbach.html",
		"results_publication_date": "2021-09-15",
		"results_publication_type": "Webseite",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_sensitivity": 0.883,
		"results_seroprevalence_specificity": 0.994,
		"results_seroprevalence_positive": 0.065,
		"results_seroprevalence_positive_95pct_lower": 0.052,
		"results_seroprevalence_positive_95pct_upper": 0.081,
		"record_modified": "2021-11-01",
		"results_underreporting": 3
	},
	{
		"organisation": [
			"Robert Koch-Institut, Berlin"
		],
		"location": [
			"Berlin"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"http://dx.doi.org/10.25646/7053",
			"https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Berlin-Mitte.html"
		],
		"title": "Seroepidemiologische Studie zur Verbreitung von SARS-CoV-2 in der Bevölkerung an besonders betroffenen Orten in Deutschland - Berlin-Mitte (CORONA-MONITORING lokal)",
		"scope_regionality": "Local/Regional",
		"region": "Berlin",
		"location_raw": "Berlin-Mitte",
		"organisation_raw": "Robert Koch-Institut, Berlin",
		"information_url": "https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/cml-studie_node.html",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Berlin Mitte",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2287,
		"sample_size_rounded": 2300,
		"start_date": "2020-11-17"
	},
	{
		"organisation": [
			"Robert Koch-Institut, Berlin"
		],
		"location": [
			"Berlin"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Seroepidemiologische Studie zur Verbreitung von SARS-CoV-2 in der Bevölkerung an besonders betroffenen Orten in Deutschland - Berlin-Mitte (CORONA-MONITORING lokal)",
		"scope_regionality": "Local/Regional",
		"region": "Berlin",
		"location_raw": "Berlin-Mitte",
		"organisation_raw": "Robert Koch-Institut, Berlin",
		"information_url": "https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/cml-studie_node.html",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Berlin-Mitte",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 92,
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2285,
		"sample_size_rounded": 2300,
		"start_date": "2020-11-17",
		"end_date": "2020-12-05",
		"results_seroprevalence_information": "Seroprevalence among inhabitants of Berlin-Mitte",
		"results_publication_url": "https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Berlin-Mitte.html",
		"results_publication_date": "2021-09-15",
		"results_publication_type": "Webseite",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_positive": 0.029,
		"results_seroprevalence_positive_95pct_lower": 0.02,
		"results_seroprevalence_positive_95pct_upper": 0.042,
		"record_modified": "2021-11-01",
		"results_underreporting": 1.4
	},
	{
		"organisation": [
			"Robert Koch-Institut, Berlin"
		],
		"location": [
			"Kupferzell"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [
			"http://dx.doi.org/10.25646/7053",
			"https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Kupferzell.html",
			"https://doi.org/10.2807/1560-7917.es.2020.25.47.2001752"
		],
		"title": "Seroepidemiologische Studie zur Verbreitung von SARS-CoV-2 in der Bevölkerung an besonders betroffenen Orten in Deutschland - Kupferzell (CORONA-MONITORING lokal)",
		"scope_regionality": "Local/Regional",
		"region": "Baden-Wuerttemberg",
		"location_raw": "Kupferzell",
		"organisation_raw": "Robert Koch-Institut, Berlin",
		"information_url": "https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/cml-studie_node.html",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Kupferzell",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 94,
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2203,
		"sample_size_rounded": 2200,
		"start_date": "2020-05-20",
		"end_date": "2020-06-09",
		"results_seroprevalence_information": "Seroprevalence among inhabitants of Kupferzell",
		"results_publication_url": "https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Dokumente/Factsheet_Kupferzell.pdf?__blob=publicationFile",
		"results_publication_date": "2021-09-15",
		"results_publication_type": "Webseite",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_sensitivity": 0.883,
		"results_seroprevalence_specificity": 0.992,
		"results_seroprevalence_positive": 0.1,
		"results_seroprevalence_positive_95pct_lower": 0.085,
		"results_seroprevalence_positive_95pct_upper": 0.118,
		"record_modified": "2021-11-01",
		"results_underreporting": 5
	},
	{
		"organisation": [
			"Robert Koch-Institut, Berlin"
		],
		"location": [
			"Straubing"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [
			"http://dx.doi.org/10.25646/7053",
			"https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Straubing.html"
		],
		"title": "Seroepidemiologische Studie zur Verbreitung von SARS-CoV-2 in der Bevölkerung an besonders betroffenen Orten in Deutschland - Straubing (CORONA-MONITORING lokal)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Straubing",
		"organisation_raw": "Robert Koch-Institut, Berlin",
		"information_url": "https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/cml-studie_node.html",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Residents of Straubing",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 96,
		"age_min": 18,
		"sample_design": "Random sampling (central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2361,
		"sample_size_rounded": 2400,
		"start_date": "2020-09-08",
		"end_date": "2020-09-26",
		"results_seroprevalence_information": "Seroprevalence among inhabitants of Straubing",
		"results_publication_url": "https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Dokumente/Factsheet_Straubing.pdf?__blob=publicationFile",
		"results_publication_date": "2021-09-15",
		"results_publication_type": "Webseite",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_positive": 0.022,
		"results_seroprevalence_positive_95pct_lower": 0.014,
		"results_seroprevalence_positive_95pct_upper": 0.033,
		"record_modified": "2021-11-01",
		"results_underreporting": 2
	},
	{
		"organisation": [
			"Robert Koch-Institut, Berlin",
			"Deutsches Institut für Wirtschaftsforschung, Berlin"
		],
		"location": [
			"Germany"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Corona-Monitoring bundesweit (RKI-SOEP-Studie)",
		"scope_regionality": "Nationwide",
		"region": "Nationwide",
		"location_raw": "Nationwide",
		"organisation_raw": "Robert Koch-Institut, Berlin; Deutsches Institut für Wirtschaftsforschung, Berlin",
		"information_url": "https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/lid/lid_node.html",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Participants from the Socio-Economic Panel (SOEP) core sample and the SOEP innovation sample, who are taking part in the \"Living in Germany\" survey",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Cohort-sample - Sampling from existing cohort study in the general population",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 11162,
		"sample_size_rounded": 11200,
		"start_date": "2021-11-11",
		"end_date": "2022-02-28",
		"results_seroprevalence_information": "Prevalence of antibodies against the spike protein among adult participants from the core and innovation samples of the Soco-Economic Panel (SOEP) for the period November 2021 to February 2022",
		"results_publication_url": "https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/lid/Factsheet-CoMoBu-Welle-2.pdf?__blob=publicationFile",
		"results_publication_date": "2022-07-21",
		"results_publication_type": "Institutional report",
		"analysis_data_source": "capillary blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_positive": 0.916,
		"results_seroprevalence_positive_95pct_lower": 0.907,
		"results_seroprevalence_positive_95pct_upper": 0.925,
		"record_created": "2022-07-22",
		"record_modified": "2022-07-25"
	},
	{
		"organisation": [
			"Robert Koch-Institut, Berlin",
			"Deutsches Institut für Wirtschaftsforschung, Berlin"
		],
		"location": [
			"Germany"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Corona-Monitoring bundesweit (RKI-SOEP-Studie)",
		"scope_regionality": "Nationwide",
		"region": "Nationwide",
		"location_raw": "Nationwide",
		"organisation_raw": "Robert Koch-Institut, Berlin; Deutsches Institut für Wirtschaftsforschung, Berlin",
		"information_url": "https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/lid/lid_node.html",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Participants from the Socio-Economic Panel (SOEP) core sample and the SOEP innovation sample, who are taking part in the \"Living in Germany\" survey",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 60,
		"sample_design": "Cohort-sample - Sampling from existing cohort study in the general population",
		"sample_analysis_unit": "Participants",
		"start_date": "2021-11-11",
		"end_date": "2022-02-28",
		"results_seroprevalence_information": "Prevalence of antibodies against the spike protein among adult participants 60 years and older from the core and innovation samples of the Soco-Economic Panel (SOEP) for the period November 2021 to February 2022",
		"results_publication_url": "https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/lid/Factsheet-CoMoBu-Welle-2.pdf?__blob=publicationFile",
		"results_publication_date": "2022-07-21",
		"results_publication_type": "Institutional report",
		"analysis_data_source": "capillary blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_positive": 0.905,
		"results_seroprevalence_positive_95pct_lower": 0.89,
		"results_seroprevalence_positive_95pct_upper": 0.919,
		"record_created": "2022-07-22",
		"record_modified": "2022-07-25"
	},
	{
		"organisation": [
			"Robert Koch-Institut, Berlin",
			"Deutsches Institut für Wirtschaftsforschung, Berlin"
		],
		"location": [
			"Germany"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Corona-Monitoring bundesweit (RKI-SOEP-Studie)",
		"scope_regionality": "Nationwide",
		"region": "Nationwide",
		"location_raw": "Nationwide",
		"organisation_raw": "Robert Koch-Institut, Berlin; Deutsches Institut für Wirtschaftsforschung, Berlin",
		"information_url": "https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/lid/lid_node.html",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Participants from the Socio-Economic Panel (SOEP) core sample and the SOEP innovation sample, who are taking part in the \"Living in Germany\" survey",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 59,
		"age_min": 18,
		"sample_design": "Cohort-sample - Sampling from existing cohort study in the general population",
		"sample_analysis_unit": "Participants",
		"start_date": "2021-11-11",
		"end_date": "2022-02-28",
		"results_seroprevalence_information": "Prevalence of antibodies against the spike protein among participants aged 18 to 59 yearsfrom the core and innovation samples of the Soco-Economic Panel (SOEP) for the period November 2021 to February 2022",
		"results_publication_url": "https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/lid/Factsheet-CoMoBu-Welle-2.pdf?__blob=publicationFile",
		"results_publication_date": "2022-07-21",
		"results_publication_type": "Institutional report",
		"analysis_data_source": "capillary blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_positive": 0.922,
		"results_seroprevalence_positive_95pct_lower": 0.91,
		"results_seroprevalence_positive_95pct_upper": 0.933,
		"record_created": "2022-07-22",
		"record_modified": "2022-07-25"
	},
	{
		"organisation": [
			"Robert Koch-Institut, Berlin",
			"Deutsches Institut für Wirtschaftsforschung, Berlin"
		],
		"location": [
			"Germany"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Corona-Monitoring bundesweit (RKI-SOEP-Studie)",
		"scope_regionality": "Nationwide",
		"region": "Nationwide",
		"location_raw": "Nationwide",
		"organisation_raw": "Robert Koch-Institut, Berlin; Deutsches Institut für Wirtschaftsforschung, Berlin",
		"information_url": "https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/lid/lid_node.html",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Participants from the Socio-Economic Panel (SOEP) core sample and the SOEP innovation sample, who are taking part in the \"Living in Germany\" survey",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 17,
		"age_min": 14,
		"sample_design": "Cohort-sample - Sampling from existing cohort study in the general population",
		"sample_analysis_unit": "Participants",
		"start_date": "2021-11-11",
		"end_date": "2022-02-28",
		"results_seroprevalence_information": "Prevalence of antibodies against the spike protein among participants aged 14 to 17 years from the core and innovation samples of the Soco-Economic Panel (SOEP) for the period November 2021 to February 2022",
		"results_publication_url": "https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/lid/Factsheet-CoMoBu-Welle-2.pdf?__blob=publicationFile",
		"results_publication_date": "2022-07-21",
		"results_publication_type": "Institutional report",
		"analysis_data_source": "capillary blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_positive": 0.864,
		"results_seroprevalence_positive_95pct_lower": 0.821,
		"results_seroprevalence_positive_95pct_upper": 0.898,
		"record_created": "2022-07-22",
		"record_modified": "2022-07-25"
	},
	{
		"organisation": [
			"Robert Koch-Institut, Berlin",
			"Deutsches Institut für Wirtschaftsforschung, Berlin"
		],
		"location": [
			"Germany"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [
			"https://www.rki.de/DE/Content/Gesundheitsmonitoring/JoHM/2021/JoHM_Inhalt_21_S01.html",
			"https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/lid/Ergebnisse.pdf?__blob=publicationFile",
			"https://doi.org/10.1136/jech-2021-217653",
			"https://doi.org/10.3238/arztebl.m2021.0376",
			"https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/lid/Factsheet-CoMoBu-Welle-2.pdf?__blob=publicationFile"
		],
		"title": "Corona-Monitoring bundesweit (RKI-SOEP-Studie)",
		"scope_regionality": "Nationwide",
		"region": "Nationwide",
		"location_raw": "Nationwide",
		"organisation_raw": "Robert Koch-Institut, Berlin; Deutsches Institut für Wirtschaftsforschung, Berlin",
		"information_url": "https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/lid/lid_node.html",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Participants from the Socio-Economic Panel (SOEP) core sample and the SOEP innovation sample, who are taking part in the \"Living in Germany\" survey",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Cohort-sample - Sampling from existing cohort study in the general population",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 14781,
		"sample_size_rounded": 14800,
		"start_date": "2020-10-06",
		"end_date": "2020-12-15",
		"results_seroprevalence_information": "Seroprevalence of adult participants from the core and innovation samples of the Soco-Economic Panel (SOEP) for the period October - November 2020",
		"results_publication_url": "http://dx.doi.org/10.25646/8999; https://jech.bmj.com/content/early/2021/09/27/jech-2021-217653",
		"results_publication_date": "2021-06-09",
		"results_publication_type": "Institutional report",
		"analysis_data_source": "capillary blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_sensitivity": 0.883,
		"results_seroprevalence_specificity": 0.994,
		"results_seroprevalence_positive": 0.017,
		"results_seroprevalence_positive_95pct_lower": 0.012,
		"results_seroprevalence_positive_95pct_upper": 0.023,
		"record_modified": "2022-02-21",
		"results_underreporting": 1.8
	},
	{
		"organisation": [
			"Robert Koch-Institut, Berlin"
		],
		"location": [
			"Germany"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2020/29/Art_02.html",
			"https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/SeBluCo_Zwischenbericht.html"
		],
		"title": "Serologische Untersuchungen von Blutspenden auf Antikörper gegen SARS-CoV-2 (SeBluCo-Studie)",
		"scope_regionality": "Nationwide",
		"region": "Nationwide",
		"location_raw": "Nationwide",
		"organisation_raw": "Robert Koch-Institut, Berlin",
		"type": "Repeated cross-sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from 28 regions",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 74,
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Samples of participants",
		"sample_size_obtained": 115256,
		"sample_size_rounded": 115300,
		"start_date": "2020-04-15",
		"end_date": "2021-04-27",
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Robert Koch-Institut, Berlin"
		],
		"location": [
			"Germany"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Serologische Untersuchungen von Blutspenden auf Antikörper gegen SARS-CoV-2 (SeBluCo-Studie)",
		"scope_regionality": "Nationwide",
		"region": "Nationwide",
		"location_raw": "Nationwide",
		"organisation_raw": "Robert Koch-Institut, Berlin",
		"type": "Repeated cross-sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from 28 regions",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 74,
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Samples of participants",
		"sample_size_obtained": 75079,
		"sample_size_rounded": 75100,
		"start_date": "2020-04-15",
		"end_date": "2020-12-31",
		"results_seroprevalence_information": "Seroprevalence among blood donors for the period of April to December 2020",
		"results_publication_url": "https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/SeBluCo_Zwischenbericht.html",
		"results_publication_date": "2021-06-10",
		"results_publication_type": "Institutional report",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_sensitivity": 0.883,
		"results_seroprevalence_specificity": 0.994,
		"results_seroprevalence_positive": 0.011,
		"results_seroprevalence_positive_95pct_lower": 0.0105,
		"results_seroprevalence_positive_95pct_upper": 0.0121,
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Robert Koch-Institut, Berlin"
		],
		"location": [
			"Germany"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Serologische Untersuchungen von Blutspenden auf Antikörper gegen SARS-CoV-2 (SeBluCo-Studie)",
		"scope_regionality": "Nationwide",
		"region": "Nationwide",
		"location_raw": "Nationwide",
		"organisation_raw": "Robert Koch-Institut, Berlin",
		"type": "Repeated cross-sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from 28 regions",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 74,
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Samples of participants",
		"sample_size_obtained": 9320,
		"sample_size_rounded": 9300,
		"start_date": "2021-01-01",
		"end_date": "2021-01-31",
		"results_seroprevalence_information": "Seroprevalence among blood donors for the period of January 2021",
		"results_publication_url": "https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/SeBluCo_Zwischenbericht.html",
		"results_publication_date": "2021-06-10",
		"results_publication_type": "Institutional report",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_sensitivity": 0.883,
		"results_seroprevalence_specificity": 0.994,
		"results_seroprevalence_positive": 0.0379,
		"results_seroprevalence_positive_95pct_lower": 0.0342,
		"results_seroprevalence_positive_95pct_upper": 0.042,
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Robert Koch-Institut, Berlin"
		],
		"location": [
			"Germany"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Serologische Untersuchungen von Blutspenden auf Antikörper gegen SARS-CoV-2 (SeBluCo-Studie)",
		"scope_regionality": "Nationwide",
		"region": "Nationwide",
		"location_raw": "Nationwide",
		"organisation_raw": "Robert Koch-Institut, Berlin",
		"type": "Repeated cross-sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from 28 regions",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 74,
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Samples of participants",
		"sample_size_obtained": 9921,
		"sample_size_rounded": 9900,
		"start_date": "2021-02-01",
		"end_date": "2021-02-28",
		"results_seroprevalence_information": "Seroprevalence among blood donors for the period of February 2021",
		"results_publication_url": "https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/SeBluCo_Zwischenbericht.html",
		"results_publication_date": "2021-06-10",
		"results_publication_type": "Institutional report",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_sensitivity": 0.883,
		"results_seroprevalence_specificity": 0.994,
		"results_seroprevalence_positive": 0.079,
		"results_seroprevalence_positive_95pct_lower": 0.0739,
		"results_seroprevalence_positive_95pct_upper": 0.0845,
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Robert Koch-Institut, Berlin"
		],
		"location": [
			"Germany"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Serologische Untersuchungen von Blutspenden auf Antikörper gegen SARS-CoV-2 (SeBluCo-Studie)",
		"scope_regionality": "Nationwide",
		"region": "Nationwide",
		"location_raw": "Nationwide",
		"organisation_raw": "Robert Koch-Institut, Berlin",
		"type": "Repeated cross-sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from 28 regions",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 74,
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Samples of participants",
		"sample_size_obtained": 9603,
		"sample_size_rounded": 9600,
		"start_date": "2021-03-01",
		"end_date": "2021-03-31",
		"results_seroprevalence_information": "Seroprevalence among blood donors for the period of March 2021",
		"results_publication_url": "https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/SeBluCo_Zwischenbericht.html",
		"results_publication_date": "2021-06-10",
		"results_publication_type": "Institutional report",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_sensitivity": 0.883,
		"results_seroprevalence_specificity": 0.994,
		"results_seroprevalence_positive": 0.1124,
		"results_seroprevalence_positive_95pct_lower": 0.1124,
		"results_seroprevalence_positive_95pct_upper": 0.1253,
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Robert Koch-Institut, Berlin"
		],
		"location": [
			"Germany"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Serologische Untersuchungen von Blutspenden auf Antikörper gegen SARS-CoV-2 (SeBluCo-Studie)",
		"scope_regionality": "Nationwide",
		"region": "Nationwide",
		"location_raw": "Nationwide",
		"organisation_raw": "Robert Koch-Institut, Berlin",
		"type": "Repeated cross-sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from 28 regions",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 74,
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Samples of participants",
		"sample_size_obtained": 11333,
		"sample_size_rounded": 11300,
		"start_date": "2021-04-01",
		"end_date": "2021-04-30",
		"results_seroprevalence_information": "Seroprevalence among blood donors for the period of April 2021",
		"results_publication_url": "https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/SeBluCo_Zwischenbericht.html",
		"results_publication_date": "2021-06-10",
		"results_publication_type": "Institutional report",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_sensitivity": 0.883,
		"results_seroprevalence_specificity": 0.994,
		"results_seroprevalence_positive": 0.1922,
		"results_seroprevalence_positive_95pct_lower": 0.1851,
		"results_seroprevalence_positive_95pct_upper": 0.1996,
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Robert Koch-Institut, Berlin"
		],
		"location": [
			"Germany"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Serologische Untersuchungen von Blutspenden auf Antikörper gegen SARS-CoV-2 (SeBluCo-Studie)",
		"scope_regionality": "Nationwide",
		"region": "Nationwide",
		"location_raw": "Nationwide",
		"organisation_raw": "Robert Koch-Institut, Berlin",
		"type": "Repeated cross-sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from 28 regions",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 74,
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Samples of participants",
		"sample_size_obtained": 3400,
		"sample_size_rounded": 3400,
		"start_date": "2021-08-30",
		"end_date": "2021-09-12",
		"results_seroprevalence_information": "Seroprevalence among blood donors for the period of Semptember 2021",
		"results_publication_url": "https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/SeBluCo_Zwischenbericht.html",
		"results_publication_date": "2021-12-16",
		"results_publication_type": "Institutional report",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_adjustment": "Not adjusted",
		"results_seroprevalence_sensitivity": 0.883,
		"results_seroprevalence_specificity": 0.994,
		"results_seroprevalence_positive": 0.876,
		"record_modified": "2022-01-21"
	},
	{
		"organisation": [
			"Institut für Virologie, Essen",
			"Universitätsklinikum Essen"
		],
		"location": [
			"Essen"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1007/s10049-021-00948-z"
		],
		"title": "SARS-CoV-2 spezifische Immunität und Serokonversion von Rettungsdienst",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Essen",
		"organisation_raw": "Klinik für Infektiologie, Institut für Virologie, Essen",
		"type": "Cross sectional",
		"subject_frame": "Essential non-healthcare workers",
		"subject_information": "Employees of the rescue service of the city of Essen",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 732,
		"sample_size_rounded": 700,
		"start_date": "2020-05-27",
		"end_date": "2020-05-29"
	},
	{
		"organisation": [
			"Institut für Virologie, Essen",
			"Universitätsklinikum Essen"
		],
		"location": [
			"Essen"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [],
		"title": "SARS-CoV-2 spezifische Immunität und Serokonversion von COVID-Kontaktpersonen",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Essen",
		"organisation_raw": "Klinik für Infektiologie, Institut für Virologie, Essen",
		"type": "Cross sectional",
		"subject_frame": "Known Contacts of COVID Patients",
		"subject_information": "Medical personnel in contact with COVID-19 patients",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 300,
		"start_date": "2020-05-01"
	},
	{
		"organisation": [
			"Universität des Saarlandes"
		],
		"location": [
			"Germany"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"http://dx.doi.org/10.1136/bjsports-2020-103150",
			"https://doi.org/10.1016/j.cmi.2020.11.033"
		],
		"title": "Bundesliga-Prävalenzstudie",
		"scope_regionality": "Local/Regional",
		"region": "Multilocal",
		"location_raw": "Multilocal",
		"organisation_raw": "Universität des Saarlandes, Labor Bioscientia Ingelheim",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Non-essential workers and unemployed persons",
		"subject_information": "Players and support staff of the 36 clubs of the 1st and 2nd German soccer league",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_max": 69,
		"age_min": 20,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Samples of participants",
		"sample_size_rounded": 2200,
		"start_date": "2020-05-01"
	},
	{
		"organisation": [
			"Klinikum Niederlausitz",
			"Brandenburgische Technische Universität Cottbus-Senftenberg",
			"Medizinische Hochschule Brandenburg"
		],
		"location": [
			"Lauchhammer",
			"Senftenberg"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.21203/rs.3.rs-84703/v1",
			"https://doi.org/10.3390/ijerph182010999"
		],
		"title": "Serologisch-epidemiologische Erhebung von Antikörpern bei Krankenhausmitarbeiterinnen und -mitarbeitern während der SARS-CoV-2-Epidemie in Brandenburg",
		"scope_regionality": "Local/Regional",
		"region": "Brandenburg",
		"location_raw": "Lauchhammer and Senftenberg",
		"organisation_raw": "Klinikum Niederlausitz, Brandenburgische Technische Universität Cottbus-Senftenberg, Medizinische Hochschule Brandenburg",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Clinic staff with different exposure levels of the Niederlausitz clinic",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_max": 65,
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 171,
		"sample_size_rounded": 200,
		"start_date": "2020-07-01",
		"end_date": "2020-07-31"
	},
	{
		"organisation": [
			"OHLY GmbH, Hamburg"
		],
		"location": [
			"Hamburg"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [],
		"title": "Freiwillige interne Unternehmensstudie zur Unterstützung der Transparenz und des betrieblichen Schutzkonzeptes im Rahmen der COVID19 Pandemie",
		"scope_regionality": "Local/Regional",
		"region": "Hamburg",
		"location_raw": "Hamburg",
		"organisation_raw": " OHLY GmbH, Hamburg ",
		"type": "Cross sectional",
		"subject_frame": "Non-essential workers and unemployed persons",
		"subject_information": "Employees at a production site of OHLY GmbH",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_max": 65,
		"age_min": 20,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 100,
		"start_date": "2020-05-15"
	},
	{
		"organisation": [
			"Kliniken Nordoberpfalz AG"
		],
		"location": [
			"Tirschenreuth"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1007/s00063-020-00761-5"
		],
		"title": "Antibody assessment for COVID-19 prevalence two months after outbreak in the hot spot Region of Tirschenreuth / Bavaria",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Tirschenreuth",
		"organisation_raw": "Kliniken Nordoberpfalz AG",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021813",
		"type": "Cross sectional",
		"subject_frame": "Other groups",
		"subject_information": "Employees from various departments and professional groups of Kliniken Oberpfalz AG and a large, medium-sized company in the Tirschenreuth/Weiden region",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1838,
		"sample_size_rounded": 1800,
		"start_date": "2020-06-29",
		"end_date": "2020-07-29"
	},
	{
		"organisation": [
			"Universitätsklinikum Freiburg"
		],
		"location": [
			"Freiburg"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [],
		"title": "Serological screening and metabolic analysis for evaluation of the immune response to SARS-CoV2 (COVID-19)",
		"scope_regionality": "Local/Regional",
		"region": "Baden-Wuerttemberg",
		"location_raw": "Freiburg",
		"organisation_raw": "Klinik für Innere Medizin I, Universitätsklinikum Freiburg",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022292",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Other groups",
		"subject_information": "Employees of the Universitätsklinikum Freiburg, the Universitätsherzzentrum Freiburg and their family members",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 5,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 300,
		"start_date": "2020-06-01"
	},
	{
		"organisation": [
			"Kassenärztliche Vereinigung Thüringen",
			"Zentralinstitut für die kassenärztliche Versorgung (Zi)"
		],
		"location": [
			"Thuringia"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [],
		"title": "Investigation of the immune status against SARS-CoV-2 of medical professionals in Doctor's Practices in Thuringia (COVID-PraxImmun)",
		"scope_regionality": "Local/Regional",
		"region": "Thuringia",
		"location_raw": "Thuringia",
		"organisation_raw": "Kassenärztliche Vereinigung Thüringen, Zentralinstitut für die kassenärztliche Versorgung (Zi)",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021815",
		"information_url": "https://www.coronatest-thueringen.de/",
		"type": "Repeated cross-sectional",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Physicians and employees in panel doctors' practices of the Thuringian Association of Panel Physicians",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Medical practices with participants",
		"sample_size_rounded": 3000,
		"start_date": "2020-07-29"
	},
	{
		"organisation": [
			"SLK-Kliniken Heilbronn GmbH"
		],
		"location": [
			"Heilbronn"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.3390/ijerph18137057"
		],
		"title": "Seroprevalence of SARS-CoV-2 in employees of a clinic with COVID-centre (COVID-19)",
		"scope_regionality": "Local/Regional",
		"region": "Baden-Wuerttemberg",
		"location_raw": "Heilbronn",
		"organisation_raw": " SLK-Kliniken Heilbronn GmbH",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022226",
		"type": "Cross sectional",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Employees of the clinic association",
		"scope_population": "Selected population groups",
		"scope_age": "Multiple",
		"age_min": 16,
		"sample_design": "Entire sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 3066,
		"sample_size_rounded": 3100,
		"start_date": "2020-07-01",
		"end_date": "2020-07-21",
		"record_modified": "2021-09-14"
	},
	{
		"organisation": [
			"Universitätsklinikum Schleswig-Holstein (UKSH), Institut für Epidemiologie und Sozialmedizin",
			"Universitätsklinikum Schleswig-Holstein (UKSH), Klinik für Infektiologie und Mikrobiologie",
			"Universitätsklinikum Schleswig-Holstein (UKSH), Institut für Neurogenetik, Campus Lübeck",
			"Universität zu Lübeck",
			"Universitätsklinikum Schleswig-Holstein (UKSH)"
		],
		"location": [
			"Lübeck"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [
			"https://elisa-luebeck.de/einjaehrige-corona-studie-zu-antikoerpern-mit-rund-3000-probandinnen-und-probanden-zeigt-dunkelziffer-ist-deutlich-zurueckgegangen/",
			"https://doi.org/10.1101/2021.05.10.21256966",
			"https://doi.org/10.1126/sciadv.abm5016",
			"https://doi.org/10.1186/s12889-022-13666-z"
		],
		"title": "LübEcker Längsschnittuntersuchung zu Infektionen mit SARS–CoV-2 (ELISA)",
		"scope_regionality": "Local/Regional",
		"region": "Schleswig-Holstein",
		"location_raw": "Lübeck and neighbouring postcode areas",
		"organisation_raw": "Institut für Epidemiologie und Sozialmedizin, Klinik für Infektiologie und Mikrobiologie und Institut für Neurogenetik des UKSH Campus Lübeck und der Universität zu Lübeck",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00023418",
		"information_url": "https://elisa-luebeck.de",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Lübeck residents who had registered via an app and were divided into two groups according to risk their behavior",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 79,
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 3051,
		"sample_size_rounded": 3100,
		"start_date": "2020-05-06",
		"end_date": "2021-02-27",
		"results_seroprevalence_information": "Seroprevalence for the total cohort for the period May 2020 to February 2021",
		"results_publication_url": "https://doi.org/10.1126/sciadv.abm5016",
		"results_publication_date": "2022-04-15",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants",
		"results_seroprevalence_positive": 0.035,
		"record_created": "2022-05-04",
		"record_modified": "2022-05-10"
	},
	{
		"organisation": [
			"Universitätsklinikum Schleswig-Holstein (UKSH), Institut für Epidemiologie und Sozialmedizin",
			"Universitätsklinikum Schleswig-Holstein (UKSH), Klinik für Infektiologie und Mikrobiologie",
			"Universitätsklinikum Schleswig-Holstein (UKSH), Institut für Neurogenetik, Campus Lübeck",
			"Universität zu Lübeck",
			"Universitätsklinikum Schleswig-Holstein (UKSH)"
		],
		"location": [
			"Lübeck"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "LübEcker Längsschnittuntersuchung zu Infektionen mit SARS–CoV-2 (ELISA)",
		"scope_regionality": "Local/Regional",
		"region": "Schleswig-Holstein",
		"location_raw": "Lübeck and neighbouring postcode areas",
		"organisation_raw": "Institut für Epidemiologie und Sozialmedizin, Klinik für Infektiologie und Mikrobiologie und Institut für Neurogenetik des UKSH Campus Lübeck und der Universität zu Lübeck",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00023418",
		"information_url": "https://elisa-luebeck.de",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Lübeck residents who had registered via an app and were divided into two groups according to risk their behavior",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 79,
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 3051,
		"sample_size_rounded": 3100,
		"start_date": "2020-05-06",
		"end_date": "2020-05-31",
		"results_seroprevalence_information": "Seroprevalence in the cohort for the month of May 2020 ",
		"results_publication_url": "https://doi.org/10.1126/sciadv.abm5016",
		"results_publication_date": "2022-04-15",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.0079,
		"record_created": "2022-05-04"
	},
	{
		"organisation": [
			"Universitätsklinikum Schleswig-Holstein (UKSH), Institut für Epidemiologie und Sozialmedizin",
			"Universitätsklinikum Schleswig-Holstein (UKSH), Klinik für Infektiologie und Mikrobiologie",
			"Universitätsklinikum Schleswig-Holstein (UKSH), Institut für Neurogenetik, Campus Lübeck",
			"Universität zu Lübeck",
			"Universitätsklinikum Schleswig-Holstein (UKSH)"
		],
		"location": [
			"Lübeck"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "LübEcker Längsschnittuntersuchung zu Infektionen mit SARS–CoV-2 (ELISA)",
		"scope_regionality": "Local/Regional",
		"region": "Schleswig-Holstein",
		"location_raw": "Lübeck and neighbouring postcode areas",
		"organisation_raw": "Institut für Epidemiologie und Sozialmedizin, Klinik für Infektiologie und Mikrobiologie und Institut für Neurogenetik des UKSH Campus Lübeck und der Universität zu Lübeck",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00023418",
		"information_url": "https://elisa-luebeck.de",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Lübeck residents who had registered via an app and were divided into two groups according to risk their behavior",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 79,
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2894,
		"sample_size_rounded": 2900,
		"start_date": "2020-07-01",
		"end_date": "2020-07-31",
		"results_seroprevalence_information": "Seroprevalence in the cohort for the month of July 2020 ",
		"results_publication_url": "https://doi.org/10.1126/sciadv.abm5016",
		"results_publication_date": "2022-04-15",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.0017,
		"record_created": "2022-05-04"
	},
	{
		"organisation": [
			"Universitätsklinikum Schleswig-Holstein (UKSH), Institut für Epidemiologie und Sozialmedizin",
			"Universitätsklinikum Schleswig-Holstein (UKSH), Klinik für Infektiologie und Mikrobiologie",
			"Universitätsklinikum Schleswig-Holstein (UKSH), Institut für Neurogenetik, Campus Lübeck",
			"Universität zu Lübeck",
			"Universitätsklinikum Schleswig-Holstein (UKSH)"
		],
		"location": [
			"Lübeck"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "LübEcker Längsschnittuntersuchung zu Infektionen mit SARS–CoV-2 (ELISA)",
		"scope_regionality": "Local/Regional",
		"region": "Schleswig-Holstein",
		"location_raw": "Lübeck and neighbouring postcode areas",
		"organisation_raw": "Institut für Epidemiologie und Sozialmedizin, Klinik für Infektiologie und Mikrobiologie und Institut für Neurogenetik des UKSH Campus Lübeck und der Universität zu Lübeck",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00023418",
		"information_url": "https://elisa-luebeck.de",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Lübeck residents who had registered via an app and were divided into two groups according to risk their behavior",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 79,
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2659,
		"sample_size_rounded": 2700,
		"start_date": "2020-09-01",
		"end_date": "2020-09-30",
		"results_seroprevalence_information": "Seroprevalence in the cohort for the month of September 2020 ",
		"results_publication_url": "https://doi.org/10.1126/sciadv.abm5016",
		"results_publication_date": "2022-04-15",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.003,
		"record_created": "2022-05-04"
	},
	{
		"organisation": [
			"Universitätsklinikum Schleswig-Holstein (UKSH), Institut für Epidemiologie und Sozialmedizin",
			"Universitätsklinikum Schleswig-Holstein (UKSH), Klinik für Infektiologie und Mikrobiologie",
			"Universitätsklinikum Schleswig-Holstein (UKSH), Institut für Neurogenetik, Campus Lübeck",
			"Universität zu Lübeck",
			"Universitätsklinikum Schleswig-Holstein (UKSH)"
		],
		"location": [
			"Lübeck"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "LübEcker Längsschnittuntersuchung zu Infektionen mit SARS–CoV-2 (ELISA)",
		"scope_regionality": "Local/Regional",
		"region": "Schleswig-Holstein",
		"location_raw": "Lübeck and neighbouring postcode areas",
		"organisation_raw": "Institut für Epidemiologie und Sozialmedizin, Klinik für Infektiologie und Mikrobiologie und Institut für Neurogenetik des UKSH Campus Lübeck und der Universität zu Lübeck",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00023418",
		"information_url": "https://elisa-luebeck.de",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Lübeck residents who had registered via an app and were divided into two groups according to risk their behavior",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 79,
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2580,
		"sample_size_rounded": 2600,
		"start_date": "2020-12-01",
		"end_date": "2020-12-31",
		"results_seroprevalence_information": "Seroprevalence in the cohort for the month of December 2020 ",
		"results_publication_url": "https://doi.org/10.1126/sciadv.abm5016",
		"results_publication_date": "2022-04-15",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.0112,
		"record_created": "2022-05-04"
	},
	{
		"organisation": [
			"Universitätsklinikum Schleswig-Holstein (UKSH), Institut für Epidemiologie und Sozialmedizin",
			"Universitätsklinikum Schleswig-Holstein (UKSH), Klinik für Infektiologie und Mikrobiologie",
			"Universitätsklinikum Schleswig-Holstein (UKSH), Institut für Neurogenetik, Campus Lübeck",
			"Universität zu Lübeck",
			"Universitätsklinikum Schleswig-Holstein (UKSH)"
		],
		"location": [
			"Lübeck"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "LübEcker Längsschnittuntersuchung zu Infektionen mit SARS–CoV-2 (ELISA)",
		"scope_regionality": "Local/Regional",
		"region": "Schleswig-Holstein",
		"location_raw": "Lübeck and neighbouring postcode areas",
		"organisation_raw": "Institut für Epidemiologie und Sozialmedizin, Klinik für Infektiologie und Mikrobiologie und Institut für Neurogenetik des UKSH Campus Lübeck und der Universität zu Lübeck",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00023418",
		"information_url": "https://elisa-luebeck.de",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Lübeck residents who had registered via an app and were divided into two groups according to risk their behavior",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 79,
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2057,
		"sample_size_rounded": 2100,
		"start_date": "2021-02-01",
		"end_date": "2021-02-27",
		"results_seroprevalence_information": "Seroprevalence in the cohort for the month of February 2021",
		"results_publication_url": "https://doi.org/10.1126/sciadv.abm5016",
		"results_publication_date": "2022-04-15",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants",
		"results_seroprevalence_positive": 0.011,
		"record_created": "2022-05-04",
		"record_modified": "2022-05-10"
	},
	{
		"organisation": [
			"BDH-Klinik Hessisch Oldendorf, Institut für neurorehabilitative Forschung (InFo)",
			"BDH-Klinik Hessisch Oldendorf"
		],
		"location": [
			"Hessian Oldendorf"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1371/journal.pone.0235417"
		],
		"title": "Prevalence of serum IgG antibodies against SARS-CoV-2 among clinic staff",
		"scope_regionality": "Local/Regional",
		"region": "Lower Saxony",
		"location_raw": "Hessian Oldendorf",
		"organisation_raw": "BDH-Klinik Hessisch Oldendorf, Institut für neurorehabilitative Forschung (InFo)",
		"type": "Cross sectional",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Employees of a neurological rehabilitation clinic",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Entire sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 385,
		"sample_size_rounded": 400,
		"start_date": "2020-04-20",
		"end_date": "2020-04-30"
	},
	{
		"organisation": [
			"Ludwig-Maximilians-Universität (LMU) München",
			"Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital",
			"Dr. von Haunersches Kinderspital"
		],
		"location": [
			"Bavaria"
		],
		"analysis_test_manufacturer": [
			"ROCHE N"
		],
		"resource_url": [],
		"title": "COVID Kids Bavaria Studie",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Institutions from all 46 electoral districts in Bavaria",
		"organisation_raw": "Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital, Ludwig-Maximilians-Universität (LMU) München",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022380",
		"information_url": "https://www.covid-kids-bavaria.de/covid-kids",
		"type": "Cross sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Students in 15 selected elementary schools from all 46 electoral districts in Bavaria",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 12,
		"age_min": 6,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 511,
		"sample_size_rounded": 500,
		"start_date": "2020-06-15",
		"end_date": "2020-07-15",
		"results_seroprevalence_information": "Seroprevalence of children attending elementary school in Bavaria for the period of June/July 2021",
		"results_publication_url": "https://doi.org/10.3389/fped.2022.888498",
		"results_publication_date": "2022-07-06",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "capillary blood",
		"analysis_target": "anti Nucleocapsid",
		"analysis_isotype": "Multiple antibodies",
		"analysis_test": "Elektrochemolumineszenz (ECL)-Immunassay; LIPS",
		"analysis_test_manufacturer_raw": "ROCHE N",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.076,
		"results_seroprevalence_positive_95pct_lower": 0.055,
		"results_seroprevalence_positive_95pct_upper": 0.103,
		"record_created": "2022-01-27",
		"record_modified": "2022-08-09"
	},
	{
		"organisation": [
			"Ludwig-Maximilians-Universität (LMU) München",
			"Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital",
			"Dr. von Haunersches Kinderspital"
		],
		"location": [
			"Bavaria",
			"Munich"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1101/2022.01.18.22269445 ",
			"https://dx.doi.org/10.3389/fped.2022.888498"
		],
		"title": "Teilprojekt der COVID Kids Bavaria Studie",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Bavaria, focus on Munich",
		"organisation_raw": "Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital, Ludwig-Maximilians-Universität (LMU) München",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022380",
		"information_url": "https://www.covid-kids-bavaria.de/covid-kids",
		"type": "Cross sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Students and teachers at selected elementary schools in Bavaria",
		"scope_population": "General population and selected population groups",
		"scope_age": "Multiple",
		"age_min": 5,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 1000,
		"start_date": "2021-04-15"
	},
	{
		"organisation": [
			"Charité - Universitätsmedizin Berlin",
			"PI Health Solutions GmbH Berlin",
			"Forsa Gesellschaft für Sozialforschung und statistische Analysen mbH Berlin",
			"Cologne Center for Genomics (CCG) der Universität zu Köln",
			"Atlas Biolabs GmbH Berlin",
			"ifo Institut für Wirtschaftsforschung München"
		],
		"location": [
			"Germany"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://www.ifo.de/publikationen/2020/monographie-autorenschaft/die-deutschen-und-corona"
		],
		"title": "SARS-CoV-2: Eine dynamische, bundesweit-repräsentative Untersuchung (Corona-BUND-Studie)",
		"scope_regionality": "Nationwide",
		"region": "Nationwide",
		"location_raw": "Nationwide",
		"organisation_raw": "Charité - Universitätsmedizin Berlin, PI Health Solutions GmbH Berlin, Forsa Gesellschaft für Sozialforschung und statistische Analysen mbH Berlin, Cologne Center for Genomics (CCG) der Universität zu Köln, Atlas Biolabs GmbH Berlin, ifo Institut für Wirtschaftsforschung München ",
		"information_url": "https://pi-healthsolutions.com/de/forschung-entwicklung/",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Participants from the long-established representative forsa cohort of the adult population",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Cohort-sample - Sampling from existing cohort study in the general population",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 11000,
		"start_date": "2020-06-30",
		"end_date": "2020-08-12"
	},
	{
		"organisation": [
			"Charité - Universitätsmedizin Berlin",
			"PI Health Solutions GmbH Berlin",
			"Forsa Gesellschaft für Sozialforschung und statistische Analysen mbH Berlin",
			"Cologne Center for Genomics (CCG) der Universität zu Köln",
			"Atlas Biolabs GmbH Berlin",
			"ifo Institut für Wirtschaftsforschung München"
		],
		"location": [
			"Germany"
		],
		"analysis_test_manufacturer": [
			"ROCHE N"
		],
		"resource_url": [],
		"title": "SARS-CoV-2: Eine dynamische, bundesweit-repräsentative Untersuchung (Corona-BUND-Studie)",
		"scope_regionality": "Nationwide",
		"region": "Nationwide",
		"location_raw": "Nationwide",
		"organisation_raw": "Charité - Universitätsmedizin Berlin, PI Health Solutions GmbH Berlin, Forsa Gesellschaft für Sozialforschung und statistische Analysen mbH Berlin, Cologne Center for Genomics (CCG) der Universität zu Köln, Atlas Biolabs GmbH Berlin, ifo Institut für Wirtschaftsforschung München ",
		"information_url": "https://pi-healthsolutions.com/de/forschung-entwicklung/",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Participants from the long-established representative forsa cohort of the adult population",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Cohort-sample - Sampling from existing cohort study in the general population",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 10221,
		"sample_size_rounded": 10200,
		"start_date": "2020-06-30",
		"end_date": "2020-08-12",
		"results_seroprevalence_information": "Seroprevalence from the first study wave of participants in the forsa cohort",
		"results_publication_url": "https://www.ifo.de/publikationen/2020/monographie-autorenschaft/die-deutschen-und-corona",
		"results_publication_date": "2020-11-27",
		"results_publication_type": "Institutional report",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti Nucleocapsid",
		"analysis_isotype": "Total antibody",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "ROCHE N",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Population-weighted",
		"results_seroprevalence_positive": 0.005,
		"results_seroprevalence_positive_95pct_lower": 0.0038,
		"results_seroprevalence_positive_95pct_upper": 0.0065,
		"record_created": "2021-08-06",
		"record_modified": "2021-11-01",
		"results_underreporting": 1.8
	},
	{
		"organisation": [
			"Charité - Universitätsmedizin Berlin",
			"PI Health Solutions GmbH Berlin",
			"Forsa Gesellschaft für Sozialforschung und statistische Analysen mbH Berlin",
			"Cologne Center for Genomics (CCG) der Universität zu Köln",
			"Atlas Biolabs GmbH Berlin",
			"ifo Institut für Wirtschaftsforschung München"
		],
		"location": [
			"Germany"
		],
		"analysis_test_manufacturer": [
			"ROCHE N"
		],
		"resource_url": [],
		"title": "SARS-CoV-2: Eine dynamische, bundesweit-repräsentative Untersuchung (Corona-BUND-Studie)",
		"scope_regionality": "Nationwide",
		"region": "Nationwide",
		"location_raw": "Nationwide",
		"organisation_raw": "Charité - Universitätsmedizin Berlin, PI Health Solutions GmbH Berlin, Forsa Gesellschaft für Sozialforschung und statistische Analysen mbH Berlin, Cologne Center for Genomics (CCG) der Universität zu Köln, Atlas Biolabs GmbH Berlin, ifo Institut für Wirtschaftsforschung München ",
		"information_url": "https://pi-healthsolutions.com/de/forschung-entwicklung/",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Participants from the long-established representative forsa cohort of the adult population",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Cohort-sample - Sampling from existing cohort study in the general population",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 9929,
		"sample_size_rounded": 9900,
		"start_date": "2020-10-26",
		"end_date": "2020-11-18",
		"results_seroprevalence_information": "Seroprevalence from the second study wave of participants in the forsa cohort",
		"results_publication_url": "https://www.ifo.de/publikationen/2020/monographie-autorenschaft/die-deutschen-und-corona",
		"results_publication_date": "2020-11-27",
		"results_publication_type": "Institutional report",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti Nucleocapsid",
		"analysis_isotype": "Total antibody",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "ROCHE N",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Population-weighted",
		"results_seroprevalence_positive": 0.0111,
		"results_seroprevalence_positive_95pct_lower": 0.0092,
		"results_seroprevalence_positive_95pct_upper": 0.0133,
		"record_created": "2021-08-06",
		"record_modified": "2021-11-03"
	},
	{
		"organisation": [
			"Eberhard Karls Universität Tübingen, Institut für Tropenmedizin",
			"Eberhard Karls Universität Tübingen"
		],
		"location": [
			"Tübingen"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.2196/27739",
			"https://doi.org/10.3389/fimmu.2021.753435"
		],
		"title": "Prospektive, sero-epidemiologische Längsschnittstudie zur SARS-CoV-2 Prävalenz bei Kita-, Kindergarten- und Schulkindern – Eine Tübinger Modellstudie (Coro-Buddy)",
		"scope_regionality": "Local/Regional",
		"region": "Baden-Wuerttemberg",
		"location_raw": "Tübingen",
		"organisation_raw": "Institut für Tropenmedizin, Eberhard Karls Universität Tübingen",
		"registry_url": "https://clinicaltrials.gov/ct2/show/NCT04581889",
		"information_url": "https://www.medizin.uni-tuebingen.de/de/covid-19-studie",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Children and teenagers from Tübingen daycare centers, kindergartens and schools",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 17,
		"age_min": 1,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1850,
		"sample_size_rounded": 1900,
		"start_date": "2020-07-02",
		"end_date": "2020-12-02",
		"record_modified": "2021-10-04"
	},
	{
		"organisation": [
			"Eberhard Karls Universität Tübingen, Institut für Tropenmedizin",
			"Eberhard Karls Universität Tübingen"
		],
		"location": [
			"Tübingen"
		],
		"analysis_test_manufacturer": [
			"In-house"
		],
		"resource_url": [],
		"title": "Prospektive, sero-epidemiologische Längsschnittstudie zur SARS-CoV-2 Prävalenz bei Kita-, Kindergarten- und Schulkindern – Eine Tübinger Modellstudie (Coro-Buddy)",
		"scope_regionality": "Local/Regional",
		"region": "Baden-Wuerttemberg",
		"location_raw": "Tübingen",
		"organisation_raw": "Institut für Tropenmedizin, Eberhard Karls Universität Tübingen",
		"registry_url": "https://clinicaltrials.gov/ct2/show/NCT04581889",
		"information_url": "https://www.medizin.uni-tuebingen.de/de/covid-19-studie",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Children and teenagers from Tübingen daycare centers, kindergartens and schools",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 10,
		"age_min": 1,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 837,
		"sample_size_rounded": 800,
		"start_date": "2020-09-09",
		"end_date": "2020-12-02",
		"results_seroprevalence_information": "Seroprevalence among children aged 1-10 years from Tübingen daycare centers, kindergartens and schools",
		"results_publication_url": "https://doi.org/10.3389/fimmu.2021.753435",
		"results_publication_date": "2021-10-08",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "no blood, sputum",
		"analysis_target": "anti -RBD domain",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "Inhouse",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity",
		"results_seroprevalence_sensitivity": 0.87,
		"results_seroprevalence_specificity": 1,
		"results_seroprevalence_positive": 0.016,
		"results_seroprevalence_positive_95pct_lower": 0.009,
		"results_seroprevalence_positive_95pct_upper": 0.029,
		"record_created": "2022-01-09",
		"record_modified": "2022-02-01",
		"results_underreporting": 3
	},
	{
		"organisation": [
			"Universitätsklinikum Marburg",
			"Universitätsklinikum Gießen und Marburg"
		],
		"location": [
			"Marburg"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [],
		"title": "UKGM-Mitarbeiter-Reihenuntersuchung zur Entwicklung eines SARS-CoV-2 („Coronavirus“)-Antikörpertiters",
		"scope_regionality": "Local/Regional",
		"region": "Hesse",
		"location_raw": "Marburg",
		"organisation_raw": "Universitätsklinikum Marburg (UKGM, Standort Marburg)",
		"type": "Cross sectional",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Employees of UKGM",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Entire sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 3600,
		"start_date": "2020-06-15"
	},
	{
		"organisation": [
			"Deutsches Zentrum für Herzinsuffizienz",
			"Universität Würzburg, Institut für Klinische Epidemiologie und Biometrie",
			"Universität Würzburg"
		],
		"location": [
			"Würzburg"
		],
		"analysis_test_manufacturer": [
			"ROCHE N"
		],
		"resource_url": [
			"https://www.uni-wuerzburg.de/aktuelles/einblick/single/news/ergebnisse-aus-staab-covid/",
			"https://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-1630-7601.pdf"
		],
		"title": "Häufigkeit und Einflussfaktoren auf frühe STadien A und B der Herzinsuffizienz in der Bevölkerung (STAAB) – COVID-Programm",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Würzburg",
		"organisation_raw": "Institut für Klinische Epidemiologie und Biometrie Würzburg, Deutsches Zentrum für Herzinsuffizienz",
		"information_url": "https://www.ukw.de/behandlungszentren/dzhi/ambulante-behandlung/staab-covid-programm/",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Participants already included in the STAAB cohort",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 87,
		"age_min": 32,
		"sample_design": "Cohort-sample - Sampling from existing cohort study in the general population",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 3001,
		"sample_size_rounded": 3000,
		"start_date": "2020-06-15",
		"end_date": "2020-10-15",
		"results_seroprevalence_information": "Participants already included in the STAAB cohort",
		"results_publication_url": "https://doi.org/10.1055/a-1630-7601",
		"results_publication_date": "2021-10-12",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti Nucleocapsid",
		"analysis_isotype": "Total antibody",
		"analysis_test": "Elektrochemolumineszenz (ECL)-Immunassay; LIPS",
		"analysis_test_manufacturer_raw": "ROCHE N",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity and population-weighted",
		"results_seroprevalence_sensitivity": 0.995,
		"results_seroprevalence_specificity": 0.998,
		"results_seroprevalence_positive": 0.011,
		"results_seroprevalence_positive_95pct_lower": 0.007,
		"results_seroprevalence_positive_95pct_upper": 0.015,
		"record_modified": "2021-11-01"
	},
	{
		"organisation": [
			"Technische Universität Dresden"
		],
		"location": [
			"Saxony"
		],
		"analysis_test_manufacturer": [
			"DIASORIN",
			"ABBOTT",
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Eastern Saxony",
		"organisation_raw": "Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Teachers of the grades 8-11",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_max": 56,
		"age_min": 34,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 364,
		"sample_size_rounded": 400,
		"start_date": "2021-03-15",
		"end_date": "2021-04-15",
		"results_seroprevalence_information": "Seroprevalence of teachers for the classes 8-11 in selected schools in Saxony for the period of March to April 2021",
		"results_publication_url": "https://doi.org/10.1007/s15010-022-01824-9",
		"results_publication_date": "2022-04-23",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "DIASORIN, ABBOTT, EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants",
		"results_seroprevalence_positive": 0.096,
		"results_seroprevalence_positive_95pct_lower": 0.066,
		"results_seroprevalence_positive_95pct_upper": 0.126,
		"record_modified": "2022-04-05"
	},
	{
		"organisation": [
			"Technische Universität Dresden"
		],
		"location": [
			"Dresden"
		],
		"analysis_test_manufacturer": [
			"DIASORIN",
			"ABBOTT",
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Dresden",
		"organisation_raw": "Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Teachers of the grades 8-11",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_max": 56,
		"age_min": 34,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 275,
		"sample_size_rounded": 300,
		"start_date": "2021-03-15",
		"end_date": "2021-04-15",
		"results_seroprevalence_information": "Seroprevalence of teachers for the classes 8-11 in selected schools in Dresden for the period of March to April 2021",
		"results_publication_url": "https://doi.org/10.1007/s15010-022-01824-9",
		"results_publication_date": "2022-04-23",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "DIASORIN, ABBOTT, EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants",
		"results_seroprevalence_positive": 0.091,
		"results_seroprevalence_positive_95pct_lower": 0.058,
		"results_seroprevalence_positive_95pct_upper": 0.127,
		"record_modified": "2022-04-05"
	},
	{
		"organisation": [
			"Technische Universität Dresden"
		],
		"location": [
			"Bautzen"
		],
		"analysis_test_manufacturer": [
			"DIASORIN",
			"ABBOTT",
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Bautzen",
		"organisation_raw": "Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Teachers of the grades 8-11",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_max": 56,
		"age_min": 34,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 73,
		"sample_size_rounded": 100,
		"start_date": "2021-03-15",
		"end_date": "2021-04-15",
		"results_seroprevalence_information": "Seroprevalence of teachers for the classes 8-11 in selected schools in Bautzen for the period of March to April 2021",
		"results_publication_url": "https://doi.org/10.1007/s15010-022-01824-9",
		"results_publication_date": "2022-04-23",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "DIASORIN, ABBOTT, EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants",
		"results_seroprevalence_positive": 0.137,
		"results_seroprevalence_positive_95pct_lower": 0.068,
		"results_seroprevalence_positive_95pct_upper": 0.219,
		"record_modified": "2022-04-05"
	},
	{
		"organisation": [
			"Technische Universität Dresden"
		],
		"location": [
			"Saxony"
		],
		"analysis_test_manufacturer": [
			"DIASORIN",
			"ABBOTT",
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Eastern Saxony",
		"organisation_raw": "Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Students of the grades 8-11",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 17,
		"age_min": 14,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1580,
		"sample_size_rounded": 1600,
		"start_date": "2021-03-15",
		"end_date": "2021-04-15",
		"results_seroprevalence_information": "Seroprevalence of students of the classes 8-11 in selected schools in Saxony for the period of March to April 2021",
		"results_publication_url": "https://doi.org/10.1007/s15010-022-01824-9",
		"results_publication_date": "2022-04-23",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "DIASORIN, ABBOTT, EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants",
		"results_seroprevalence_positive": 0.128,
		"results_seroprevalence_positive_95pct_lower": 0.113,
		"results_seroprevalence_positive_95pct_upper": 0.146,
		"record_modified": "2022-04-05"
	},
	{
		"organisation": [
			"Technische Universität Dresden"
		],
		"location": [
			"Dresden"
		],
		"analysis_test_manufacturer": [
			"DIASORIN",
			"ABBOTT",
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Dresden",
		"organisation_raw": "Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Students of the grades 8-11",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 17,
		"age_min": 14,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1369,
		"sample_size_rounded": 1400,
		"start_date": "2021-03-15",
		"end_date": "2021-04-15",
		"results_seroprevalence_information": "Seroprevalence of students of the classes 8-11 in selected schools in Dresden for the period of March to April 2021",
		"results_publication_url": "https://doi.org/10.1007/s15010-022-01824-9",
		"results_publication_date": "2022-04-23",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "DIASORIN, ABBOTT, EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants",
		"results_seroprevalence_positive": 0.112,
		"results_seroprevalence_positive_95pct_lower": 0.096,
		"results_seroprevalence_positive_95pct_upper": 0.129,
		"record_modified": "2022-04-05"
	},
	{
		"organisation": [
			"Technische Universität Dresden"
		],
		"location": [
			"Bautzen"
		],
		"analysis_test_manufacturer": [
			"DIASORIN",
			"ABBOTT",
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Bautzen",
		"organisation_raw": "Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Students of the grades 8-11",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 17,
		"age_min": 14,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 196,
		"sample_size_rounded": 200,
		"start_date": "2021-03-15",
		"end_date": "2021-04-15",
		"results_seroprevalence_information": "Seroprevalence of students of the classes 8-11 in selected schools in Bautzen for the period of March to April 2021",
		"results_publication_url": "https://doi.org/10.1007/s15010-022-01824-9",
		"results_publication_date": "2022-04-23",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "DIASORIN, ABBOTT, EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants",
		"results_seroprevalence_positive": 0.25,
		"results_seroprevalence_positive_95pct_lower": 0.184,
		"results_seroprevalence_positive_95pct_upper": 0.316,
		"record_modified": "2022-04-05"
	},
	{
		"organisation": [
			"Technische Universität Dresden"
		],
		"location": [
			"Saxony"
		],
		"analysis_test_manufacturer": [
			"DIASORIN",
			"ABBOTT",
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Eastern Saxony",
		"organisation_raw": "Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Teachers of the grades 8-11",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_max": 59,
		"age_min": 35,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 46,
		"sample_size_rounded": 50,
		"start_date": "2021-06-15",
		"end_date": "2021-07-15",
		"results_seroprevalence_information": "Seroprevalence of teachers for the classes 8-11 in selected schools in Saxony for the period of June to July 2021",
		"results_publication_url": "https://doi.org/10.1007/s15010-022-01824-9",
		"results_publication_date": "2022-04-23",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "DIASORIN, ABBOTT, EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants",
		"results_seroprevalence_positive": 0.304,
		"results_seroprevalence_positive_95pct_lower": 0.174,
		"results_seroprevalence_positive_95pct_upper": 0.435,
		"record_modified": "2022-04-05"
	},
	{
		"organisation": [
			"Technische Universität Dresden"
		],
		"location": [
			"Dresden"
		],
		"analysis_test_manufacturer": [
			"DIASORIN",
			"ABBOTT",
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Dresden",
		"organisation_raw": "Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Teachers of the grades 8-11",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_max": 59,
		"age_min": 35,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 54,
		"sample_size_rounded": 100,
		"start_date": "2021-06-15",
		"end_date": "2021-07-15",
		"results_seroprevalence_information": "Seroprevalence of teachers for the classes 8-11 in selected schools in Dresden for the period of June to July 2021",
		"results_publication_url": "https://doi.org/10.1007/s15010-022-01824-9",
		"results_publication_date": "2022-04-23",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "DIASORIN, ABBOTT, EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants",
		"results_seroprevalence_positive": 0.222,
		"results_seroprevalence_positive_95pct_lower": 0.111,
		"results_seroprevalence_positive_95pct_upper": 0.333,
		"record_modified": "2022-04-05"
	},
	{
		"organisation": [
			"Technische Universität Dresden"
		],
		"location": [
			"Bautzen"
		],
		"analysis_test_manufacturer": [
			"DIASORIN",
			"ABBOTT",
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Bautzen",
		"organisation_raw": "Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Teachers of the grades 8-11",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_max": 59,
		"age_min": 35,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 6,
		"sample_size_rounded": 5,
		"start_date": "2021-06-15",
		"end_date": "2021-07-15",
		"results_seroprevalence_information": "Seroprevalence of teachers for the classes 8-11 in selected schools in Bautzen for the period of June to July 2021",
		"results_publication_url": "https://doi.org/10.1007/s15010-022-01824-9",
		"results_publication_date": "2022-04-23",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "DIASORIN, ABBOTT, EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants",
		"results_seroprevalence_positive": 0.333,
		"results_seroprevalence_positive_95pct_lower": 0,
		"results_seroprevalence_positive_95pct_upper": 0.667,
		"record_modified": "2022-04-05"
	},
	{
		"organisation": [
			"Technische Universität Dresden"
		],
		"location": [
			"Saxony"
		],
		"analysis_test_manufacturer": [
			"DIASORIN",
			"ABBOTT",
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Eastern Saxony",
		"organisation_raw": "Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Students of the grades 8-11",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 16,
		"age_min": 13,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 841,
		"sample_size_rounded": 800,
		"start_date": "2021-06-15",
		"end_date": "2021-07-15",
		"results_seroprevalence_information": "Seroprevalence of students of the classes 8-11 in selected schools in Saxony for the period of June to July 2021",
		"results_publication_url": "https://doi.org/10.1007/s15010-022-01824-9",
		"results_publication_date": "2022-04-23",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "DIASORIN, ABBOTT, EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants",
		"results_seroprevalence_positive": 0.215,
		"results_seroprevalence_positive_95pct_lower": 0.188,
		"results_seroprevalence_positive_95pct_upper": 0.244,
		"record_modified": "2022-04-05"
	},
	{
		"organisation": [
			"Technische Universität Dresden"
		],
		"location": [
			"Dresden"
		],
		"analysis_test_manufacturer": [
			"DIASORIN",
			"ABBOTT",
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Dresden",
		"organisation_raw": "Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Students of the grades 8-11",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 16,
		"age_min": 13,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 670,
		"sample_size_rounded": 700,
		"start_date": "2021-06-15",
		"end_date": "2021-07-15",
		"results_seroprevalence_information": "Seroprevalence of students of the classes 8-11 in selected schools in Dresden for the period of June to July 2021",
		"results_publication_url": "https://doi.org/10.1007/s15010-022-01824-9",
		"results_publication_date": "2022-04-23",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "DIASORIN, ABBOTT, EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants",
		"results_seroprevalence_positive": 0.2,
		"results_seroprevalence_positive_95pct_lower": 0.17,
		"results_seroprevalence_positive_95pct_upper": 0.233,
		"record_modified": "2022-04-05"
	},
	{
		"organisation": [
			"Technische Universität Dresden"
		],
		"location": [
			"Bautzen"
		],
		"analysis_test_manufacturer": [
			"DIASORIN",
			"ABBOTT",
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Bautzen",
		"organisation_raw": "Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Students of the grades 8-11",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 16,
		"age_min": 13,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 133,
		"sample_size_rounded": 100,
		"start_date": "2021-06-15",
		"end_date": "2021-07-15",
		"results_seroprevalence_information": "Seroprevalence of students of the classes 8-11 in selected schools in Bautzen for the period of June to July 2021",
		"results_publication_url": "https://doi.org/10.1007/s15010-022-01824-9",
		"results_publication_date": "2022-04-23",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "DIASORIN, ABBOTT, EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants",
		"results_seroprevalence_positive": 0.293,
		"results_seroprevalence_positive_95pct_lower": 0.218,
		"results_seroprevalence_positive_95pct_upper": 0.376,
		"record_modified": "2022-04-05"
	},
	{
		"organisation": [
			"Technische Universität Dresden"
		],
		"location": [
			"Saxony"
		],
		"analysis_test_manufacturer": [
			"N/A"
		],
		"resource_url": [],
		"title": "Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Eastern Saxony",
		"organisation_raw": "Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Students of the grades 8-11 and teachers",
		"scope_population": "General population and selected population groups",
		"scope_age": "Multiple",
		"age_max": 57,
		"age_min": 14,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2045,
		"sample_size_rounded": 2045,
		"start_date": "2020-05-25",
		"end_date": "2020-06-30",
		"results_seroprevalence_information": "Seroprevalence of students and teachers of the classes 8-11 in selected schools in Saxony for the period of May to June 2020",
		"results_publication_url": "http://dx.doi.org/10.1136/bmjopen-2021-049876",
		"results_publication_date": "2021-06-10",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "N/A",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.006,
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Technische Universität Dresden"
		],
		"location": [
			"Saxony"
		],
		"analysis_test_manufacturer": [
			"N/A"
		],
		"resource_url": [],
		"title": "Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Eastern Saxony",
		"organisation_raw": "Universitätsklinikum Carl Gustav Carus, an der Technischen Universität Dresden",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455",
		"information_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Students of the grades 8-11 ",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 16,
		"age_min": 14,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1538,
		"sample_size_rounded": 1538,
		"start_date": "2020-05-25",
		"end_date": "2020-06-30",
		"results_seroprevalence_information": "Seroprevalence of students of the classes 8-11 in selected schools in Saxony for the period of May to June 2020",
		"results_publication_url": "http://dx.doi.org/10.1136/bmjopen-2021-049876",
		"results_publication_date": "2021-06-10",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "N/A",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Not adjusted",
		"results_seroprevalence_positive": 0.007,
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Technische Universität Dresden"
		],
		"location": [
			"Saxony"
		],
		"analysis_test_manufacturer": [
			"DIASORIN",
			"ABBOTT",
			"EUROIMMUN"
		],
		"resource_url": [],
		"title": "Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Eastern Saxony",
		"organisation_raw": "Universitätsklinikum Carl Gustav Carus, an der Technischen Universität Dresden",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455",
		"information_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Teachers of the grades 8-11",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_max": 57,
		"age_min": 37,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 507,
		"sample_size_rounded": 500,
		"start_date": "2020-05-25",
		"end_date": "2020-06-30",
		"results_seroprevalence_information": "Seroprevalence among teachers of the grades 8-11 in selected schools in Saxony for the period of May to June 2020",
		"results_publication_url": "http://dx.doi.org/10.1136/bmjopen-2021-049876",
		"results_publication_date": "2021-06-10",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "DIASORIN, ABBOTT, EUROIMMUN",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.002,
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Technische Universität Dresden"
		],
		"location": [
			"Saxony"
		],
		"analysis_test_manufacturer": [
			"N/A"
		],
		"resource_url": [],
		"title": "Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Eastern Saxony",
		"organisation_raw": "Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Students of the grades 8-11 and teachers",
		"scope_population": "General population and selected population groups",
		"scope_age": "Multiple",
		"age_max": 57,
		"age_min": 14,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1779,
		"sample_size_rounded": 1800,
		"start_date": "2020-09-15",
		"end_date": "2020-10-13",
		"results_seroprevalence_information": "Seroprevalence of students and teachers of the classes 8-11 in selected schools in Saxony for the period of September to October 2020",
		"results_publication_url": "http://dx.doi.org/10.1136/bmjopen-2021-049876",
		"results_publication_date": "2021-06-10",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "N/A",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.007,
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Technische Universität Dresden"
		],
		"location": [
			"Saxony"
		],
		"analysis_test_manufacturer": [
			"N/A"
		],
		"resource_url": [],
		"title": "Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Eastern Saxony",
		"organisation_raw": "Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Students of the grades 8-11",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 16,
		"age_min": 14,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1334,
		"sample_size_rounded": 1300,
		"start_date": "2020-09-15",
		"end_date": "2020-10-13",
		"results_seroprevalence_information": "Seroprevalence of students of the classes 8-11 in selected schools in Saxony for the period of September to October 2020",
		"results_publication_url": "http://dx.doi.org/10.1136/bmjopen-2021-049876",
		"results_publication_date": "2021-06-10",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "N/A",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Not adjusted",
		"results_seroprevalence_positive": 0.008,
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Technische Universität Dresden"
		],
		"location": [
			"Saxony"
		],
		"analysis_test_manufacturer": [
			"N/A"
		],
		"resource_url": [],
		"title": "Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Eastern Saxony",
		"organisation_raw": "Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Teachers of the grades 8-11",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_max": 57,
		"age_min": 37,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1779,
		"sample_size_rounded": 1800,
		"start_date": "2020-09-15",
		"end_date": "2020-10-13",
		"results_seroprevalence_information": "Seroprevalence of teachers for the classes 8-11 in selected schools in Saxony for the period of September to October 2020",
		"results_publication_url": "http://dx.doi.org/10.1136/bmjopen-2021-049876",
		"results_publication_date": "2021-06-10",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "N/A",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.002,
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Technische Universität Dresden"
		],
		"location": [
			"Saxony"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://dx.doi.org/10.1136/bmjopen-2021-049876",
			"https://tu-dresden.de/med/mf/die-fakultaet/newsuebersicht/schulen-sind-keine-silent-hotspots",
			"http://dx.doi.org/10.1136/bmjpo-2021-001036",
			"https://doi.org/10.1007/s15010-022-01824-9"
		],
		"title": "Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (SchoolCoviDD19)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Eastern Saxony",
		"organisation_raw": "Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022455",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Students of the grades 8-11 and teachers",
		"scope_population": "General population and selected population groups",
		"scope_age": "Multiple",
		"age_max": 59,
		"age_min": 13,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2045,
		"sample_size_rounded": 2000,
		"start_date": "2020-05-25",
		"end_date": "2021-07-15"
	},
	{
		"organisation": [
			"Universitätsklinikum Essen"
		],
		"location": [
			"North Rhine-Westphalia"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://dx.doi.org/10.1002/jmv.27385"
		],
		"title": "Infection rate of Covid-19 among medical staff in GP practices in North Rhine-Westphalia (Germany)",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "North Rhine-Westphalia",
		"organisation_raw": "Institut für Allgemeinmedizin des Universitätsklinikums Essen",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021788",
		"type": "Cross sectional",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Medical staff (physicians, medical assistants, trainees) from more than 180 practices (existing supraregional teaching practice network of the Institute of General Medicine at Essen University Hospital)",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 900,
		"start_date": "2020-06-10"
	},
	{
		"organisation": [
			"Pius-Hospital Oldenburg"
		],
		"location": [
			"Oldenburg"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [],
		"title": "Prevalence of SARS-CoV-2 Infections in the employees of the Pius-Hospital Oldenburg, confirmed through virus antibody testing - COVID-19 (Co-KI-Ak)",
		"scope_regionality": "Local/Regional",
		"region": "Lower Saxony",
		"location_raw": "Oldenburg",
		"organisation_raw": "Pius-Hospital Oldenburg",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022259",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Employees from all professional groups of the hospital",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 1300,
		"start_date": "2020-06-22"
	},
	{
		"organisation": [
			"Universitätsklinikum Jena, Institut für Infektionsmedizin und Krankenhaushygiene",
			"Universitätsklinikum Jena"
		],
		"location": [
			"Jena"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1101/2020.09.29.20203737",
			"https://dx.doi.org/10.1111/tbed.14041"
		],
		"title": "Survey of the seroprevalence and infection status of SARS-CoV-2 among employees of the University Hospital Jena",
		"scope_regionality": "Local/Regional",
		"region": "Thuringia",
		"location_raw": "Jena",
		"organisation_raw": "Institut für Infektionsmedizin und Krankenhaushygiene, Universitätsklinikum Jena",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022432",
		"type": "Cross sectional",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Employees of the University Hospital Jena",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 660,
		"sample_size_rounded": 700,
		"start_date": "2020-05-19",
		"end_date": "2020-06-19"
	},
	{
		"organisation": [
			"Deutsche Bahn AG"
		],
		"location": [
			"Frankfurt",
			"Berlin",
			"Munich",
			"Hamburg"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://www.deutschebahn.com/de/presse/pressestart_zentrales_uebersicht/Wissenschaftliche-Studie-Keine-Anzeichen-fuer-erhoehte-Corona-Gefahr-bei-Zugpersonal--5581064",
			"https://www.deutschebahn.com/de/presse/pressestart_zentrales_uebersicht/Abschluss-Charit%C3%A9-Langzeitstudie-Kein-erhoehtes-Corona-Risiko-im-Fernverkehr-6189116"
		],
		"title": "Studie der DB Fernverkehr AG zu Corona-Infektionen und Corona-Immunitäten ihrer Mitarbeiter",
		"scope_regionality": "Local/Regional",
		"region": "Multilocal",
		"location_raw": "Frankfurt, Berlin, Munich, Hamburg",
		"organisation_raw": "Deutsche Bahn AG",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022359",
		"type": "Repeated cross-sectional",
		"subject_frame": "Non-essential workers and unemployed persons",
		"subject_information": "Employees of three occupational groups (train crews, train drivers, plant craftsmen) at four locations",
		"scope_population": "Selected population groups",
		"scope_age": "Multiple",
		"age_max": 65,
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 3200,
		"start_date": "2020-06-29"
	},
	{
		"organisation": [
			"Heinrich-Heine Universität, Düsseldorf"
		],
		"location": [
			"Germany"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1371/journal.pone.0248813"
		],
		"title": "National Covid-19 Surveillance Physicians (NAT-COV-SURV)",
		"scope_regionality": "Local/Regional",
		"region": "Multilocal",
		"location_raw": "Multilocal",
		"organisation_raw": "Klinik für Anästhesiologie, Heinrich-Heine Universität, Düsseldorf ",
		"registry_url": "https://clinicaltrials.gov/ct2/show/NCT04459312",
		"type": "Cross sectional",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Intensive care and emergency physicians from different federal states of Germany",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 516,
		"sample_size_rounded": 500,
		"start_date": "2020-06-16",
		"end_date": "2020-07-02"
	},
	{
		"organisation": [
			"Herz- und Diabeteszentrum NRW"
		],
		"location": [
			"North Rhine-Westphalia",
			"Hesse",
			"Lower Saxony"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN",
			"ABBOTT N",
			"DIASORIN"
		],
		"resource_url": [],
		"title": "SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Northrhine-Westfalia, Hesse and Lower Saxony",
		"organisation_raw": "Herz- und Diabeteszentrum NRW, Bad Oeynhausen ",
		"type": "Repeated cross-sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from North Rhine-Westphalia, Hesse, and Lower Saxony",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 3759,
		"sample_size_rounded": 3200,
		"start_date": "2020-06-15",
		"end_date": "2021-07-15",
		"results_seroprevalence_information": "Total seroprevalence of antibodies against the nucleocapsid among blood donors (North Rhine-Westphalia, Hesse, Lower Saxony) for the period from June 2020 to July 2021",
		"results_publication_url": "https://doi.org/10.1101/2022.02.11.22270833 ",
		"results_publication_date": "2022-02-15",
		"results_publication_type": "Preprint",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN; ABBOTT N; DIASORIN ",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_positive": 0.0548,
		"results_seroprevalence_positive_95pct_lower": 0.0477,
		"results_seroprevalence_positive_95pct_upper": 0.0625,
		"record_created": "2022-03-15",
		"record_modified": "2022-03-23"
	},
	{
		"organisation": [
			"Herz- und Diabeteszentrum NRW"
		],
		"location": [
			"North Rhine-Westphalia",
			"Hesse",
			"Lower Saxony"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN",
			"ABBOTT N",
			"DIASORIN"
		],
		"resource_url": [],
		"title": "SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Northrhine-Westfalia, Hesse and Lower Saxony",
		"organisation_raw": "Herz- und Diabeteszentrum NRW, Bad Oeynhausen ",
		"type": "Repeated cross-sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from North Rhine-Westphalia, Hesse, and Lower Saxony",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 65,
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Samples of participants",
		"sample_size_obtained": 3186,
		"sample_size_rounded": 3200,
		"start_date": "2020-03-09",
		"end_date": "2020-06-03",
		"results_seroprevalence_information": "Total seroprevalence of blood donors (North Rhine-Westphalia, Hesse, Lower Saxony) for the period from March to June 2020",
		"results_publication_url": "https://dx.doi.org/10.2807/1560-7917.ES.2020.25.28.2001285",
		"results_publication_date": "2020-07-16",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN; ABBOTT N; DIASORIN ",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity",
		"results_seroprevalence_positive": 0.009,
		"results_seroprevalence_positive_95pct_lower": 0.006,
		"results_seroprevalence_positive_95pct_upper": 0.012,
		"record_modified": "2021-10-21"
	},
	{
		"organisation": [
			"Herz- und Diabeteszentrum NRW"
		],
		"location": [
			"Hesse"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN",
			"ABBOTT N",
			"DIASORIN"
		],
		"resource_url": [],
		"title": "SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states (Hesse)",
		"scope_regionality": "Local/Regional",
		"region": "Hesse",
		"location_raw": "Hesse",
		"organisation_raw": "Herz- und Diabeteszentrum NRW, Bad Oeynhausen ",
		"type": "Repeated cross-sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from Hessen",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1271,
		"sample_size_rounded": 600,
		"start_date": "2020-06-15",
		"end_date": "2021-07-15",
		"results_seroprevalence_information": "Seroprevalence of antibodies against the nucleocapsid among blood donors in Lower Saxony for the period from June 2020 to July 2021",
		"results_publication_url": "https://doi.org/10.1101/2022.02.11.22270833 ",
		"results_publication_date": "2022-02-15",
		"results_publication_type": "Preprint",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN; ABBOTT N; DIASORIN ",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_positive": 0.0551,
		"results_seroprevalence_positive_95pct_lower": 0.0432,
		"results_seroprevalence_positive_95pct_upper": 0.0691,
		"record_created": "2022-03-15",
		"record_modified": "2022-03-23"
	},
	{
		"organisation": [
			"Herz- und Diabeteszentrum NRW"
		],
		"location": [
			"Hesse"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN",
			"ABBOTT N",
			"DIASORIN"
		],
		"resource_url": [],
		"title": "SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states (Hesse)",
		"scope_regionality": "Local/Regional",
		"region": "Hesse",
		"location_raw": "Hesse",
		"organisation_raw": "Herz- und Diabeteszentrum NRW, Bad Oeynhausen ",
		"type": "Cross sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from Hessen",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 65,
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 576,
		"sample_size_rounded": 600,
		"start_date": "2020-03-09",
		"end_date": "2020-06-03",
		"results_seroprevalence_information": "Seroprevalence of blood donors in Lower Saxony for the period from March to June 2020",
		"results_publication_url": "https://dx.doi.org/10.2807/1560-7917.ES.2020.25.28.2001285",
		"results_publication_date": "2020-07-16",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN; ABBOTT N; DIASORIN ",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity",
		"results_seroprevalence_positive": 0.012,
		"results_seroprevalence_positive_95pct_lower": 0.003,
		"results_seroprevalence_positive_95pct_upper": 0.021,
		"record_modified": "2021-09-10"
	},
	{
		"organisation": [
			"Herz- und Diabeteszentrum NRW"
		],
		"location": [
			"Hesse"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.2807/1560-7917.ES.2020.25.28.2001285",
			"https://doi.org/10.1101/2022.02.11.22270833 "
		],
		"title": "SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states (Hesse)",
		"scope_regionality": "Local/Regional",
		"region": "Hesse",
		"location_raw": "Hesse",
		"organisation_raw": "Herz- und Diabeteszentrum NRW, Bad Oeynhausen ",
		"type": "Cross sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from Hessen",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 65,
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 576,
		"sample_size_rounded": 600,
		"start_date": "2020-03-09",
		"end_date": "2021-07-15",
		"record_modified": "2022-03-23"
	},
	{
		"organisation": [
			"Herz- und Diabeteszentrum NRW"
		],
		"location": [
			"Lower Saxony"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN",
			"ABBOTT N",
			"DIASORIN"
		],
		"resource_url": [],
		"title": "SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states (Lower Saxony)",
		"scope_regionality": "Local/Regional",
		"region": "Lower Saxony",
		"location_raw": "Lower Saxony",
		"organisation_raw": "Herz- und Diabeteszentrum NRW, Bad Oeynhausen ",
		"type": "Repeated cross-sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from Lower Saxony",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 816,
		"sample_size_rounded": 900,
		"start_date": "2020-06-15",
		"end_date": "2021-07-15",
		"results_seroprevalence_information": "Seroprevalence of antibodies against the nucleocapsid among blood donors in Hesse for the period from June 2020 to July 2021",
		"results_publication_url": "https://doi.org/10.1101/2022.02.11.22270833 ",
		"results_publication_date": "2022-02-15",
		"results_publication_type": "Preprint",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN; ABBOTT N; DIASORIN ",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_positive": 0.0515,
		"results_seroprevalence_positive_95pct_lower": 0.0373,
		"results_seroprevalence_positive_95pct_upper": 0.0689,
		"record_created": "2022-03-15",
		"record_modified": "2022-03-23"
	},
	{
		"organisation": [
			"Herz- und Diabeteszentrum NRW"
		],
		"location": [
			"Lower Saxony"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN",
			"ABBOTT N",
			"DIASORIN"
		],
		"resource_url": [],
		"title": "SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states (Lower Saxony)",
		"scope_regionality": "Local/Regional",
		"region": "Lower Saxony",
		"location_raw": "Lower Saxony",
		"organisation_raw": "Herz- und Diabeteszentrum NRW, Bad Oeynhausen ",
		"type": "Cross sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from Lower Saxony",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 65,
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 910,
		"sample_size_rounded": 900,
		"start_date": "2020-03-09",
		"end_date": "2020-06-03",
		"results_seroprevalence_information": "Seroprevalence of blood donors in Hesse for the period from March to June 2020",
		"results_publication_url": "https://dx.doi.org/10.2807/1560-7917.ES.2020.25.28.2001285",
		"results_publication_date": "2020-07-16",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN; ABBOTT N; DIASORIN ",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity",
		"results_seroprevalence_positive": 0.007,
		"results_seroprevalence_positive_95pct_lower": 0.001,
		"results_seroprevalence_positive_95pct_upper": 0.012,
		"record_modified": "2021-09-10"
	},
	{
		"organisation": [
			"Herz- und Diabeteszentrum NRW"
		],
		"location": [
			"Lower Saxony"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.2807/1560-7917.ES.2020.25.28.2001285",
			"https://doi.org/10.1101/2022.02.11.22270833 "
		],
		"title": "SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states (Lower Saxony)",
		"scope_regionality": "Local/Regional",
		"region": "Lower Saxony",
		"location_raw": "Lower Saxony",
		"organisation_raw": "Herz- und Diabeteszentrum NRW, Bad Oeynhausen ",
		"type": "Cross sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from Lower Saxony",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 65,
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 910,
		"sample_size_rounded": 900,
		"start_date": "2020-03-09",
		"end_date": "2021-07-15",
		"record_modified": "2022-03-24"
	},
	{
		"organisation": [
			"Herz- und Diabeteszentrum NRW"
		],
		"location": [
			"North Rhine-Westphalia"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN",
			"ABBOTT N",
			"DIASORIN"
		],
		"resource_url": [],
		"title": "SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states (Nord Rhine-Westphalia)",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "North Rhine-Westphalia",
		"organisation_raw": "Herz- und Diabeteszentrum NRW, Bad Oeynhausen ",
		"type": "Repeated cross-sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from North Rhine-Westphalia ",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1672,
		"sample_size_rounded": 1700,
		"start_date": "2020-06-15",
		"end_date": "2021-07-15",
		"results_seroprevalence_information": "Seroprevalence of antibodies against the nucleocapsid among blood donors in North Rhine-Westphalia for the period from June 2020 to July 2021",
		"results_publication_url": "https://doi.org/10.1101/2022.02.11.22270833 ",
		"results_publication_date": "2022-02-15",
		"results_publication_type": "Preprint",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN; ABBOTT N; DIASORIN ",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_positive": 0.0562,
		"results_seroprevalence_positive_95pct_lower": 0.0457,
		"results_seroprevalence_positive_95pct_upper": 0.0684,
		"record_created": "2022-03-15",
		"record_modified": "2022-03-23"
	},
	{
		"organisation": [
			"Herz- und Diabeteszentrum NRW"
		],
		"location": [
			"North Rhine-Westphalia"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN",
			"ABBOTT N",
			"DIASORIN"
		],
		"resource_url": [],
		"title": "SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states (Nord Rhine-Westphalia)",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "North Rhine-Westphalia",
		"organisation_raw": "Herz- und Diabeteszentrum NRW, Bad Oeynhausen ",
		"type": "Cross sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from North Rhine-Westphalia ",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 65,
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1700,
		"sample_size_rounded": 1700,
		"start_date": "2020-03-09",
		"end_date": "2020-06-03",
		"results_seroprevalence_information": "Seroprevalence of blood donors in North Rhine-Westphalia for the period from March to June 2020",
		"results_publication_url": "https://dx.doi.org/10.2807/1560-7917.ES.2020.25.28.2001285",
		"results_publication_date": "2020-07-16",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "EUROIMMUN; ABBOTT N; DIASORIN ",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity",
		"results_seroprevalence_positive": 0.009,
		"results_seroprevalence_positive_95pct_lower": 0.005,
		"results_seroprevalence_positive_95pct_upper": 0.014,
		"record_modified": "2021-09-10"
	},
	{
		"organisation": [
			"Herz- und Diabeteszentrum NRW"
		],
		"location": [
			"North Rhine-Westphalia"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.2807/1560-7917.ES.2020.25.28.2001285",
			"https://doi.org/10.1101/2022.02.11.22270833 "
		],
		"title": "SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states (Nord Rhine-Westphalia)",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "North Rhine-Westphalia",
		"organisation_raw": "Herz- und Diabeteszentrum NRW, Bad Oeynhausen ",
		"type": "Cross sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from North Rhine-Westphalia ",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 65,
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1700,
		"sample_size_rounded": 1700,
		"start_date": "2020-03-09",
		"end_date": "2021-07-15",
		"record_modified": "2022-03-25"
	},
	{
		"organisation": [
			"Technische Universität Dresden"
		],
		"location": [
			"Dresden"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://dx.doi.org/10.1016/j.jpeds.2021.07.054"
		],
		"title": "SARS-CoV-2 Surveillance in Day Care Centers (KiTaCoviDD19)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Dresden",
		"organisation_raw": "Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022729",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Pedagogical staff from day care centers of the city of Dresden and the parents of the children cared for there",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 800,
		"start_date": "2020-07-15"
	},
	{
		"organisation": [
			"Krankenhaus Barmherzige Brüder Regensburg"
		],
		"location": [
			"Regensburg"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1111/pai.13278",
			"https://dx.doi.org/10.1016%2Fj.jcv.2020.104575"
		],
		"title": "Mitarbeiterstudie COVID-19 Klinik St. Hedwig",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Regensburg",
		"organisation_raw": "Klinik St. Hedwig, Krankenhaus Barmherzige Brüder Regensburg",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Employees of the St. Hedwig Clinic who had participated in the PCR series testing performed in the context of an outbreak",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_max": 65,
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 201,
		"sample_size_rounded": 200,
		"start_date": "2020-03-15",
		"end_date": "2020-06-07"
	},
	{
		"organisation": [
			"Technische Universität München",
			"Klinikum rechts der Isar "
		],
		"location": [
			"Munich"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [],
		"title": "SARS-CoV-2 serology in HIV PrEP users during the COVID-19 pandemic (PrEP-Co-Study)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Munich",
		"organisation_raw": "Klinik und Poliklinik für Innere Medizin II des Klinikums rechts der Isar der Technischen Universität (TU) München",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022403",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Patients of the infectious disease outpatient clinic who take HIV-PrEP",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 300,
		"start_date": "2020-05-18"
	},
	{
		"organisation": [
			"Universitätsklinikum Hamburg-Eppendorf"
		],
		"location": [
			"Hamburg"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1101/2020.07.31.20165936",
			"https://dx.doi.org/10.1016/j.ijheh.2020.113671",
			"https://doi.org/10.1101/2021.08.02.21260667",
			"https://doi.org/10.3390/vaccines10071086"
		],
		"title": "Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study",
		"scope_regionality": "Local/Regional",
		"region": "Hamburg",
		"location_raw": "Hamburg",
		"organisation_raw": "University Medical Center Hamburg-Eppendorf",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Employees of the Universitätsklinikum Hamburg-Eppendorf",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_max": 69,
		"age_min": 16,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1253,
		"sample_size_rounded": 1300,
		"start_date": "2020-03-20",
		"end_date": "2021-05-31",
		"record_modified": "2021-08-27"
	},
	{
		"organisation": [
			"Universitätsmedizin Rostock, Zentrum für Innere Medizin, Abteilung für Infektionskrankheiten und Tropenmedizin",
			"Universitätsmedizin Rostock "
		],
		"location": [
			"Rostock"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [],
		"title": "Prospective Study initiated by University Hospital Rostock concerning COVID-19 in mothers, nursery and school teachers of children in Rostock",
		"scope_regionality": "Local/Regional",
		"region": "Mecklenburg-Western Pomerania",
		"location_raw": "Rostock",
		"organisation_raw": "Abteilung für Tropenmedizin und Infektionskrankheiten; Klinik für Innere Medizin Universitätsmedizin Rostock",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022504",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Other groups",
		"subject_information": "Mothers of children aged 1 to 10 years (RoKiCo A), caregivers of children (RoKiCo B), and those affected by COVID-19 (RoKiCo C)",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 600,
		"start_date": "2020-08-10"
	},
	{
		"organisation": [
			"Universitätsklinikum Düsseldorf",
			"Stadt Düsseldorf",
			"Ministerium für Arbeit, Gesundheit und Soziales Nordrhein-Westfalen"
		],
		"location": [
			"Dusseldorf"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1093/occmed/kqab164"
		],
		"title": "Seroprävalenz COVID-19 Düsseldorf: Rettungsdienst (SERODUS II)",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Dusseldorf",
		"organisation_raw": "Universitätsklinikum Düsseldorf; Stadt Düsseldorf; Ministerium für Arbeit, Gesundheit und Soziales Nordrhein-Westfalen",
		"information_url": "https://www.uniklinik-duesseldorf.de/patienten-besucher/klinikeninstitutezentren/institut-fuer-medizinische-soziologie/das-institut/forschung/serodus",
		"type": "Cross sectional",
		"subject_frame": "Essential non-healthcare workers",
		"subject_information": "Employees of the rescue service of the city of Düsseldorf",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_max": 65,
		"age_min": 18,
		"sample_design": "Random sampling (not central registration-based)",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 745,
		"sample_size_rounded": 700,
		"start_date": "2020-11-27",
		"end_date": "2021-12-04"
	},
	{
		"organisation": [
			"Johannes Gutenberg Universität Mainz"
		],
		"location": [
			"Hesse"
		],
		"analysis_test_manufacturer": [
			"ABBOTT N",
			"ROCHE"
		],
		"resource_url": [
			"https://www.unimedizin-mainz.de/GCS/dashboard/"
		],
		"title": "Gutenberg COVID-19 Studie",
		"scope_regionality": "Local/Regional",
		"region": "Rhineland-Palatinate",
		"location_raw": "Rhine Hesse",
		"organisation_raw": "Universitätsmedizin der Johannes Gutenberg-Universität Mainz",
		"information_url": "https://www.unimedizin-mainz.de/gcs/uebersicht.html",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Predominantly participants from the Gutenberg Health Study cohort and newly recruited study participants",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 88,
		"age_min": 25,
		"sample_design": "Cohort-sample - Sampling from existing cohort study in the general population",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 10250,
		"sample_size_rounded": 10300,
		"start_date": "2020-10-15",
		"end_date": "2021-06-15",
		"results_seroprevalence_information": "Proportion of SARS-CoV-2 infections (PCR or antibody positive) among the population sample for the period October 2020 - June 2021",
		"results_publication_url": "https://www.unimedizin-mainz.de/GCS/dashboard/#/app/pages/AktuelleErgebnisse/ergebnisse",
		"results_publication_date": "2021-12-20",
		"results_publication_type": "Presentation",
		"analysis_data_source": "whole blood",
		"analysis_test": "ELISA ",
		"analysis_test_manufacturer_raw": "ABBOTT N, ROCHE",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_positive": 0.049,
		"results_seroprevalence_positive_95pct_lower": 0.045,
		"results_seroprevalence_positive_95pct_upper": 0.053,
		"record_modified": "2022-02-11",
		"results_underreporting": 1.6
	},
	{
		"organisation": [
			"Krankenhaus Barmherzige Brüder Regensburg"
		],
		"location": [
			"Rosenheim",
			"Tirschenreuth",
			"Regensburg"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.22541/au.160776187.78854537/v1",
			"https://doi.org/10.3389/fped.2021.678937"
		],
		"title": "Corona-Virus bei Kindern in Bayern (CoKiBa)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Rosenheim, Tirschenreuth, Regensburg",
		"organisation_raw": "Klinik und Poliklinik für Kinder- und Jugendmedizin der Universität Regensburg (KUNO), Klinik St. Hedwig, Krankenhaus Barmherzige Brüder Regensburg",
		"type": "Cross sectional",
		"subject_frame": "Patients seeking care for non-COVID-19 reasons",
		"subject_information": "Children and adolescents who attended routine checkups in pediatric offices and children and adolescents with possible COVID-19 symptoms/contacts",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 14,
		"age_min": 1,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 2800,
		"start_date": "2020-05-22",
		"end_date": "2020-07-22",
		"record_modified": "2021-09-27"
	},
	{
		"organisation": [
			"Krankenhaus Barmherzige Brüder Regensburg"
		],
		"location": [
			"Tirschenreuth"
		],
		"analysis_test_manufacturer": [
			"ROCHE N",
			"In-house ELISA"
		],
		"resource_url": [],
		"title": "Corona-Virus bei Kindern in Bayern (CoKiBa)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Tirschenreuth",
		"organisation_raw": "Klinik und Poliklinik für Kinder- und Jugendmedizin der Universität Regensburg (KUNO), Klinik St. Hedwig, Krankenhaus Barmherzige Brüder Regensburg",
		"type": "Cross sectional",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Children and adolescents who attended routine checkups in pediatric offices and children and adolescents with possible COVID-19 symptoms/contacts",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 14,
		"age_min": 1,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"start_date": "2020-05-22",
		"end_date": "2020-07-22",
		"results_seroprevalence_information": "Seroprevalence among children and adolescents, attending routine checkups in pediatric offices in Tirschenreuth",
		"results_publication_url": "https://www.frontiersin.org/articles/10.3389/fped.2021.678937/full",
		"results_publication_date": "2020-12-12",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "Multiple antibodies",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "ROCHE, In-house ELISA",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.072,
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Krankenhaus Barmherzige Brüder Regensburg"
		],
		"location": [
			"Regensburg"
		],
		"analysis_test_manufacturer": [
			"ROCHE N",
			"In-house ELISA"
		],
		"resource_url": [],
		"title": "Corona-Virus bei Kindern in Bayern (CoKiBa)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Regensburg",
		"organisation_raw": "Klinik und Poliklinik für Kinder- und Jugendmedizin der Universität Regensburg (KUNO), Klinik St. Hedwig, Krankenhaus Barmherzige Brüder Regensburg",
		"type": "Cross sectional",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Children and adolescents who attended routine checkups in pediatric offices and children and adolescents with possible COVID-19 symptoms/contacts",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 14,
		"age_min": 1,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"start_date": "2020-05-22",
		"end_date": "2020-07-22",
		"results_seroprevalence_information": "Seroprevalence among children and adolescents, attending routine checkups in pediatric offices in Regensburg",
		"results_publication_url": "https://www.frontiersin.org/articles/10.3389/fped.2021.678937/full",
		"results_publication_date": "2020-12-12",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "Multiple antibodies",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "ROCHE, In-house ELISA",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.031,
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Krankenhaus Barmherzige Brüder Regensburg"
		],
		"location": [
			"Bavaria"
		],
		"analysis_test_manufacturer": [
			"ROCHE N",
			"In-house ELISA"
		],
		"resource_url": [],
		"title": "Corona-Virus bei Kindern in Bayern (CoKiBa)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Upper Bavaria/The Alps",
		"organisation_raw": "Klinik und Poliklinik für Kinder- und Jugendmedizin der Universität Regensburg (KUNO), Klinik St. Hedwig, Krankenhaus Barmherzige Brüder Regensburg",
		"type": "Cross sectional",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Children and adolescents who attended routine checkups in pediatric offices and children and adolescents with possible COVID-19 symptoms/contacts",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 14,
		"age_min": 1,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"start_date": "2020-05-22",
		"end_date": "2020-07-22",
		"results_seroprevalence_information": "Seroprevalence among children and adolescents, attending routine checkups in pediatric offices in Upper Bavaria and the Alps region",
		"results_publication_url": "https://www.frontiersin.org/articles/10.3389/fped.2021.678937/full",
		"results_publication_date": "2020-12-12",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "Multiple antibodies",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "ROCHE, In-house ELISA",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.018,
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Krankenhaus Barmherzige Brüder Regensburg"
		],
		"location": [
			"Tirschenreuth"
		],
		"analysis_test_manufacturer": [
			"ROCHE N",
			"In-house ELISA"
		],
		"resource_url": [],
		"title": "Corona-Virus bei Kindern in Bayern (CoKiBa)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Tirschenreuth",
		"organisation_raw": "Klinik und Poliklinik für Kinder- und Jugendmedizin der Universität Regensburg (KUNO), Klinik St. Hedwig, Krankenhaus Barmherzige Brüder Regensburg",
		"type": "Cross sectional",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Children and adolescents who attended routine checkups in pediatric offices and children and adolescents with possible COVID-19 symptoms/contacts",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 18,
		"age_min": 1,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"start_date": "2020-05-22",
		"end_date": "2020-07-22",
		"results_seroprevalence_information": "Seroprevalence amoong children and adolescents with possible COVID-19 symptoms/contacts in Tirschenreugth, who were interested in taking part in the CoKiBa study",
		"results_publication_url": "https://www.frontiersin.org/articles/10.3389/fped.2021.678937/full",
		"results_publication_date": "2020-12-12",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "Multiple antibodies",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "ROCHE, In-house ELISA",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.159,
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Krankenhaus Barmherzige Brüder Regensburg"
		],
		"location": [
			"Regensburg"
		],
		"analysis_test_manufacturer": [
			"ROCHE N",
			"In-house ELISA"
		],
		"resource_url": [],
		"title": "Corona-Virus bei Kindern in Bayern (CoKiBa)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Regensburg",
		"organisation_raw": "Klinik und Poliklinik für Kinder- und Jugendmedizin der Universität Regensburg (KUNO), Klinik St. Hedwig, Krankenhaus Barmherzige Brüder Regensburg",
		"type": "Cross sectional",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Children and adolescents who attended routine checkups in pediatric offices and children and adolescents with possible COVID-19 symptoms/contacts",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 18,
		"age_min": 1,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"start_date": "2020-05-22",
		"end_date": "2020-07-22",
		"results_seroprevalence_information": "Seroprevalence amoong children and adolescents with possible COVID-19 symptoms/contacts in Regensburg, who were interested in taking part in the CoKiBa study",
		"results_publication_url": "https://www.frontiersin.org/articles/10.3389/fped.2021.678937/full",
		"results_publication_date": "2020-12-12",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "Multiple antibodies",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "ROCHE, In-house ELISA",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.023,
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Krankenhaus Barmherzige Brüder Regensburg"
		],
		"location": [
			"Bavaria"
		],
		"analysis_test_manufacturer": [
			"ROCHE N",
			"In-house ELISA"
		],
		"resource_url": [],
		"title": "Corona-Virus bei Kindern in Bayern (CoKiBa)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Upper Bavaria/The Alps",
		"organisation_raw": "Klinik und Poliklinik für Kinder- und Jugendmedizin der Universität Regensburg (KUNO), Klinik St. Hedwig, Krankenhaus Barmherzige Brüder Regensburg",
		"type": "Cross sectional",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Children and adolescents who attended routine checkups in pediatric offices and children and adolescents with possible COVID-19 symptoms/contacts",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 18,
		"age_min": 1,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"start_date": "2020-05-22",
		"end_date": "2020-07-22",
		"results_seroprevalence_information": "Seroprevalence amoong children and adolescents with possible COVID-19 symptoms/contacts in Upper Bavaria and the Alps region, who were interested in taking part in the CoKiBa study",
		"results_publication_url": "https://www.frontiersin.org/articles/10.3389/fped.2021.678937/full",
		"results_publication_date": "2020-12-12",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "Multiple antibodies",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "ROCHE, In-house ELISA",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.078,
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"St. Vincenz Krankenhaus Datteln"
		],
		"location": [
			"Datteln",
			"Waltrop"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1016/j.ijheh.2021.113771",
			"https://doi.org/10.3390/ijerph19042402"
		],
		"title": "COVID-19: Hotspot hospital?- Epidemiological analysis time shifted antibody tests of hospital employees",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Datteln and Waltrop",
		"organisation_raw": "St. Vincenz Krankenhaus Datteln",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022941",
		"type": "Cross sectional and selective longitudinal",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Employees of three peripheral hospital providing basic and standard care, as well as from the local fire brigade",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_max": 65,
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1842,
		"sample_size_rounded": 1800,
		"start_date": "2020-06-15",
		"end_date": "2021-06-15",
		"record_modified": "2022-03-23"
	},
	{
		"organisation": [
			"Ludwig-Maximilians-Universität (LMU) München",
			"Medizinisches Versorgungszentrum Dachau, München",
			"Labor Augsburg MVZ GmbH",
			"Medizinische Klinik und Poliklinik I der Ludwigs-Maximilians-Universität (LMU)"
		],
		"location": [
			"Dachau",
			"Fürstenfeldbruck",
			"Munich"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1093/fampra/cmaa078"
		],
		"title": "Infection with SARS-CoV2 in primary care health care workers assessed by antibody testing",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "District of Dachau, Fürstenfeldbruck and Munich",
		"organisation_raw": "Medizinische Klinik und Poliklinik I der Ludwig-Maximilians-Universität (LMU) München; Medizinisches Versorgungszentrum Dachau, München; Labor Augsburg MVZ GmbH",
		"type": "Cross sectional",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Medical staff (physicians, medical assistants) of the MVZ Dachau",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 151,
		"sample_size_rounded": 200,
		"start_date": "2020-04-02",
		"end_date": "2020-04-06"
	},
	{
		"organisation": [
			"Universitätsklinikum Leipzig, Institut für Medizinische Mikrobiologie und Virologie",
			"Universitätsklinikum Leipzig, Institut für Transfusionsmedizin",
			"Universitätsklinikum Leipzig, Institut für Laboratoriumsmedizin",
			"Universitätsklinikum Leipzig, Neurologische Klinik und Poliklinik",
			"Universitätsklinikum Leipzig"
		],
		"location": [
			"Leipzig"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [],
		"title": "Seroprevalence of SARS CoV-2 infections/Covid-19 in blood donors and patients of the University Hospitals in Leipzig (CovSeroUKL)",
		"scope_regionality": "Local/Regional",
		"region": "Saxony",
		"location_raw": "Leipzig",
		"organisation_raw": "Institut für Medizinische Mikrobiologie und Virologie, Institut für Transfusionsmedizin, Institut für Laboratoriumsmedizin, Neurologische Klinik und Poliklinik, Universitätsklinikum Leipzig",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00023364",
		"type": "Repeated cross-sectional",
		"subject_frame": "Blood donors and non-COVID-patients",
		"subject_information": "Blood donors and patients of the University Hospital who have had blood serum drawn for a medical examination",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 2000,
		"start_date": "2020-06-20"
	},
	{
		"organisation": [
			"University of Erlangen-Nürnberg Medical School, Children and Youth Clinic",
			"University of Erlangen-Nürnberg Medical School",
			"Friedrich-Alexander-Universität Erlangen-Nürnberg "
		],
		"location": [
			"Erlangen"
		],
		"analysis_test_manufacturer": [
			"ROCHE S"
		],
		"resource_url": [],
		"title": "Determination of SARS-CoV2 Antibody Prevalence in Pediatric Patients (SARS-CoV2_KIDS)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Erlangen",
		"organisation_raw": "Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",
		"registry_url": "https://clinicaltrials.gov/ct2/show/NCT04581148",
		"type": "Repeated cross-sectional",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Inpatients and outpatients of the Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",
		"scope_population": "Selected population groups",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 17,
		"age_min": 0,
		"sample_design": "Entire sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 872,
		"sample_size_rounded": 900,
		"start_date": "2020-10-16",
		"end_date": "2020-11-16",
		"results_seroprevalence_information": "Seroprevalence of antibodies against the spike protein among children and adolescents, who presented themselves during the period of October to November 2020 at the department of pediatrics and adolescent medicine of the University Hospital Erlangen for non-COVID reasons",
		"results_publication_url": "https://doi.org/10.1515/cclm-2022-0037",
		"results_publication_date": "2022-02-25",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "blood plasma",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "Total antibody",
		"analysis_test": "Elektrochemolumineszenz (ECL)-Immunassay; LIPS",
		"analysis_test_manufacturer_raw": "ROCHE S",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.0138,
		"record_created": "2022-03-15",
		"results_underreporting": 5.66
	},
	{
		"organisation": [
			"University of Erlangen-Nürnberg Medical School, Children and Youth Clinic",
			"University of Erlangen-Nürnberg Medical School",
			"Friedrich-Alexander-Universität Erlangen-Nürnberg "
		],
		"location": [
			"Erlangen"
		],
		"analysis_test_manufacturer": [
			"ROCHE S"
		],
		"resource_url": [],
		"title": "Determination of SARS-CoV2 Antibody Prevalence in Pediatric Patients (SARS-CoV2_KIDS)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Erlangen",
		"organisation_raw": "Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",
		"registry_url": "https://clinicaltrials.gov/ct2/show/NCT04581148",
		"type": "Repeated cross-sectional",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Inpatients and outpatients of the Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",
		"scope_population": "Selected population groups",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 17,
		"age_min": 0,
		"sample_design": "Entire sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 808,
		"sample_size_rounded": 800,
		"start_date": "2021-04-01",
		"end_date": "2021-04-30",
		"results_seroprevalence_information": "Seroprevalence of antibodies against the spike protein among children and adolescents, who presented themselves during April 2021 at the department of pediatrics and adolescent medicine of the University Hospital Erlangen for non-COVID reasons",
		"results_publication_url": "https://doi.org/10.1515/cclm-2022-0037",
		"results_publication_date": "2022-02-25",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "blood plasma",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "Total antibody",
		"analysis_test": "Elektrochemolumineszenz (ECL)-Immunassay; LIPS",
		"analysis_test_manufacturer_raw": "ROCHE S",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_positive": 0.0916,
		"record_created": "2022-03-15",
		"results_underreporting": 4.35
	},
	{
		"organisation": [
			"University of Erlangen-Nürnberg Medical School, Children and Youth Clinic",
			"University of Erlangen-Nürnberg Medical School",
			"Friedrich-Alexander-Universität Erlangen-Nürnberg "
		],
		"location": [
			"Erlangen"
		],
		"analysis_test_manufacturer": [
			"ROCHE S"
		],
		"resource_url": [],
		"title": "Determination of SARS-CoV2 Antibody Prevalence in Pediatric Patients (SARS-CoV2_KIDS)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Erlangen",
		"organisation_raw": "Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",
		"registry_url": "https://clinicaltrials.gov/ct2/show/NCT04581148",
		"type": "Repeated cross-sectional",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Inpatients and outpatients of the Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",
		"scope_population": "Selected population groups",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 17,
		"age_min": 0,
		"sample_design": "Entire sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 946,
		"sample_size_rounded": 900,
		"start_date": "2021-06-15",
		"end_date": "2021-07-15",
		"results_seroprevalence_information": "Seroprevalence of antibodies against the spike protein among children and adolescents, who presented themselves during the period of June to July 2021 at the department of pediatrics and adolescent medicine of the University Hospital Erlangen for non-COVID reasons",
		"results_publication_url": "https://doi.org/10.1515/cclm-2022-0037",
		"results_publication_date": "2022-02-25",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "blood plasma",
		"analysis_target": "anti -S1 domain",
		"analysis_isotype": "Total antibody",
		"analysis_test": "Elektrochemolumineszenz (ECL)-Immunassay; LIPS",
		"analysis_test_manufacturer_raw": "ROCHE S",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_positive": 0.1459,
		"record_created": "2022-03-15",
		"results_underreporting": 3.93
	},
	{
		"organisation": [
			"University of Erlangen-Nürnberg Medical School, Children and Youth Clinic",
			"University of Erlangen-Nürnberg Medical School",
			"Friedrich-Alexander-Universität Erlangen-Nürnberg "
		],
		"location": [
			"Erlangen"
		],
		"analysis_test_manufacturer": [
			"ROCHE N"
		],
		"resource_url": [],
		"title": "Determination of SARS-CoV2 Antibody Prevalence in Pediatric Patients (SARS-CoV2_KIDS)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Erlangen",
		"organisation_raw": "Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",
		"registry_url": "https://clinicaltrials.gov/ct2/show/NCT04581148",
		"type": "Repeated cross-sectional",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Inpatients and outpatients of the Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",
		"scope_population": "Selected population groups",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 17,
		"age_min": 0,
		"sample_design": "Entire sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 872,
		"sample_size_rounded": 900,
		"start_date": "2020-10-16",
		"end_date": "2020-11-16",
		"results_seroprevalence_information": "Seroprevalence of antibodies against the nucleocapsid among children and adolescents, who presented themselves during the period of October to November 2020 at the department of pediatrics and adolescent medicine of the University Hospital Erlangen for non-COVID reasons",
		"results_publication_url": "https://doi.org/10.1515/cclm-2022-0037",
		"results_publication_date": "2022-02-25",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "blood plasma",
		"analysis_target": "anti Nucleocapsid",
		"analysis_isotype": "Total antibody",
		"analysis_test": "Elektrochemolumineszenz (ECL)-Immunassay; LIPS",
		"analysis_test_manufacturer_raw": "ROCHE N",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_positive": 0.0126,
		"record_created": "2022-03-15"
	},
	{
		"organisation": [
			"University of Erlangen-Nürnberg Medical School, Children and Youth Clinic",
			"University of Erlangen-Nürnberg Medical School",
			"Friedrich-Alexander-Universität Erlangen-Nürnberg "
		],
		"location": [
			"Erlangen"
		],
		"analysis_test_manufacturer": [
			"ROCHE N"
		],
		"resource_url": [],
		"title": "Determination of SARS-CoV2 Antibody Prevalence in Pediatric Patients (SARS-CoV2_KIDS)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Erlangen",
		"organisation_raw": "Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",
		"registry_url": "https://clinicaltrials.gov/ct2/show/NCT04581148",
		"type": "Repeated cross-sectional",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Inpatients and outpatients of the Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",
		"scope_population": "Selected population groups",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 17,
		"age_min": 0,
		"sample_design": "Entire sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 808,
		"sample_size_rounded": 800,
		"start_date": "2021-04-01",
		"end_date": "2021-04-30",
		"results_seroprevalence_information": "Seroprevalence of antibodies against the nucleocapsid among children and adolescents, who presented themselves during April 2021 at the department of pediatrics and adolescent medicine of the University Hospital Erlangen for non-COVID reasons",
		"results_publication_url": "https://doi.org/10.1515/cclm-2022-0037",
		"results_publication_date": "2022-02-25",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "blood plasma",
		"analysis_target": "anti Nucleocapsid",
		"analysis_isotype": "Total antibody",
		"analysis_test": "Elektrochemolumineszenz (ECL)-Immunassay; LIPS",
		"analysis_test_manufacturer_raw": "ROCHE N",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_positive": 0.0619,
		"record_created": "2022-03-15"
	},
	{
		"organisation": [
			"University of Erlangen-Nürnberg Medical School, Children and Youth Clinic",
			"University of Erlangen-Nürnberg Medical School",
			"Friedrich-Alexander-Universität Erlangen-Nürnberg "
		],
		"location": [
			"Erlangen"
		],
		"analysis_test_manufacturer": [
			"ROCHE N"
		],
		"resource_url": [],
		"title": "Determination of SARS-CoV2 Antibody Prevalence in Pediatric Patients (SARS-CoV2_KIDS)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Erlangen",
		"organisation_raw": "Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",
		"registry_url": "https://clinicaltrials.gov/ct2/show/NCT04581148",
		"type": "Repeated cross-sectional",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Inpatients and outpatients of the Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",
		"scope_population": "Selected population groups",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 17,
		"age_min": 0,
		"sample_design": "Entire sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 946,
		"sample_size_rounded": 900,
		"start_date": "2021-06-15",
		"end_date": "2021-07-15",
		"results_seroprevalence_information": "Seroprevalence of antibodies against the nucleocapsid among children and adolescents, who presented themselves during the period of June to July 2021 at the department of pediatrics and adolescent medicine of the University Hospital Erlangen for non-COVID reasons",
		"results_publication_url": "https://doi.org/10.1515/cclm-2022-0037",
		"results_publication_date": "2022-02-25",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "blood plasma",
		"analysis_target": "anti Nucleocapsid",
		"analysis_isotype": "Total antibody",
		"analysis_test": "Elektrochemolumineszenz (ECL)-Immunassay; LIPS",
		"analysis_test_manufacturer_raw": "ROCHE N",
		"subject_vaccination": "Seroprevalence in all participants",
		"results_seroprevalence_positive": 0.0856,
		"record_created": "2022-03-15"
	},
	{
		"organisation": [
			"University of Erlangen-Nürnberg Medical School, Children and Youth Clinic",
			"University of Erlangen-Nürnberg Medical School",
			"Friedrich-Alexander-Universität Erlangen-Nürnberg "
		],
		"location": [
			"Erlangen"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://www.degruyter.com/document/doi/10.1515/cclm-2022-0037/html"
		],
		"title": "Determination of SARS-CoV2 Antibody Prevalence in Pediatric Patients (SARS-CoV2_KIDS)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Erlangen",
		"organisation_raw": "Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",
		"registry_url": "https://clinicaltrials.gov/ct2/show/NCT04581148",
		"type": "Repeated cross-sectional",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Inpatients and outpatients of the Children and Youth Clinic, University of Erlangen-Nürnberg Medical School",
		"scope_population": "Selected population groups",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 17,
		"sample_design": "Entire sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2626,
		"sample_size_rounded": 2600,
		"start_date": "2020-10-15",
		"end_date": "2021-07-15"
	},
	{
		"organisation": [
			"Johannes Gutenberg Universität Mainz"
		],
		"location": [
			"Rhine-Main area"
		],
		"analysis_test_manufacturer": [
			"ABBOTT N",
			"ROCHE"
		],
		"resource_url": [
			"https://doi.org/10.7754/clin.lab.2020.200915"
		],
		"title": "Prevalence of Severe Acute Respiratory Syndrome Coronavirus-2-specific Antibodies in German Blood Donors during the COVID-19 Pandemic",
		"scope_regionality": "Local/Regional",
		"region": "Rhineland-Palatinate",
		"location_raw": "Rhineland-Palatinate and Rhine-Main area",
		"organisation_raw": "Universitätsmedizin der Johannes Gutenberg Universität Mainz, Transfusionszentrale",
		"type": "Repeated cross-sectional",
		"subject_frame": "Blood donors",
		"subject_information": "Blood donors from Rhineland-Palatinate and the Rhine-Main region",
		"scope_population": "General population",
		"scope_age": "Adults",
		"age_max": 71,
		"age_min": 18,
		"sample_design": "Blood donation",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 3880,
		"sample_size_rounded": 3900,
		"start_date": "2020-03-15",
		"end_date": "2020-06-15",
		"results_seroprevalence_information": "Seroprevalence among blood donors from Rhineland-Palatinate and the Rhine-Main region for the period from March to June 2020",
		"results_publication_url": "https://doi.org/10.7754/clin.lab.2020.200915",
		"results_publication_date": "2020-10-01",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "anti Nucleocapsid",
		"analysis_isotype": "IgG",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "ABBOTT N, ROCHE",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity",
		"results_seroprevalence_positive": 0.0039,
		"record_created": "2021-08-06",
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Gesundheitsamt der Hansestadt Lübeck"
		],
		"location": [
			"Lübeck"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [],
		"title": "COVID Study on Educational Personnel (COVID-STEP)",
		"scope_regionality": "Local/Regional",
		"region": "Schleswig-Holstein",
		"location_raw": "Lübeck",
		"organisation_raw": "Gesundheitsamt der Hansestadt Lübeck",
		"information_url": "https://www.luebeck.de/covid-step",
		"type": "Repeated cross-sectional",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Teachers and educators of schools and day care centers",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 1500,
		"start_date": "2020-06-29"
	},
	{
		"organisation": [
			"Universität Ulm"
		],
		"location": [
			"Ulm"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1101/2021.05.04.21256382"
		],
		"title": "Longitudinal SARS-CoV-2-infection study with medical and dental students at Ulm University (COVID-19 MedStud Ulm)",
		"scope_regionality": "Local/Regional",
		"region": "Baden-Wuerttemberg",
		"location_raw": "Ulm",
		"organisation_raw": "Institut für Anatomie und Zellbiologie und Medizinisches Dekanat der Universität Ulm",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00024860",
		"type": "Cross sectional",
		"subject_frame": "Students",
		"subject_information": "Students and teachers of medicine and dentistry",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 868,
		"sample_size_rounded": 900,
		"start_date": "2020-11-05"
	},
	{
		"organisation": [
			"Arbeitsmedizinischer Dienst der Berufsgenossenschaft für Bauwirtschaft GmbH"
		],
		"location": [
			"Germany"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [],
		"title": "COVID-19 Infection Rate in the Construction- and Cleaning Industry",
		"scope_regionality": "Local/Regional",
		"region": "Multilocal",
		"location_raw": "15 centres of occupational medicine, nationwide",
		"organisation_raw": "Arbeitsmedizinischer Dienst der Berufsgenossenschaft für Bauwirtschaft GmbH",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00024860",
		"type": "Cross sectional",
		"subject_frame": "Non-essential workers and unemployed persons",
		"subject_information": "Employees in the construction and cleaning trades who attend an occupational health screening appointment",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 3000,
		"start_date": "2020-11-20"
	},
	{
		"organisation": [
			"Universitätsmedizin Greifswald",
			"Friedrich-Loeffler-Institut",
			"Friedrich-Loeffler-Institut für Medizinische Mikrobiologie",
			"Friedrich-Loeffler-Institut, Zentralbereich Hygiene"
		],
		"location": [
			"Greifswald"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [],
		"title": "Screening for COVID-19 in Teachers, Childcare Educators, Pupils and Preschoolers (COKITS)",
		"scope_regionality": "Local/Regional",
		"region": "Mecklenburg-Western Pomerania",
		"location_raw": "Western Pomerania - Greifswald",
		"organisation_raw": "Universitätsmedizin Greifswald, Friedrich-Loeffler-Institut für Medizinische Mikrobiologie und Zentralbereich Hygiene",
		"registry_url": "https://clinicaltrials.gov/ct2/show/NCT04619407",
		"information_url": "http://www2.medizin.uni-greifswald.de/mikrobio/index.php?id=556",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "School, Kindergarten/Daycare",
		"subject_information": "Pedagogical staff, daycare children and students in the district of Vorpommern-Greifswald",
		"scope_population": "General population",
		"scope_age": "Multiple",
		"age_max": 67,
		"age_min": 3,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 142,
		"sample_size_rounded": 100,
		"start_date": "2020-11-04",
		"end_date": "2021-03-26"
	},
	{
		"organisation": [
			"Innere Medizin und Labormedizin; Prof. Dr. Herrmann, Bochum"
		],
		"location": [
			"Bochum"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://dx.doi.org/10.1007%2Fs15006-020-0750-y"
		],
		"title": "SARS-CoV-2 IgG-Screening bei asymptomatischen ambulanten Patienten ",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Bochum",
		"organisation_raw": "Innere Medizin und Labormedizin; Prof. Dr. Herrmann, Bochum",
		"type": "Cross sectional",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Asymptomatic patients in an outpatient medical practice",
		"scope_population": "Selected population groups",
		"scope_age": "Multiple",
		"age_max": 78,
		"age_min": 10,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 415,
		"sample_size_rounded": 400,
		"start_date": "2020-03-26",
		"end_date": "2020-06-04"
	},
	{
		"organisation": [
			"Ruhr-Universität Bochum",
			"St. Josef Hospital Bochum",
			"Medizinische Klinik I, Ruhr-Universität Bochum",
			"Abteilung für medizinische Informatik, Biometrie und Epidemiologie, Ruhr-Universität Bochum",
			"Abteilung für Molekulare und Medizinische Virologie, Ruhr-Universität Bochum"
		],
		"location": [
			"Bochum"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.3390/covid1010029"
		],
		"title": "Assessment, Surveillance and Testing in Students' Accommodations (SARS-CoV-2 ASTA)",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Bochum",
		"organisation_raw": "Ruhr-Universität Bochum, St. Josef Hospital Bochum, Medizinische Klinik I, Abteilung für medizinische Informatik, Biometrie und Epidemiologie, Abteilung für Molekulare und Medizinische Virologie",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00024143",
		"information_url": "https://news.rub.de/presseinformationen/wissenschaft/2020-10-13-covid-19-forschung-studie-zum-ansteckungsrisiko-von-studierenden-mit-sars-cov-2",
		"type": "Repeated cross-sectional",
		"subject_frame": "Students",
		"subject_information": "Students in living in student halls",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_max": 39,
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 810,
		"sample_size_rounded": 800,
		"start_date": "2020-11-02",
		"end_date": "2021-02-15"
	},
	{
		"organisation": [
			"Ludwig-Maximilians-Universität (LMU) München"
		],
		"location": [
			"Munich"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1093/cid/ciaa1935"
		],
		"title": "Prospective Longitudinal Serosurvey of Health Care Workers in the First Wave of the SARS-CoV-2 Pandemic in a Quaternary Care Hospital in Munich, Germany",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Munich",
		"organisation_raw": "Ludwigs-Maximilians-Universität München",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Employees from four different organizational units of the hospital",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_max": 69,
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 300,
		"sample_size_rounded": 300,
		"start_date": "2020-03-24",
		"end_date": "2020-07-07"
	},
	{
		"organisation": [
			"Universitätsklinikum Hamburg-Eppendorf, Competenzzentrum Epidemiologie und Versorgungsforschung bei Pflegeberufen (CVcare)",
			"Universitätsklinikum Hamburg-Eppendorf, Zentralinstitut für Arbeitsmedizin und Maritime Medizin",
			"Universitätsklinikum Hamburg-Eppendorf (UKE)"
		],
		"location": [
			"Hamburg"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [],
		"title": "Serokonversion gegen SARS-CoV-2 bei Beschäftigten in ambulanten Pflegeeinrichtungen: Inzidenz, Klinik und Risikofaktoren",
		"scope_regionality": "Local/Regional",
		"region": "Hamburg",
		"location_raw": "Hamburg",
		"organisation_raw": "Competenzzentrum Epidemiologie und Versorgungsforschung bei Pflegeberufen (CVcare) und Zentralinstitut für Arbeitsmedizin und Maritime Medizin, Universitätsklinikum Hamburg-Eppendorf",
		"information_url": "https://www.uke.de/kliniken-institute/institute/versorgungsforschung-in-der-dermatologie-und-bei-pflegeberufen/bereiche/cvcare/cvcare-projektseite.html",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Employees in outpatient care services",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 600,
		"start_date": "2020-06-15",
		"end_date": "2021-08-15"
	},
	{
		"organisation": [
			"Universitätsmedizin Greifswald",
			"Kinderportalpraxisklinik Wolgast",
			"Asklepios Klinik Pasewalk",
			"Sana Krankenhaus Rügen Bergen",
			"Helios Hanseklinikum Stralsund",
			"Kreiskrankenhaus Demmin",
			"Ameos Klinikum Anklam",
			"University Medicine Greifswald"
		],
		"location": [
			"Western Pomerania"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://www.ndr.de/nachrichten/mecklenburg-vorpommern/Corona-Studie-Die-meisten-Jugendlichen-haben-Antikoerper,coronazahlen1848.html"
		],
		"title": "Analyzing the incidence of SARS-Cov-2 infected children and teenager in Western Pomerania",
		"scope_regionality": "Local/Regional",
		"region": "Mecklenburg-Western Pomerania",
		"location_raw": "Western Pomerania",
		"organisation_raw": "Klinik und Poliklinik für Kinder- und Jugenmedizin der Universitätsmedizin Greifswald; Kinderportalpraxisklinik Wolgast; Klinik für Kinder- und Jugendmedizin der Asklepios Klinik Pasewalk; Kinderklinik Sana Krankenhaus Rügen Bergen; Klinik für Kinder- und Jugendmedizin Helios Hanseklinikum Stralsund; Klinik für Kinder- und Jugendmedizin Kreiskrankenhaus Demmin; Klinik für Kinder- und Jugendmedizin Ameos Klinikum Anklam",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00024635",
		"type": "Repeated cross-sectional",
		"subject_frame": "Persons seeking care for non-COVID reasons",
		"subject_information": "Children and adolescents treated on an outpatient basis in the children's hospitals and medical practices of Western Pomerania",
		"scope_population": "Selected population groups",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 17,
		"age_min": 1,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 4000,
		"start_date": "2020-12-10"
	},
	{
		"organisation": [
			"Charité Research Organisation GmbH",
			"INFRA DIALOG Deutschland GmbH"
		],
		"location": [
			"Rhine-Main area"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [],
		"title": "Study to investigate the risk of Corona infection (COVID-19) in local public transport",
		"scope_regionality": "Local/Regional",
		"region": "Hesse",
		"location_raw": "Rhine-Main area",
		"organisation_raw": "Charité Research Organisation GmbH/ INFRA DIALOG Deutschland GmbH",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00024104",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Travellers in public transport and other travellers",
		"subject_information": "Commuters who use public transport or a private vehicle",
		"scope_population": "Selected population groups",
		"scope_age": "Multiple",
		"age_max": 65,
		"age_min": 16,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 800,
		"start_date": "2020-02-15",
		"end_date": "2021-04-15"
	},
	{
		"organisation": [
			"Helmholtz Zentrum München, Institut für Diabetesforschung",
			"Helmholtz Zentrum München"
		],
		"location": [
			"Bavaria"
		],
		"analysis_test_manufacturer": [
			"Author designed"
		],
		"resource_url": [
			"https://doi.org/10.1016/j.medj.2020.10.003"
		],
		"title": "Freder1k-Studie: Typ-1-Diabetes-Risiko früh erkennen",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Bavaria",
		"organisation_raw": "Institut für Diabetesforschung, Helmholtz Zentrum München",
		"type": "Repeated cross-sectional",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Participating infants of the Freder1k study (cohort of infants for early detection of type 1 diabetes)",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 1,
		"age_min": 0,
		"sample_design": "Cohort-sample - Sampling from existing cohort study in the general population",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1916,
		"sample_size_rounded": 1900,
		"start_date": "2020-04-15",
		"end_date": "2020-06-15",
		"results_seroprevalence_information": "Total seroprevalence of participating infants of the Freder1k study (cohort of infants for early detection of type 1 diabetes) for the period from April to June 2020",
		"results_publication_url": "https://doi.org/10.1016/j.medj.2020.10.003",
		"results_publication_date": "2021-02-12",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "capillary blood",
		"analysis_target": "multiple",
		"analysis_isotype": "Total antibody",
		"analysis_test": "Elektrochemolumineszenz (ECL)-Immunassay; LIPS",
		"analysis_test_manufacturer_raw": "Author designed",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_sensitivity": 0.973,
		"results_seroprevalence_specificity": 1,
		"results_seroprevalence_positive": 0.0047,
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Helmholtz Zentrum München, Institut für Diabetesforschung",
			"Helmholtz Zentrum München"
		],
		"location": [
			"Bavaria"
		],
		"analysis_test_manufacturer": [
			"Author designed"
		],
		"resource_url": [],
		"title": "Freder1k-Studie: Typ-1-Diabetes-Risiko früh erkennen",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Bavaria",
		"organisation_raw": "Institut für Diabetesforschung, Helmholtz Zentrum München",
		"type": "Cross sectional",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Participating infants of the Freder1k study (cohort of infants for early detection of type 1 diabetes) April 2020",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 1,
		"age_min": 0,
		"sample_design": "Cohort-sample - Sampling from existing cohort study in the general population",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 757,
		"sample_size_rounded": 800,
		"start_date": "2020-04-15",
		"end_date": "2020-04-30",
		"results_seroprevalence_information": "Seroprevalence of participating infants of the Freder1k study (cohort of infants for early detection of type 1 diabetes) for the period of April 2020",
		"results_publication_url": "https://doi.org/10.1016/j.medj.2020.10.003",
		"results_publication_date": "2021-02-12",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "capillary blood",
		"analysis_target": "multiple",
		"analysis_isotype": "Total antibody",
		"analysis_test": "Elektrochemolumineszenz (ECL)-Immunassay; LIPS",
		"analysis_test_manufacturer_raw": "Author designed",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_sensitivity": 0.973,
		"results_seroprevalence_specificity": 1,
		"results_seroprevalence_positive": 0.0013,
		"results_seroprevalence_positive_95pct_lower": 0,
		"results_seroprevalence_positive_95pct_upper": 0.0073,
		"record_created": "2021-09-24",
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Helmholtz Zentrum München, Institut für Diabetesforschung",
			"Helmholtz Zentrum München"
		],
		"location": [
			"Bavaria"
		],
		"analysis_test_manufacturer": [
			"Author designed"
		],
		"resource_url": [],
		"title": "Freder1k-Studie: Typ-1-Diabetes-Risiko früh erkennen",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Bavaria",
		"organisation_raw": "Institut für Diabetesforschung, Helmholtz Zentrum München",
		"type": "Cross sectional",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Participating infants of the Freder1k study (cohort of infants for early detection of type 1 diabetes) May 2020",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 1,
		"age_min": 0,
		"sample_design": "Cohort-sample - Sampling from existing cohort study in the general population",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 784,
		"sample_size_rounded": 800,
		"start_date": "2020-05-15",
		"end_date": "2020-05-15",
		"results_seroprevalence_information": "Seroprevalence of participating infants of the Freder1k study (cohort of infants for early detection of type 1 diabetes) for the period of May 2020",
		"results_publication_url": "https://doi.org/10.1016/j.medj.2020.10.003",
		"results_publication_date": "2021-02-12",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "capillary blood",
		"analysis_target": "multiple",
		"analysis_isotype": "Total antibody",
		"analysis_test": "Elektrochemolumineszenz (ECL)-Immunassay; LIPS",
		"analysis_test_manufacturer_raw": "Author designed",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_sensitivity": 0.973,
		"results_seroprevalence_specificity": 1,
		"results_seroprevalence_positive": 0.0038,
		"results_seroprevalence_positive_95pct_lower": 0.0008,
		"results_seroprevalence_positive_95pct_upper": 0.0111,
		"record_created": "2021-09-24",
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Helmholtz Zentrum München, Institut für Diabetesforschung",
			"Helmholtz Zentrum München"
		],
		"location": [
			"Bavaria"
		],
		"analysis_test_manufacturer": [
			"Author designed"
		],
		"resource_url": [],
		"title": "Freder1k-Studie: Typ-1-Diabetes-Risiko früh erkennen",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Bavaria",
		"organisation_raw": "Institut für Diabetesforschung, Helmholtz Zentrum München",
		"type": "Cross sectional",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Participating infants of the Freder1k study (cohort of infants for early detection of type 1 diabetes) June 2020",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 1,
		"age_min": 0,
		"sample_design": "Cohort-sample - Sampling from existing cohort study in the general population",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 375,
		"sample_size_rounded": 400,
		"start_date": "2020-06-15",
		"end_date": "2020-06-30",
		"results_seroprevalence_information": "Seroprevalence of participating infants of the Freder1k study (cohort of infants for early detection of type 1 diabetes) for the period of June 2020",
		"results_publication_url": "https://doi.org/10.1016/j.medj.2020.10.003",
		"results_publication_date": "2021-02-12",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "capillary blood",
		"analysis_target": "multiple",
		"analysis_isotype": "Total antibody",
		"analysis_test": "Elektrochemolumineszenz (ECL)-Immunassay; LIPS",
		"analysis_test_manufacturer_raw": "Author designed",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_sensitivity": 0.973,
		"results_seroprevalence_specificity": 1,
		"results_seroprevalence_positive": 0.0133,
		"results_seroprevalence_positive_95pct_lower": 0.0043,
		"results_seroprevalence_positive_95pct_upper": 0.0308,
		"record_created": "2021-09-24",
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Universitätsklinikum Bonn",
			"Universitätsklinikum Bonn, Medizinische Klinik I",
			"Universitätsklinikum Bonn, Infektiologische Ambulanz"
		],
		"location": [
			"Bonn"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1007/s15010-021-01641-6"
		],
		"title": "SARS-CoV-2 seroconversions and chains of infection in healthcare professionals in a German maximum care provider (The CoSHeP study)",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Bonn",
		"organisation_raw": "Universitätsklinikum Bonn, Medizinische Klinik I, Infektiologische Ambulanz",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Employees from emergency room, internal medicine intensive care unit, infectious diseases ward, and infectious diseases outpatient clinic",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_max": 68,
		"age_min": 19,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 150,
		"sample_size_rounded": 200,
		"start_date": "2020-05-15",
		"end_date": "2021-01-15"
	},
	{
		"organisation": [
			"Brandenburg Medical School Theodor Fontane"
		],
		"location": [
			"Brandenburg/Havel",
			"Neuruppin"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.3390/healthcare9050498"
		],
		"title": "Bicentric exploratory healthcare worker cohort study in two centers of a medical school in the federal state of Brandenburg in Germany (Test-SARS-CoV-2-BB)",
		"scope_regionality": "Local/Regional",
		"region": "Brandenburg",
		"location_raw": "Brandenburg/Havel and Neuruppin",
		"organisation_raw": "Brandenburg Medical School Theodor Fontane",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Health care workers of the University Hospital in Brandenburg/Havel and Neuruppin",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_max": 65,
		"age_min": 19,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1013,
		"sample_size_rounded": 1000,
		"start_date": "2020-03-30",
		"end_date": "2020-04-07"
	},
	{
		"organisation": [
			"Bundeswehr Institute of Microbiology in Munich"
		],
		"location": [
			"Ortenaukreis"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.3390/ijerph18083910"
		],
		"title": "SARS-CoV-2 Seroprevalence among Health Care Workers—A Voluntary Screening Study in a Regional Medical Center in Southern Germany",
		"scope_regionality": "Local/Regional",
		"region": "Baden-Wuerttemberg",
		"location_raw": "Ortenaukreis",
		"organisation_raw": "Bundeswehr Institute of Microbiology in Munich",
		"type": "Cross sectional",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Medical staff with direct contact to laboratory-confirmed COVID-19 patients from the Ortenau-Klinikum Offenburg, from various medical practices and from a pharmacy in the region",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 198,
		"sample_size_rounded": 200,
		"start_date": "2020-04-02",
		"end_date": "2020-04-08"
	},
	{
		"organisation": [
			"Altona Children’s Hospital, Universität Hamburg"
		],
		"location": [
			"Hamburg"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1007/s12519-021-00447-8"
		],
		"title": "SARS‑CoV‑2 seroprevalence among healthcare workers at children’s hospital ",
		"scope_regionality": "Local/Regional",
		"region": "Hamburg",
		"location_raw": "Hamburg, Altona",
		"organisation_raw": "Altona Children’s Hospital, Universität Hamburg",
		"type": "Cross sectional",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Employees of the Altona Children’s Hospital",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 616,
		"sample_size_rounded": 600,
		"start_date": "2020-08-19",
		"end_date": "2020-09-18",
		"record_created": "2021-09-02"
	},
	{
		"organisation": [
			"Max von Pettenkofer-Institut",
			"Ludwig-Maximilians-Universität (LMU) München",
			"Medizinische Klinik und Poliklinik I der Ludwigs-Maximilians-Universität (LMU)"
		],
		"location": [
			"Munich"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1007/s15010-021-01672-z"
		],
		"title": "All-Corona-Care-Studie (ACC-Studie)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Munich",
		"organisation_raw": "Max von Pettenkofer-Institut, Medizinische Klinik und Poliklinik I der Ludwigs-Maximilians-Universität (LMU) München",
		"information_url": "https://www.lmu-klinikum.de/aktuelles/pressemitteilungen/grosse-all-corona-care-studie-am-lmu-klinikum/7f18eb645e957774",
		"type": "Cross sectional",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Employees of the Ludwig-Maximilians Universität (LMU) Munich",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 7554,
		"sample_size_rounded": 7600,
		"start_date": "2020-05-27",
		"end_date": "2020-08-12",
		"record_created": "2021-10-04"
	},
	{
		"organisation": [
			"Universitätsklinikum Ulm"
		],
		"location": [
			"Ulm",
			"Alb-Donau-Kreis"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1007/s00391-021-01931-6"
		],
		"title": "The occurrence of psychosocial stress related to the COVID-19 pandemic and SARS-CoV-2 prevalence in care facilities",
		"scope_regionality": "Local/Regional",
		"region": "Baden-Wuerttemberg",
		"location_raw": "Ulm, Alb-Donau-Kreis",
		"organisation_raw": "Universitätsklinikum Ulm",
		"type": "Cross sectional",
		"subject_frame": "Assisted living and long-term care facilities",
		"subject_information": "Employees and residents from 7 care facilities in the Alb-Donau region and in the city of Ulm",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_max": 104,
		"age_min": 17,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 494,
		"sample_size_rounded": 500,
		"start_date": "2020-07-27",
		"end_date": "2020-08-25"
	},
	{
		"organisation": [
			"Universitätsklinikum Augsburg"
		],
		"location": [
			"Augsburg"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [],
		"title": "Covid-19-Antibody-Level-Monitoring-Universitätsklinikum Augsburg (CALM-UKA)",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Augsburg",
		"organisation_raw": "Universitätsklinikum Augsburg",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Employees of the Universitätsklinikum Augsburg",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_max": 82,
		"age_min": 17,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_rounded": 1500,
		"start_date": "2021-01-01"
	},
	{
		"organisation": [
			"University Hospital Regensburg"
		],
		"location": [
			"Regensburg"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1007/s00063-021-00890-5"
		],
		"title": "Low incidence of SARS-CoV-2 infections in healthcare workers at a tertiary care hospital",
		"scope_regionality": "Local/Regional",
		"region": "Bavaria",
		"location_raw": "Regensburg",
		"organisation_raw": "University Hospital Regensburg",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Employees with contact to  COVID-19 patients and treating COVID-19 patients",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 205,
		"sample_size_rounded": 200,
		"start_date": "2020-03-15",
		"end_date": "2021-02-15",
		"record_modified": "2022-02-01"
	},
	{
		"organisation": [
			"University Medicine Greifswald, Department of Oral and Maxillofacial Surgery/Plastic Surgery",
			"University Medicine Greifswald",
			"Universitätsmedizin Greifswald"
		],
		"location": [
			"Berlin",
			"Hamburg",
			"Dresden",
			"Stuttgart",
			"Cologne",
			"Düsseldorf"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1007/s00784-021-04363-z"
		],
		"title": "Prevalence of SARS-CoV-2 IgG antibodies among dental teams in Germany",
		"scope_regionality": "Local/Regional",
		"region": "Multilocal",
		"location_raw": "Berlin, Hamburg, Dresden, Stuttgart, Cologne/Düsseldorf",
		"organisation_raw": "Department of Oral and Maxillofacial Surgery/Plastic Surgery, University Medicine Greifswald",
		"type": "Cross sectional",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Employees and Employers of Dentistries in Berlin, Hamburg, Dresden, Stuttgart, and Cologne/Düsseldorf",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Medical practices with participants",
		"sample_size_obtained": 2784,
		"sample_size_rounded": 2800,
		"start_date": "2021-01-15",
		"end_date": "2021-04-15",
		"record_created": "2022-01-27",
		"record_modified": "2022-02-01"
	},
	{
		"organisation": [
			"Leibniz University Hannover"
		],
		"location": [
			"Hannover",
			"Göttingen"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1128/spectrum.01512-21"
		],
		"title": "Combined Prospective Seroconversion and PCR Data of Selected Cohorts Indicate a High Rate of Subclinical SARS-CoV-2 Infections",
		"scope_regionality": "Local/Regional",
		"region": "Lower Saxony",
		"location_raw": "Hannover, Göttingen",
		"organisation_raw": "Institute for Technical Chemistry, Leibniz University Hannover",
		"type": "Repeated cross-sectional",
		"subject_frame": "Other groups",
		"subject_information": "Employees out of universities, schools, city administration of Hannover, theater, employees from a\r\nbiotechnological company in Goettingen, and residents and employees of two nursing homes in Hannover",
		"scope_population": "Selected population groups",
		"scope_age": "Multiple",
		"age_max": 104,
		"age_min": 15,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1883,
		"sample_size_rounded": 1900,
		"start_date": "2020-04-15",
		"end_date": "2020-11-15",
		"record_created": "2022-03-15"
	},
	{
		"organisation": [
			"St. Antonius Hospital Eschweiler"
		],
		"location": [
			"Eschweiler"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://doi.org/10.1183/13993003.congress-2021.PA3187",
			"https://doi.org/10.3390/ijerph19042429"
		],
		"title": "Cumulative Incidence of SARS-CoV-2 in Healthcare Workers at a General Hospital in Germany during the Pandemic—A Longitudinal Analysis",
		"scope_regionality": "Local/Regional",
		"region": "North Rhine-Westphalia",
		"location_raw": "Eschweiler",
		"organisation_raw": "Clinik for Acute and Emergency Medicine, St. Antonius Hospital Eschweiler",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Healthcare workers and caregivers",
		"subject_information": "Medical staff of the St. Antonius hospital in Eschweiler",
		"scope_population": "Selected population groups",
		"scope_age": "Adults",
		"age_max": 75,
		"age_min": 18,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 1212,
		"sample_size_rounded": 1200,
		"start_date": "2020-04-15",
		"end_date": "2021-04-15",
		"record_modified": "2022-05-10"
	},
	{
		"organisation": [
			"Universitätsklinikum Heidelberg",
			"Universitätsklinikum Freiburg",
			"Universitätsklinikum Ulm",
			"Universitätsklinikum Tübingen",
			"Zentrum für Infektionskrankheiten und Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Heidelberg",
			"Centrum für Chronische Immundefizienz im Zentrum für Translationale Zellforschung, Universitätsklinikum Freiburg",
			"Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Ulm",
			"Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Tübingen"
		],
		"location": [
			"Heidelberg",
			"Ulm",
			"Freiburg",
			"Tübingen"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN",
			"ROCHE",
			"In-house"
		],
		"resource_url": [],
		"title": "Prevalence of COVID-19 in children in Baden-Württemberg - Sample A",
		"scope_regionality": "Local/Regional",
		"region": "Baden-Wuerttemberg",
		"location_raw": "Heidelberg, Ulm, Freiburg, Tübingen",
		"organisation_raw": "Zentrum für Infektionskrankheiten und Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Heidelberg; Centrum für Chronische Immundefizienz im Zentrum für Translationale Zellforschung, Universitätsklinikum Freiburg; Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Ulm; Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Tübingen",
		"type": "Cross sectional",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Children aged 1-10 years",
		"scope_population": "General population",
		"scope_age": "Children/adolescents ≤18 years",
		"age_max": 10,
		"age_min": 1,
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2482,
		"sample_size_rounded": 2482,
		"start_date": "2020-04-22",
		"end_date": "2020-05-15",
		"results_seroprevalence_information": "Seroprevalence of children 1-10 years of age",
		"results_publication_url": "https://doi.org/10.1001/jamapediatrics.2021.0001",
		"results_publication_date": "2021-01-22",
		"results_publication_type": "Peer-reviewed Publikation",
		"analysis_data_source": "whole blood",
		"analysis_target": "multiple",
		"analysis_isotype": "IgG",
		"analysis_test": "Mehrere/andere",
		"analysis_test_manufacturer_raw": "EUROIMMUN, ROCHE, In-house",
		"subject_vaccination": "Seroprevalence unvaccinated participants/  in participants before 2021",
		"results_seroprevalence_adjustment": "Adjusted for test-specificity/test-sensitivity",
		"results_seroprevalence_positive": 0.006,
		"results_seroprevalence_positive_95pct_lower": 0.003,
		"results_seroprevalence_positive_95pct_upper": 0.01,
		"record_created": "2021-08-20",
		"record_modified": "2021-10-17"
	},
	{
		"organisation": [
			"Universitätsklinikum Heidelberg",
			"Universitätsklinikum Freiburg",
			"Universitätsklinikum Ulm",
			"Universitätsklinikum Tübingen",
			"Zentrum für Infektionskrankheiten und Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Heidelberg",
			"Centrum für Chronische Immundefizienz im Zentrum für Translationale Zellforschung, Universitätsklinikum Freiburg",
			"Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Ulm",
			"Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Tübingen"
		],
		"location": [
			"Heidelberg",
			"Ulm",
			"Freiburg",
			"Tübingen"
		],
		"analysis_test_manufacturer": [],
		"resource_url": [
			"https://www.klinikum.uni-heidelberg.de/fileadmin/pressestelle/Kinderstudie/Prevalence_of_COVID-19_in_BaWu__.pdf",
			"https://doi.org/10.1001/jamapediatrics.2021.0001"
		],
		"title": "Prevalence of COVID-19 in children in Baden-Württemberg",
		"scope_regionality": "Local/Regional",
		"region": "Baden-Wuerttemberg",
		"location_raw": "Heidelberg, Ulm, Freiburg, Tübingen",
		"organisation_raw": "Zentrum für Infektionskrankheiten und Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Heidelberg; Centrum für Chronische Immundefizienz im Zentrum für Translationale Zellforschung, Universitätsklinikum Freiburg; Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Ulm; Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Tübingen",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021521",
		"type": "Cross sectional",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Children aged 1 to 10 years and one related parent",
		"scope_population": "General population",
		"scope_age": "Multiple",
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Participants",
		"sample_size_obtained": 2000,
		"sample_size_rounded": 2000,
		"start_date": "2020-04-22",
		"end_date": "2020-05-15",
		"record_modified": "2021-09-27"
	},
	{
		"organisation": [
			"Universitätsklinikum Heidelberg",
			"Universitätsklinikum Freiburg",
			"Universitätsklinikum Ulm",
			"Universitätsklinikum Tübingen",
			"Zentrum für Infektionskrankheiten und Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Heidelberg",
			"Centrum für Chronische Immundefizienz im Zentrum für Translationale Zellforschung, Universitätsklinikum Freiburg",
			"Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Ulm",
			"Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Tübingen"
		],
		"location": [
			"Heidelberg",
			"Ulm",
			"Freiburg",
			"Tübingen"
		],
		"analysis_test_manufacturer": [
			"EUROIMMUN",
			"Roche Elecsys",
			"Mikrogen",
			"In-house"
		],
		"resource_url": [
			"https://doi.org/10.1101/2021.07.20.21260863"
		],
		"title": "Prevalence of COVID-19 in children in Baden-Württemberg",
		"scope_regionality": "Local/Regional",
		"region": "Baden-Wuerttemberg",
		"location_raw": "Heidelberg, Ulm, Freiburg, Tübingen",
		"organisation_raw": "Zentrum für Infektionskrankheiten und Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Heidelberg; Centrum für Chronische Immundefizienz im Zentrum für Translationale Zellforschung, Universitätsklinikum Freiburg; Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Ulm; Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Tübingen",
		"registry_url": "https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00021521",
		"type": "Longitudinal/Prospectice cohort study",
		"subject_frame": "Household and Community Samples",
		"subject_information": "Households with at least one adult and one child <18 years of age in which at least one member was confirmed to be infected by SRAS-CoV-2",
		"scope_population": "Selected population groups",
		"scope_age": "Multiple",
		"sample_design": "Convenience sample",
		"sample_analysis_unit": "Households with participants",
		"sample_size_obtained": 328,
		"sample_size_rounded": 300,
		"start_date": "2020-05-15",
		"end_date": "2020-05-15",
		"analysis_test_manufacturer_raw": "Euroimmun; Roche Elecsys' Mikrogen in-house"
	}
]